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Abstract 
 
Proteinase-activated receptor 2 (PAR-2) belongs to a novel family of G-protein 
coupled receptors that are unique in their activation mechanism by which a 
proteolytic cleavage at N-terminus by a proteinase reveals a ‘tethered ligand’ to 
activate the receptor. Albeit at a low level, PAR-2 is extensively expressed in 
normal and pathological brains, including the hippocampus. Qualitative studies 
into the expression of PAR-2 in several disease conditions, including ischaemia, 
HIV-associated dementia, Parkinson’s disease, Alzheimer’s disease, as well as 
multiple sclerosis, have suggested that PAR-2 plays either degenerative or 
protective role depending on in which cell type an increase in PAR-2 expression 
is observed. However, its potential roles in modulating neuronal excitability, 
synaptic transmission as well as network activities remain to be determined. 
 
Utilising the whole-cell patch clamp recording technique, I demonstrate, for the 
first time, that the activation of PAR-2 leads to a depolarisation of cultured 
hippocampal neurones following application of SLIGRL (100M), a selective PAR-
2 activating peptide (5.52 ± 1.48mV, n=16, P<0.05) and paradoxically a reduction 
of spontaneous action potential (AP) frequency (29.63 ± 5.03% of control, n=13, 
P<0.05). Pharmacological manipulation reveals that the PAR-2-mediated 
depolarisation is most likely dependent on astrocytic glutamate release, which 
takes effect on ionotropic glutamate receptors. In addition, an overt depression 
of synaptic transmission among the cultured neurones upon PAR-2 activation is 
more likely to cause the reduction of spontaneous APs.  
 
In further experiments, I show, for the first time, that the activation of PAR-2 
induces a long term depression (LTD) of glutamatergic synaptic transmission at 
the Schaffer collateral-to-CA1 synapse in acute hippocampal slices following 
SLIGRL (100M) application (80.75 ± 2.54% of control at 30 minute, n=12, P<0.05). 
Additionally, this novel form of LTD is independent of metabotropic glutamate 
receptors but mediated by NR2B subunit-containing N-methyl-D-aspartic acid 
(NMDA) receptors. It is also suggested from these experiments that glial-
neuronal signalling is contributing to this novel form of LTD. 
 
In the final set of experiments, by monitoring field potentials in the stratum 
pyramidale of the CA3 area in acute hippocampal slices, I demonstrate that PAR-
3 
2 activation depresses the frequency of epileptiform activities induced by the 
application of 4-AP/0 Mg2+, an in vitro model of epilepsy (1.53 ± 0.21Hz to 1.18 ± 
0.17Hz, n=13, P<0.05, 100M SLIGRL). In contrast, PAR-2 activation has no effect 
on the frequency of epileptiform activities induced by bicuculline (0.14 ± 0.03Hz 
to 0.13 ± 0.03Hz, n=6, P>0.05, 100M SLIGRL).  
 
In summary, in this thesis, I demonstrate that PAR-2 modulates neuronal 
excitability and depresses excitatory synaptic transmission in the hippocampus. 
These data indicate that PAR-2 may play a regulatory role in neuronal signalling 
at single cell level by controlling neuronal intrinsic properties, as well as at 
synaptic level by tuning excitatory synaptic strength, which ultimately affects 
global excitability in the neural circuits as a whole. Therefore, this investigation 
suggests a novel physiological/pathophysiological role for PAR-2 in the brain. 
These data may reveal valuable clues for the development of drugs targeting a 
novel and potentially promising candidate. 
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1 Introduction 
1.1 General Introduction 
It is widely estimated that 550 genes in the human genome encode proteolytic 
enzymes, termed proteinases or proteases (Southan, 2001; Puente et al., 2003). 
Therefore, it is not surprising that proteinases take part in a variety of biological 
processes from digesting dietary proteins and peptides in the gastrointestinal 
tract to destroying antigen and aging cells in macrophages. Interestingly, 
proteolytic events occur on the cell membrane as well, initiating signal 
transduction through proteinase activated receptors (PARs).  
PARs belong to a novel G-protein coupled receptor family which is unique in its 
activation mechanism. A proteolytic cleavage in the N-terminus unveils a 
sequence to act as “tethered ligand”. This “tethered ligand” then binds to the 
second extracellular loop of the receptor, leading to the receptor activation 
(Macfarlane et al., 2001; Ossovskaya & Bunnett, 2004; Bushell, 2007; Luo et al., 
2007; Hansen et al., 2008; Ramachandran & Hollenberg, 2008). Whilst PARs are 
widely expressed in the mammalian body with extensive studies so far focusing 
on the cardiovascular, gastrointestinal, and immune systems, PARs are also 
expressed in the central nervous system (CNS) (Noorbakhsh et al., 2003; Bushell 
et al., 2006; Luo et al., 2007), yet PARs involvement in the brain function under 
either physiological or pathophysiological conditions is poorly characterised. 
This thesis therefore makes an initial attempt to elucidate if the activation of 
PARs modulates fundamental properties in the neuronal function such as 
neuroexcitability, synaptic transmission and synaptic plasticity in the 
hippocampus, a well organized brain structure with readily experimental access.  
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1.2 G-protein coupled receptors 
As presented in figure 1.1, G-protein coupled receptors (GPCRs), also described 
as seven-transmembrane (7TM) receptors, represent the largest receptor 
superfamily to transfer extracellular stimuli into intracellular cascades of 
biochemical reactions through the signal transduction system of a cell in the 
animal kingdom (Findlay et al., 1993; Baldwin, 1994; Pierce et al., 2002). It is 
estimated that there are more than 1000 GPCRs encoded by the human genome 
(Premont & Gainetdinov, 2007). Ligands for these receptors are relatively 
diverse including biogenic amines, amino acids, ions, lipids, peptides to proteins, 
light, odorants, pheromones, nucleotides, opiates, cannabinoids, endorphins 
(Premont & Gainetdinov, 2007). Despite this diversity of ligands, the 
characteristic activation mechanism for GPCRs is relatively uniform (Strader et 
al., 1994; McCudden et al., 2005). The binding of an appropriate ligand to the 
second extracellular loop, in some cases, to the N-terminus or transmembrane 
domains,  of a GPCR initiates conformational changes in the intracellular domain 
of the GPCR (Wess et al., 2008), resulting in the substitution of GDP by GTP from 
the α-subunit of the inactive heterotrimeric (αβγ) guanine nucleotide-binding 
protein (G protein), which in turn dissociate the G protein to Gα-GTP and βγ 
dimer. This ‘activated’ G protein, through the dissociated Gα-GTP and βγ dimer, 
interacts with downstream effectors in the cytoplasm.  
It is widely acknowledged that GPCRs coupled to at least 16 heterotrimeric G 
protein subtypes (Premont & Gainetdinov, 2007; Tuteja, 2009), leading to 
diverse second messenger cascades in the cytoplasm. They are functionally 
grouped into four major classes as Gs, Gi, Gq/11 and G12/13. Gs primarily activates 
adenylate cyclase, which in turn, increases the cytoplasmic concentration of 
cAMP, which in turn upregulates the activity of cAMP-dependent kinase or 
protein kinase A (PKA)(Gilman, 1995). In contrast, Gi mainly inhibits adenylate 
cyclase activity, which therefore reduces the production of cytoplasmic cAMP 
from ATP, which in turn downregulates the activity of PKA (Gilman, 1995). Gq/11 
subunit stimulates phospholipase C (PLC), and PLC cleaves a membrane 
phospholipid, the phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl 
glycerol (DAG) and inositol 1,4,5-triphosphate (IP3). Then, IP3 primarily binds to 
IP3 receptors, which are Ca2+ channels in the endoplasmic reticulum (ER), leading 
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to Ca2+ release from the ER to increase cytoplasmic Ca2+ concentration (Majerus, 
1992). Furthermore, Ca2+ and DAG together activate protein kinase C (PKC), 
which phosphorylates other downstream molecules (Tanaka & Nishizuka, 1994). 
Finally, G12/13 regulates cellular responses through guanine nucleotide exchange 
factors (GEFs) (Dhanasekaran & Dermott, 1996), which are activators of small 
GTPases, notably the Ras GTPases superfamily, such as Ras, Rho, and Ran, which 
regulate cell growth, differentiation, and vesicle transport (Wennerberg et al., 
2005). For a single GPCR, it may interact primarily with only one class of G 
proteins, whereas it can interplay with all four G protein subtypes, which leads 
to a broad spectrum of cellular responses (see figure 1.1). It should also be 
noticed that GPCRs could activate signalling pathways independent of (or 
parallel to) all G proteins (Premont & Gainetdinov, 2007). Notably, the β-
arrestin pathway, where GPCR-β-arrestin directly recruits several signalling 
proteins, such as Src family tyrosine kinases and components of mitogen-
activated protein kinases (MAPKs), has been well documented (Luttrell & 
Lefkowitz, 2002; Lefkowitz & Shenoy, 2005; Shenoy & Lefkowitz, 2005). 
A striking feature of all GPCRs is that their responsiveness to a given agonist is 
plastic (Freedman & Lefkowitz, 1996; Premont & Gainetdinov, 2007). When 
exposed to prolonged or repeated agonist stimulation, GPCRs desensitise, 
whereas it resensitises when not exposed to agonist for some time (Huganir & 
Greengard, 1990). It has been demonstrated that the G protein-coupled receptor 
kinase (GRK)-arrestin system is primarily responsible for this feature (Hausdorff 
et al., 1990; Gainetdinov et al., 2004). That is the GRK recognises the activated 
GPCR and phosphorylates the C-terminus of the GPCR. Once phosphorylated, the 
GPCR is recognised by arrestin, and the binding of GPCR with arrestin prevents 
the GPCR to activate more G proteins and therefore terminates its signalling 
(Premont & Gainetdinov, 2007). The arrestin binding also facilitates GPCR 
internalisation and trafficking. In addition, GPCRs have been documented to 
behave functionally as hetero-/homo- dimers or oligomers to transduce 
extracellular signals into cytoplasm, which attracts intensive investigations into 
its mechanism and functional consequences in recent years (Bai, 2004; Prinster 
et al., 2005; Wess et al., 2008).  
In summary, GPCRs are widely found on the cell membrane with common seven 
transmembrane domains structure. Characteristic activation mechanisms and 
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signalling pathways of GPCRs have been described. GPCRs are major mediators 
of transmembrane information flow. They are key controllers of a variety of 
physiological processes such as neurotransmitter release, secretion, cellular 
metabolism, growth, and differentiation. Therefore, bearing these features, 
GPCRs are celebrated targets for the majority of medicine development. 
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Figure 1-1 Summary of ligands, structure, activation mechanism, and signalling pathways of 
GPCR.  
Adapted and modified from Marinissen et al.,2001 (Marinissen & Gutkind, 2001). 
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1.3 Proteinase activated receptors 
PARs also described as protease activated receptors, are a recently 
characterised, novel family of GPCRs. Rather than being activated by the free 
ligand occupying the ligand-biding site, it is mobilised through a proteolytic 
cleavage in the N-terminus of the receptor by a serine proteinase, exposing a 
newly formed N-terminus to act as a “tethered ligand” that interacts with the 
receptor in the second extracellular loop. To date, four PARs have been 
discovered, with distinct cleavage sites as well as “tethered ligand”, which give 
rise to differential molecular and cellular responses (Macfarlane et al., 2001; 
Ossovskaya & Bunnett, 2004; Bushell, 2007; Luo et al., 2007; Hansen et al., 2008; 
Ramachandran & Hollenberg, 2008) 
1.3.1 Cloning of PARs 
The discovery of the first PAR was largely based on extensive research into the 
regulation of blood clot formation and platelet aggregation in the cardiovascular 
system by a serine proteinase, thrombin. Thrombin was the product of 
prothrombin by factor Xa and was regarded as a key player in the coagulation 
cascade linking tissue damage to wound healing (Davie et al., 1991). In addition, 
several studies demonstrated that thrombin alone had a direct effect on 
different cell types other than blood cells, including endothelial cells, 
monocytes, lymphocytes and smooth muscle cells (Chen et al., 1976; Bizios et 
al., 1986; Daniel et al., 1986; Shuman, 1986; Hattori et al., 1989). Meanwhile, 
parallel studies suggested that the protelytic property of thrombin was required 
as proteinase inhibitors abolished thrombin’s action (Shuman, 1986). Based on 
these experimental data, the existence of a thrombin receptor on the cell 
membrane was proposed, however initial screens failed to identify any such 
receptor (Okumura et al., 1978; Gronke et al., 1987). 
1.3.1.1 Cloning of PAR-1 
In 1991, two laboratories cloned the hamster and the human thrombin receptor 
respectively (Rasmussen et al., 1991; Vu et al., 1991a), later termed as 
proteinase activated receptor 1 (PAR-1), by expressing mRNA from thrombin-
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responsive cells in oocytes of Xenopus. The putative protein contained 425 or 
427 amino acids for human or hamster respectively. Hydropathy analysis 
revealed the receptor to be a member of the seven transmembrane domain 
receptor family. A remarkable feature of the receptor was its relatively long (75 
amino acid) extracellular N-terminus, which includes a thrombin cleavage site. 
Furthermore, the PAR-1 response to thrombin was abolished by hirudin, a 
specific thrombin antagonist, confirming the selective nature of the receptor to 
thrombin (Vu et al., 1991a). In the following years, PAR-1 was also cloned in rat 
(Zhong et al., 1992) and mouse (Soifer et al., 1994). 
1.3.1.2 Cloning of PAR-2 
As not all the actions of thrombin could solely be attributed to PAR-1 receptor 
activation (Vouret-Craviari et al., 1992), it was widely believed that a second 
thrombin receptor must exist. By screening the mouse genome library using a 
mixture of two 60-oligomers corresponding to the second and sixth 
transmembrane domains of the bovine substance K receptor (Masu et al., 1987), 
Nystedt and co-authors cloned a DNA sequence encoding a protein of 395 
residues with seven transmembrane domain structure (Nystedt et al., 1994; 
Nystedt et al., 1995b). A putative proteinase cleavage site was deduced in its 
long N-terminus. This receptor shared 30% amino acids with human PAR-1 
receptor, and was 28% identical with mouse PAR-1 receptor. Surprisingly, rather 
than been stimulated by thrombin, the receptor was highly sensitive to another 
proteinase, trypsin. Similar to PAR-1, cleavage of a trypsin cleavage site in the N 
terminus was shown to be required for the receptor activation (Nystedt et al., 
1994). This receptor was accordingly termed as proteinase activated receptor 2 
(PAR-2). Subsequently, the human PAR-2 receptor was cloned in the following 
year (Nystedt et al., 1995a). 
1.3.1.3 Cloning of PAR-3 
The cloning of PAR-2 opened doors for hunting for more members of the PARs 
family. Indeed, platelets in the PAR-1 deficient mice still responded strongly to 
thrombin (Connolly et al., 1996). PAR-3 was subsequently cloned by polymerase 
chain reaction (PCR) using degenerate primers corresponding to conserved 
domains in PAR-1 and PAR-2 to screen platelet RNA from rat. Then, this rat 
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sequence was used to obtain mouse and human cDNA clones (Ishihara et al., 
1997). The human PAR-3 shares 27% sequence homology with human PAR-1, and 
28% with human PAR-2.  
1.3.1.4 Cloning of PAR-4 
Coughlin’s group found the thrombin responses in platelet from PAR-3 deficient 
mice was largely delayed, but not absent (Kahn et al., 1998). As PAR-1 played no 
roles in mouse platelet aggregation (Connolly et al., 1994; Connolly et al., 1996), 
it indicated another receptor was activated in response to thrombin. Two 
laboratories using the strategy of GenBank BLAST (Basic Local Alignment Search 
Tool)  based on the conserved Expressed Sequence Tag (ETS) among PARs, 
discovered the PAR-4 in mouse and human respectively (Kahn et al., 1998; Xu et 
al., 1998).  
1.3.2 Structural features of PARs 
Each PAR has a proteinase cleavage site within its long N-terminus, although 
distinctive sequence location and sensitivity to a variety of proteinase differ 
among PARs as illustrated in Figure 1.2. Taking human PARs for instance, 
proteinase cleavage site in PAR-1 is LDPR41↓S42FLLRN (↓  indicates specific 
cleavage position), SKGR34↓S35LIGKV for PAR-2, LPIK38↓T39FRGAP for PAR-3, and 
PAPR47↓G48YPGQV for PAR-4. The cleavage sites in PAR-1, PAR-3 and PAR-4 are 
preferentially sensitive to thrombin, whereas, PAR-2 is preferentially to trypsin. 
In addition, PAR-1 and PAR-3 have a hirudin-like domain in their N-terminals as 
demonstrated in Figure 1.2. This feature is distinct as this domain is not found in 
either PAR-2 or PAR-4. Experiments indicated the hirudin-like domain facilitated 
receptor-thrombin interaction by reducing kinetic barrier, leading to 
conformational change in the catalytic site of thrombin to perform proteolysis 
(Vu et al., 1991b; Ishii et al., 1993). The lack of a hirudin-like domain in PAR-2 
also explains its irresponsiveness to thrombin. 
Apart from the features in the N-terminus, the second extracellular loop in PARs 
is highly conserved in the four members across species. It has been confirmed 
the second extracellular loop alone has the ability to recognise “proteinase 
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identity” (Lerner et al., 1996). Together with the N-terminus cleavage site, they 
jointly confer the specificity of proteinase binding (Bahou & Demetrick, 1997). 
Finally, the intracellular C-terminus of PARs has been shown to participate in 
PARs desensitisation and trafficking.  
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Figure 1-2 Structural features of PARs.  
A. Schematic structure of PARs during rest (Left) and activation (Right) B. Functional 
important domains on PARs.  Adapted and modified from Ossovskaya VS&Bunnett NW, 
2004 (Ossovskaya & Bunnett, 2004) 
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1.3.3 Mode of activation of PARs 
The default mechanism by which the proteinases cleave and activate PARs 
endogenously is identical. Proteinases interact with PAR, recognise the 
conserved domains in the N-terminal, and cleave at the proteinase cleavage site, 
unveiling a new N-terminal to serve as “tethered ligand”, which binds to the 
second extracellular loop, initiating cellular signalling. In addition to their 
endogenous activation mode, all PARs with the exception of PAR-3, have been 
demonstrated to be activated by synthetic short peptides, which mimic the 
amino acid sequence of the “tethered ligand” (Vu et al., 1991a; Nystedt et al., 
1994). These synthetic peptides with relatively high selectivity offer valuable 
tools to test function of specific PAR member in biological systems usually 
expressing more than one PAR. Furthermore, they provide an accessible 
experimental strategy to bypass the dilemma of destroying the integrity of PARs 
by using proteinases, such as thrombin and trypsin. (see figure 1.3)  More 
importantly, synthetic “scrambled” peptides which are in reverse order of the 
amino acid sequence of activating peptide and not able to activate PARs, have 
been developed to use as “control peptides” in investigating PARs function. 
However, It has been noticed that in certain circumstances, the PAR activating 
peptides can stimulate a receptor other than any one of the four PARs (Vergnolle 
et al., 1998; Hollenberg et al., 2004). These data suggest it is necessary to use 
both PAR activating peptide and its corresponding PAR inactive peptide to study 
a given PAR rigorously (Ramachandran & Hollenberg, 2008).  
Recently, two structurally different, potent, selective, and metabolically stable 
small-molecule PAR-2 agonists, AC-55541 and AC-264613, were discovered and 
characterised in vitro by in cellular proliferation assays, phosphatidylinositol 
hydrolysis assays, and Ca2+ mobilisation assays from cell culture preparations, 
with potencies ranging from 200 to 1000 nM for AC-55541 and 30 to 100 nM for 
AC-263613 (Gardell et al., 2008; Seitzberg et al., 2008). Although these PAR-2 
agonist molecules were only tested in expression systems, they may be useful in 
probing the physiological functions of PAR-2 receptor as alternatives for short 
peptides in brain tissues.   
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As PARs are regularly co-expressed, it has been proposed that the interactions 
among PAR members within proximity would share a single proteinase agonist or 
react as activation facilitators. This appeared to be the case for PAR-3 and PAR-
4 located in mouse platelets (Nakanishi-Matsui et al., 2000). In mouse platelet, 
PAR-3 and PAR-4 are receptors for thrombin with differential affinity. PAR-3 
responds to low concentration of thrombin, whereas PAR-4 activation needs high 
dose (Nakanishi-Matsui et al., 2000). However, when PAR-3 alone was expressed, 
or even overexpressed in COS cells, it did not respond to thrombin at all 
(Nakanishi-Matsui et al., 2000). Interestingly, when co-expressed PAR-3 and PAR-
4, the signalling to thrombin through PAR-4 increased 6 to 15 fold, whereas PAR-
4 response to its activating peptide was not changed (Nakanishi-Matsui et al., 
2000). This suggested a novel way that PAR-3 does not mediate signalling itself 
but plays as a co-factor for the cleavage and activation PAR-4 by thrombin. 
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Figure 1-3 Schematic demonstration of activation mechanisms of PARs.  
Adapted and modified from Bushell,2007 (Bushell, 2007) 
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 PAR-1 PAR-2 PAR-3 PAR-4 
Proteinase cleavage site R41↓S42FLLRN (Human) 
R41↓S42FFLRN (Rat) 
R41↓S42FFLRN (Mouse) 
R34↓S35LIGKV (Human) 
R36↓S37LIGRL (Rat) 
R34↓S35LIGRL (Mouse) 
K38↓T39FRGAP (Human) 
K37↓ S38FNGGP (Mouse) 
R47↓G48YPGQV (Human) 
R58↓ G59FPGKP (Rat) 
R59↓G60 YPGKF (Mouse) 
Proteinase agonists Thrombin 
Plasmin 
Trypsin 
FXa 
FVⅡa 
APC 
Granzyme A 
Gingipians-R 
Trypsin 
Tryptase 
Kallikrein-4, -5, -6,-14 
FXa 
FVⅡa 
MT-SP1 
Proteinase-3 
Acrosien 
Gingipians-R 
Thrombin Thrombin 
Trypsin 
Kallikrein-14 
Cathepsin G 
FXa 
FVⅡa  
Gingipians-R 
 
 
Activating peptide TFLLR-NH2 
SFLLR-NH2 
SLIGRL-NH2 
SLIGKV-NH2 
2-furoyle-LIGRLO-NH2 
None AYPGKF-NH2 
Other agonists  PAR-2 molecule agonists 
AC-55541, AC-264613 
  
Antagonist RWJ-56110 
RWJ-58259 
SCH-205831 
SCH530348 
BMS-200261 
P1pal-12 pepducin 
FSLLRY-NH2 
LSIGRL-NH2 
N1-3-methylbutyryl-N4-6- 
aminohexanoyl-piperazine 
(ENMD-1068) 
None trans-cinnamoyl-YPGKF-NH2 
P4pal-12 pepducin 
PAR knockout mouse YES YES YES YES 
  
Table 1-1 Summary of pharmacology of PARs.
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1.3.4 Cellular signalling of PARs 
1.3.4.1 PAR-1 signalling 
PAR-1 has been confirmed to couple with three groups of G proteins as Gi, Gq/11, 
and G12/13 as discussed in the following. The signalling through Gαi pathway, 
which inhibits adenylyl cyclase and suppresses formation of cAMP, was 
demonstrated in several cell types including HEL cells (Brass et al., 1991), 
osteosarcoma cells (Babich et al., 1990), vascular smooth muscle cells (Kanthou 
et al., 1996), fibroblasts (Hung et al., 1992), platelets (Kim et al., 2002), 
astrocytes (Wang et al., 2002), and endothelial cells (Vanhauwe et al., 2002). 
Another major pathway for PAR-1 signalling is through Gαq/11, which stimulates 
PLC-β. PLC-β generates IP3, which mobilises intracellular Ca2+ and DAG that 
activates PKC. Coupling of PAR-1 to Gαq/11 was evidenced by the blockade of 
PAR-1 mediated Ca2+ signalling by using antibody against Gαq/11 subunit in 
fibroblast cells (Baffy et al., 1994) and through co-immunoprecipitation of Gαq/11 
with PAR-1 (Ogino et al., 1996). Gαq/11 coupling to PAR-1 was found also in 
astrocytes (Wang et al., 2002), and astrocytoma cells (LaMorte et al., 1993). The 
interaction between PAR-1 and Gα12/13 emerged in platelets and astrocytoma 
cells. Gα12/13 interacts with Rho guanine-nucleotide exchange factors (GEFs), 
permitting Rho-mediated control of cell shape and migration by  activating Rho-
kinases (Offermanns et al., 1994; Aragay et al., 1995). The Gβγ subunits released 
from the coupling of PAR-1 to heterogeneous G proteins also initiate signal 
transduction, notably, the activation of phosphatidylinositol (PI) 3-kinase which 
leads to changes in cytoskeletal structure, cell motility, survival, and 
mitogenesis (Wang et al., 2002). 
Apart from classical G protein signalling, PAR-1 activates other multiple 
intracellular kinase cascades in a G protein dependent or independent manner. 
One important substrate of PAR-1 is the MAPKs. The MAPK family has been 
characterised in mammalian cells with several MAPK signalling molecules, 
including extracellular-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), 
and p38 MAP kinase (Widmann et al., 1999). They share a common activation 
mechanism by which a MAP kinase kinase Kinase (MAPKKK) phosphorylates and 
activates MAP kinase kinase (MAPKK), which in turn phosphorylates and activates 
MAP kinase. Then specific MAP kinase targets molecules in the cytoplasm and 
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nucleus, leading to a biological response such as mitogenesis, cytoskeleton 
change, and cell survival. PAR-1 has been confirmed to activate ERKs in 
astrocytes (Wang et al., 2002), intestinal epithelial cells (Buresi et al., 2002), 
and fibroblasts (Vouret-Craviari et al., 1993). PAR-1 also activates p38 MAP 
kinase for example in fibroblasts (Sabri et al., 2002; Wang et al., 2006a), and 
human endothelial cells (Banfi et al., 2009). JNK has also been recently shown to 
involved in PAR-1 signaling in astrocytes (Wang et al., 2006b). PAR-1 signalling to 
the nuclear factor (NF)-κB has also been reported (Rahman et al., 2002; 
Tantivejkul et al., 2005), but the underlying mechanisms are still under debate. 
1.3.4.2 PAR-2 signalling 
Compared to extensive studies into PAR-1-mediated signalling, PAR-2 signalling 
was less investigated. However, it was widely reported that both trypsin and 
PAR-2 activating peptide (PAR-2-AP), elevated intracellular Ca2+ concentration 
subsequent to the release of IP3 alongside with DAG in numerous cell types 
including transfected cell lines, ovary cells, tumor cells, neurons, and astrocytes 
(Nystedt et al., 1995a; Bohm et al., 1996; Ubl et al., 1998; Bushell et al., 2006). 
These data suggested that PAR-2 coupled to Gq/11. The PAR-2 coupling to Gi is 
disputed. One report showed the PAR-2 signalling was not affected when treated 
with pertussis toxin (PTX), a Gi blocker, in enterocytes, suggesting PAR-2 did not 
signal through Gi pathway (DeFea et al., 2000). However, another report 
challenged this suggestion, and demonstrated the Ca2+ signalling in Xenopus 
oocytes in response to trypsin was PTX sensitive (Schultheiss et al., 1997). So far, 
the coupling of PAR-2 with G12/13 has not been reported. 
A novel aspect of PAR-2 signalling is its ability to activate cellular kinase 
cascades in a β-arrestin dependent, G protein independent mechanism. PAR-2 
activators strongly activated ERK1/2 but p38 MAP kinase moderately (Belham et 
al., 1996). Further studies demonstrated that trypsin and PAR-2-AP stimulated 
the formation of a multiprotein complex, containing internalised PAR-2, β-
arrestin, Raf-1, and activated ERK, which was required in ERK1/2 activation 
(DeFea et al., 2000). A recent report showed PAR-2 promoted β-arrestin 
dependent dephosphorylation and activation of the actin filament-severing 
protein (cofilin) independently of Gq/11 signalling (Zoudilova et al., 2007). These 
findings indicate PAR-2 may signal through ‘dual’ mechanisms, and act via both 
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Gq/11 and β-arrestin simultaneously to exert a large variety of cellular functions. 
In keratinocytes (Macfarlane et al., 2005) and smooth muscle cells 
(Bretschneider et al., 1999), the intracellular Ca2+ concentration induced by 
PAR-2 activation was an important determinant of NF-κB activation.  
1.3.4.3 PAR-3 and PAR-4 signalling 
PAR-3 does not appear to signal on its own. However, it indeed plays a role as a 
co-activator for PAR-4 activation. One intriguing aspect of this is the possible 
ability of PAR-3 to form heterodimers with other PARs, PAR-1 for instance, 
jointly exerting regulatory role for signal transduction (McLaughlin et al., 2007). 
PAR-4 activation led to the aggregation of platelets in mouse and human 
platetes (Kahn et al., 1998) and presumably via Gq/11 as PAR-4 resulted in the 
formation of intracellular IP3 when transiently transfected into COS cells (Xu et 
al., 1998). PAR-4 signalling through ERK1/2 was documented in smooth muscle 
cells (Bretschneider et al., 2001). A recent study reported PAR-4 upregulated 
p38 MAP kinase in endothelial cells (Fujiwara et al., 2005). 
1.3.5 Expression and localisation of PARs in the brain under 
disease conditions 
Various pathological processes have been shown to modulate the expression of 
PARs in the brain.  
 
1.3.5.1 Ischaemia 
Different experimental models of ischaemia, both in vitro and in vivo, have 
demonstrated a differential regulation of PARs in the brain. PAR-1 and PAR-3 are 
upregulated in rat hippocampal slices culture in an in vitro ischaemia model, 
oxygen-glucose deprivation (Striggow et al., 2001). In one in vivo study, PAR-2 
expression was strongly upregulated at 8-24 hours after transient middle 
cerebral artery occlusion in neurones in the cortex in mice (Jin et al., 2005). In 
another report, the mRNA expression level of PAR1-4 was analysed in a transient 
focal ischaemia in rat brain, induced by microinjection of endothelin near the 
middle cerebral artery (Rohatgi et al., 2004a). Interestingly, PAR-1 mRNA was 
strongly downregulated, whereas, PAR-2 mRNA was only decreased modestly 
  37 
(Rohatgi et al., 2004a). PAR-3 was upregulated transiently and then 
downregulated, and PAR-4 mRNA levels showed the most striking (2.5-fold) 
increase 12 hr after ischaemia (Rohatgi et al., 2004a). This group further 
demonstrated a de novo expression of PAR-1 and PAR-3 in microglia in the 
penumbra zone of the infarct in rat 12 or 48 hours after endothelin-induced 
middlecerebral artery occlusion (Rohatgi et al., 2004a).  
 
1.3.5.2 Parkinson’s disease 
One Japanese group reported the upregulation of PAR-1 in astrocytes in 
Parkinson’s brain (Ishida et al., 2006). This group examined PAR-1 expression in 
substantia nigra pars compacta (SNpc) of brains from patients with Parkinson’s 
disease. PAR-1 was exclusively found in astrocytes in these samples. 
Interestingly, the numbers of astrocytes expressing PAR-1 increased in the 
specimens of Parkinson’s disease but not in healthy controls (Ishida et al., 2006).  
 
1.3.5.3 HIV infection 
Human immunodeficiency virus (HIV) infection has several implications in the 
brain, in which PARs expression is altered. During HIV encephalitis, the 
expression of PAR-1 is upregulated at both mRNA and protein levels in astrocytes 
in humans in vivo (Boven et al., 2003). Furthermore, PAR-2 is upregulated on 
neurones in conjunction with neuroinflammation in brain tissue from patients 
with HIV infection associated dementia (Noorbakhsh et al., 2005).  
 
1.3.5.4 Alzheimer’s disease 
Two studies demonstrated the altered levels of PARs expression during 
Alzheimer’s disease (Pompili et al., 2004; Afkhami-Goli et al., 2007). Direct 
post-mortem study examining the brain tissue from patients with Alzheimer’s 
disease revealed that PAR-2 expression was downregulated in neurones but 
upregulated in proximal astrocytes in Alzheimer’s specimens compared to 
healthy controls (Afkhami-Goli et al., 2007). Furthermore, one study utilising an 
in vitro model of Alzheimer’s disease by trimethyltin administration 
demonstrated that all PARs particularly PAR-1 expression at both mRNA and 
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protein levels increased significantly in hippocampal astrocytes (Pompili et al., 
2004). 
 
1.3.5.5 Multiple sclerosis and experimental autoimmune encephalomyelitis 
PAR-2 expression is increased on astrocytes and infiltrating macrophages in brain 
white matter from human multiple sclerosis samples (Noorbakhsh et al., 2006). 
Similar observation is reported in experimental autoimmune encephalomyelitis 
(EAE) in mouse (Noorbakhsh et al., 2006).  
 
1.3.5.6 Radiation damage 
Expression of PAR-2 is investigated in a study into the consequences of single 
exposure to nuclear radiation. Significant PAR-2 immunoactivity in cell 
membrane is discovered in deeper cortical layers (Olejar et al., 2002). At the 
same time, diffuse cytoplasmic PAR-2 immunoactivity is demonstrated in cortex 
and hippocampus (Olejar et al., 2002). Increased cytoplasmic and polarised 
membrane positivity is also noticed on the neurones of hypothalamic nuclei 
(Olejar et al., 2002). 
 
In conclusion, a variety of pathological conditions differentially altered the 
expression of PAR1-4 in brain depending on diseases themselves or experimental 
disease models that were used and which cell type was studied. More precisely, 
the cell type specific, concentration/time course dependent dynamic expression 
profiles under pathological conditions indicates either harmful or protective 
roles for PARs in pathophysiology.   
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1.3.6 Dual functions of PARs in the brain under disease 
conditions 
1.3.6.1 PARs in neurodegeneration 
Numerous studies have demonstrated neurodegenerative role of PARs in a 
variety of conditions in the brain. Although most of current knowledge about 
PAR-mediated neurodegeneration is from PAR-1, PAR-2 and PAR-4 have been 
shown to participate in this process as well.  
1.3.6.1.1 Ischaemia 
 
Ischaemia has been shown to regulate PARs expression (Striggow et al., 2001; 
Rohatgi et al., 2004a; Jin et al., 2005), and actually, PARs directly contribute to 
ischaemia-induced cell death. It is widely accepted that thrombin, the PAR-1 
activator, is released into the brain tissue during the damage of the blood-brain 
barrier, which is a characteristic feature of brain ischaemia, such as stroke. 
Thrombin has been shown to be able to kill cultured hippocampal neurones and 
astrocytes mediated by PAR-1 activation (Donovan et al., 1997). It has been 
shown that thrombin activity is increased in the ischaemic areas of the brain (Xi 
et al., 2003). At high concentrations, thrombin deceases neuronal survival, and 
even causes neuronal cell death in a concentration dependent manner (50-500nM) 
in hippocampal slice culture following oxygen and glucose deprivation, an in 
vitro model of ischaemia (Striggow et al., 2000). It is further demonstrated that 
blocking thrombin activity by selective inhibitor, hirudin, attenuated ischaemic 
damage before in vitro ischaemia was induced (Striggow et al., 2000; 
Karabiyikoglu et al., 2004). In vivo studies further reported that PAR-1 
contributed to the infarct volume in the brain after transient focal cerebral 
ischaemia, which was significantly reduced in PAR-1 knockout mice (Junge et al., 
2003). Similar neuronal damage caused by PAR-1 activation was reported, and 
also prevented in PAR-1 knockout mice after unilateral cerebral 
hypoxia/ischaemia (Olson et al., 2004).  
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1.3.6.1.2 Alzheimer’s disease 
 
A high level of thrombin has been detected in brain tissues from Alzheimer’s 
disease patients, especially in senile plaques, some diffuse amyloid deposits and 
neurofibrillary tangles (Akiyama et al., 1992). The presence of thrombin in the 
Alzheimer’s brain was also documented by other groups (Arai et al., 2006; 
Grammas et al., 2006). It was further demonstrated that thrombin in 
Alzheimer’s brain induced rapid tau hyperphosphorylation and aggregation in 
hippocampal neurones via PAR-1 and PAR-4, resulting in delayed synaptophysin 
reduction and apoptotic neuronal death (Suo et al., 2003). A recent report 
showed PAR-4 is involved in regulation of beta-secretase cleavage of the 
Alzheimer amyloid precursor protein (Xie & Guo, 2005). All these studies suggest 
the activation of PAR-1 and PAR-4 contribute to the pathogenesis of Alzheimer’s 
disease.  
 
1.3.6.1.3 Parkinson’s disease 
 
PAR-1 expression is up-regulated in astrocytes in substantia nigra pars compacta 
of Parkinson disease brains (Ishida et al., 2006). It was further demonstrated 
that PAR-1 contributes to the pathogenesis of Parkinson’s disease. Using a mouse 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's 
disease, Hamill and colleagues found after MPTP injection, PAR-1 knockout mice 
showed significantly higher residual levels of dopamine, the dopamine 
transporter, tyrosine hydroxylase and diminished microgliosis compared with 
wild-type controls (Hamill et al., 2007). Furthermore, PAR-1 antagonist BMS-
200261 exerted comparable levels of dopaminergic neuroprotection from MPTP-
induced toxicity (Hamill et al., 2007). These data indicate that PAR-1 activation 
can contribute to dopaminergic terminal damage in this model of early 
Parkinson's disease.  
 
1.3.6.2 Mechanisms underlying PAR-mediated neurodegeneration 
Glutamate receptors, in particular NMDA receptors and Ca2+-permeable AMPA 
receptors play a crucial role in maintaining homeostasis in brain morphology and 
activity. It is widely accepted that excessive activation of glutamate receptors is 
toxic to neurones via an excessive influx of Ca2+. This mechanism has been 
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confirmed to associate with several neurodegenerative diseases, such as 
ischaemic insults, Alzheimer’s disease, and HIV-associated dementia 
(Hardingham & Bading, 2003; Liu & Zukin, 2007). Interestingly, activation of 
PAR-1 in astrocytes induced the release of glutamate (Lee et al., 2007; 
Shigetomi et al., 2008). The elevated extracellular glutamate in turn activates 
NMDA receptors on the neighboring neurones (Lee et al., 2007). Furthermore, it 
has been demonstrated that activation of PAR-1 on neurones potentiates NMDA 
receptor function (Gingrich et al., 2000). These data suggest PAR-1 activation 
may further strengthen the NMDA receptor mediated neuronal toxicity in 
neurodegeneration during pathological conditions such as ischaemia and stroke.  
 
Another possible mechanism underlying PAR mediated neurodegeneration may 
involve neuroinflammation. Up-regulation of inflammatory cytokines, such as 
TNF-α, TNF-β, IL-1β, and IL-6, was observed in ischaemia, Alzheimer’s disease, 
Parkinson’s disease and multiple sclerosis (Campbell, 2004; Lucas et al., 2006).  
Interestingly, the up-regulation of cytokines is observed in a variety of 
neurodegenerative conditions involving neuroinflammation, such as HIV-
associated encephalitis, EAE and multiple sclerosis, has been reported 
accompanied simultaneously with PAR’s activation (Boven et al., 2003; 
Noorbakhsh et al., 2005; Noorbakhsh et al., 2006). In one study, PAR-1 
activating peptide significantly increased levels of IL-1β in human astrocytes, 
and supernatants of these cells were neurotoxic (Boven et al., 2003). Moreover, 
striatal implantation of the PAR-1-AP significantly induced brain inflammation 
and neurobehavioral deficits in mice (Boven et al., 2003). In the other study, 
macrophages from PAR-2 knockout mice showed higher expression of IL-10, and 
released soluble oligodendrocyte cytotoxins after experimental autoimmune 
encephalomyelitis (Noorbakhsh et al., 2006). Moreover, PAR-2 wildtype animals 
showed markedly greater microglial activation and T lymphocyte infiltration 
accompanied by worsened demyelination and axonal injury compared to controls 
(Noorbakhsh et al., 2006). Taken together, these data demonstrate PAR-
mediated neuroinflammation is an important contributor to neuronal death in 
neruodegeneration in the brain.  
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1.3.6.3 PARs in neuroprotection 
The neurodegenerative effect of PARs activation is well documented and 
summarized above. However, it is also noticed that under certain conditions, 
PAR activation turns out to be neuroprotective.  
 
Thrombin or PAR-1-AP at very low and moderate concentrations is suggested to 
be neuroprotective in the brain. Low concentration of thrombin at 50pM, or of 
PAR-1-AP at 10µM, induced significant neuroprotection against experimental 
ischaemia (Striggow et al., 2000). Another study reported that pretreatment 
with a low dose of thrombin as preconditioning, attenuated brain edema induced 
by a subsequent intracerebral injection of a high dose of thrombin (Xi et al., 
1999). It was further demonstrated that the thrombin preconditioning would 
offer protection from ischaemic brain damage in vivo (Masada et al., 2000). In 
addition, in vitro, low concentrations of thrombin protect neurones and 
astrocytes from cell death induced by hypoglycemia and oxidative stress 
(Vaughan et al., 1995). Furthermore, an anticoagulant and cytoprotector blood 
serine, proteinase-activated protein C protected cultured hippocampal and 
cortical neurons against glutamate-induced excitotoxicity at low concentrations 
(0.01-10nM) via PAR-1 activation (Gorbacheva et al., 2008).  
 
Neuroprotective role of PARs has been demonstrated in several disease models 
as well. Thrombin preconditioning reduced dopaminergic terminal loss and 
ventricular enlargement as compared to saline-treated animals in 6-
hydroxydopamine Parkinson's disease model (Cannon et al., 2005). These authors 
further demonstrated the protective effect of thrombin preconditioning in this 
Parkinson’s disease model was mediated PAR-1(Cannon et al., 2006). In another 
study, neuronal PAR-2 activation protected human neurones against the toxic 
effects of fibrillar 42-aa form of beta-amyloid, a key component of 
neuropathogenesis in Alzheimer’s disease (Afkhami-Goli et al., 2007).  During 
HIV infection induced dementia, PAR-2 activation has been confirmed to prevent 
neuronal cell death and induction of the tumor suppressor, p53, caused by the 
HIV-encoded protein, Tat, in brain tissue from human patients (Noorbakhsh et 
al., 2005). In addition, PAR-2-AP also inhibited Tat-induced neurotoxicity in a 
mouse model of HIV neuropathogenesis (Noorbakhsh et al., 2005). PAR-2 
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knockout mice displayed significantly increased infarct volume and the number 
of apoptosis cells at 24 hours of reperfusion in a model of acute focal ischemic 
brain injury (Jin et al., 2005). Reiser’s group has shown that activation of either 
PAR-1 or PAR-2 prevents ceramide-induced apoptosis in cultured rat 
hippocamapl astrocytes, providing a novel mechanism of PAR-dependant 
protection (Wang et al., 2006a; Wang et al., 2007). PAR-1 or PAR-2 activation 
induced release of a chemokine, growth-regulated oncogene/cytokine-induced 
neutrophil chemoattractant-1 (GRO/CINC-1) in primary rat astrocytes via c-Jun 
N-terminal kinase (JNK) activation (Wang et al., 2006a; Wang et al., 2007). 
Interestingly, GRO/CINC-1 inhibited cytochrome c release from mitochondria 
through chemokine receptor CXCR2 in a feedback manner to protect astryocytes 
from apoptosis (Wang et al., 2006a; Wang et al., 2007). One recent publication 
from our group further demonstrated that PAR-2 activation protects neurones in 
organotypic hippocampal slice cultures (OHSC) against kainate acid-induced 
neuronal death via activation of chemokine receptor CXCR2 and mGluRs in 
response to astrocytic release of gliotransmitter (Greenwood & Bushell, 2010). In 
addition, it is demonstrated that PAR-2-mediated neuroprotection in OHSC 
involves MAPK signalling pathways because PAR-2 activation significantly reduces 
both p38 MAPK and ERK activities in OHSC and co-application of antagonists for 
p38 MAPK and ERK can mimic PAR-2-mediated neuroprotection in OHSC 
(Greenwood & Bushell, 2010).   
 
In summary, duality of function of PARs has been widely documented. However, 
the determining factors of this duality still remain to be elucidated. Initial 
suggestion, though not definite, is the final actions of PAR-1 in neurones, either 
degenerative or protective, depend on the magnitude and duration of activator 
exposure, such as thrombin, and PAR-1-AP. Low concentration or brief exposure 
leads to neuroprotection, whereas medium or high concentration results in 
degeneration. Similarly, the ultimate consequence of PAR-2 activation seems 
depending on the cell type in which the activation occurs. PAR-2 activation in 
astrycytes is neurodegenerative, and in contrast, its activation in neurones is 
protective (Bushell, 2007; Greenwood & Bushell, 2010).  
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1.3.7 Limitations in PAR research 
As PARs activate a variety of second messenger cascades in different tissues and 
cell types, it is not surprising that the signal transduction mediated by PARs, 
ultimately gives rise to a wide range of physiological and pathophysiological 
responses. However, quantitative and specific analysis of individual PAR 
involvement in various processes was compromised by the following limitations: 
 
Firstly, the system where PAR takes its function is complex. PARs’ signalling 
needs a focal coherent interaction involving multiple proteinases, proteinase 
inhibitors, cofactors in a timing dependent manner. In many situations, the full 
components of this system remain unclear.  
 
Secondly, selective, potent and readily accessible antagonists for all PARs are 
not available although much progress has been made. Indeed, compounds such 
as RWJ-56110 and RWJ-58259 were developed by the Johnson & Johnson team as 
potential PAR-1 antagonists to, at least, locally block thrombosis in arterial stent 
adducts (Andrade-Gordon et al., 1999; Zhang et al., 2001). Another compound 
SCH-205831 or PAR-1 antagonist 55, which competitively inhibits PAR-1-AP biding 
site on PAR-1, was reported to be antithrombotic in human (Chackalamannil et 
al., 2005). Moreover, BMS-200261, another PAR-1 antagonist, which blocks the 
cleavage of Arg41 of PAR-1 by proteinases (Bernatowicz et al., 1996), fully 
blocked PAR-1-induced Ca2+ signalling in astrocytes (Nicole et al., 2005), and 
reduced dopaminergic terminal damage in a mouse model of Parkinson’s disease 
(Hamill et al., 2007). Very recently a new compound SCH530348 was described 
as a hope for orally available PAR-1 antagonist to target thrombosis (Camerer, 
2007). Developing antagonists for PAR-2 has been much challenging. A few 
peptides, such as FSLLRY-NH2 and LSIGRL-NH2, were made but potency was too 
low (Al-Ani et al., 2002). A recent progress was achieved by reporting a novel 
PAR-2 antagonist molecule N1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine 
(ENMD-1068) attenuated PAR-2-mediated joint inflammation (Kelso et al., 2006). 
Antagonist peptides for PAR-4, trans-cinnamoyl-YPGKF-NH2 was also 
demonstrated by Hollenberg’s group in 2001(Hollenberg & Saifeddine, 2001).  
 
  45 
Novel strategies to antagonize PARs were attempted by 1) targeting the receptor 
intracellular loops with cell-penetrating membrane-tethered peptides termed 
pepducins (Covic et al., 2002a; Covic et al., 2002b; Kuliopulos & Covic, 2003). 2) 
disrupting proteolysis of PAR by antiserum or PAR specific monoclonal antibody 
(Kelso et al., 2006).  
 
These PAR antagonists have greatly facilitated PAR research, but limitations are 
still clear: 1) lack of selectivity 2) low potency 3) non-PAR actions 4) cost  
 
Thirdly, to develop selective serine proteinase inhibitors has been proved 
difficult. Furthermore, even after a selective proteinase inhibitor was 
established, it would still be a challenge to interpretate PAR actions, because in 
most cases, PAR could be activated by more than one activator. Inversely, a 
given proteinase could activate more than one PAR. For example, upon the 
discovery of PAR-1 and PAR-2, it is evidenced clear that although trypsin at low 
concentration (<10U/ml, 20nM) activate selectively PAR-2, high concentration of 
trypsin (<=50U/ml, 100nM) also mobilises PAR-1 (Hollenberg & Compton, 2002).    
  
Finally, the endogenous activators for PARs in the brain are largely based on 
speculation. Indeed, several studies have suggested possible endogenous 
activators for PARs in the brain, but whether they actually signal through PARs is 
far from certain. Thrombin expression in situ in the brain is wide spread 
(Yoshida & Shiosaka, 1999; Rohatgi et al., 2004b). Tissue-type plasminogen 
activator (tPA), urokinase-type plasminogen activator (uPA) and plasmin have 
functional roles in ischaemia, synaptic plasticity, neurodegeneration and 
neuroregeneration (Xi et al., 2003; Sheehan & Tsirka, 2005). Signalling of 
thrombin or thrombin-like proteinase endogenously was hypothesized through 
PAR-1. Meanwhile, trypsin expression in situ in the brain is also demonstrated 
(Lohman et al., 2008). Trypsin-like proteinase have also been detected in the 
brain including mast cell tryptase (Ibrahim et al., 1996; Mitsui et al., 1999; 
Kempuraj et al., 2006),  trypsin Ⅳ/ mesotrypsin (Toth et al., 2007), kallikrein 
6/neurosin (Oikonomopoulou et al., 2006), Kallikrein 8/neuropsin (Mitsui et al., 
1999), neuropsin (Shimizu et al., 1998; Matsumoto-Miyai et al., 2003), and 
neurotrypsin (Gschwend et al., 1997; Reif et al., 2007). These trypsin-like 
proteinases modulate several physiological functions in the brain including 
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synaptogenesis, synaptic transmission, synaptic plasticity and learning and 
memory. However, the target of trypsin and trypsin-like proteinases 
endogenously in the brain, PAR-2 or not, is under investigation. 
1.4 Electrical properties of a central neurone 
Typically, normal brain function, from complex cognitive task to simple 
movement control, is achieved by coherent flow of information encoded by 
heterogeneous neuronal activities, which are, in physical nature, proved to be 
electrical activities. The fundamental unit of these electrical flows is the 
neurone, characterised by its ability to initiate, propagate, and terminate 
electrical signals in a timely order. Furthermore, this property of a neurone is 
determined by its capability to allow charged ions to cross its excitable 
membrane in a precisely regulated spatiotemporal manner. In the following 
section, the electrical properties of a central neurone are summarised. 
 
1.4.1 Neuronal excitability 
Neuronal excitability, in cellular neurophysiology, means the ability of neurone 
to generate an AP in response to stimulation (Hille, 2001b). It is attributed to 
the presence of a broad range of voltage-dependent ion channels across the 
neuronal membrane, in particular the voltage-dependent Na+ channels and the 
voltage-dependent K+ channels (Hodgkin & Huxley, 1952d). Neuronal excitability 
is the intrinsic property of a neurone. Several factors have been considered to 
influence neuronal excitability (Armstrong & Hille, 1998). Notable, three main 
factors determine the neuronal excitability, namely membrane potential, 
threshold level and voltage-dependent Na+ channels. Membrane potential and 
threshold level are dependent on each other. Depolarising the membrane 
towards the threshold level is a prerequisite of generating an AP. So, the closer 
the two are, the higher the excitability is. The further apart the two are, the 
lower the excitability is. Furthermore, activation of the voltage-dependent Na+ 
channels, in most cases, is the initiator of AP. The more functional voltage-gated 
Na+ channels are expressed on a given neurone, the larger chance that the 
excitability of the neurone is higher.  
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1.4.2 Model equivalent circuit of a functional neurone 
The plasma membrane of a neurone is a semipermeable lipid bilayer 
characterised in fluid mosaic model (Singer & Nicolson, 1972). It effectively 
separates the neuronal plasma from the extracellular environment both 
morphologically and electrically. In the majority of the time, the membrane of a 
neurone is of high electrical resistance because it is selectively impermeable to 
water soluble charged ions. As both extracellular and intracellular fluids are 
excellent conductors, this configuration confers a ‘membrane capacitor’ 
property. Meanwhile, the lipid bilayer of a neuronal membrane is anchored with 
ion channels, that are permeable to specific charged ions to convey electricity 
current under certain condition, leading to a ‘membrane resistor’ property. Thus, 
a functional neurone in fact could fit into a simplified model electrical circuit as 
illustrated in figure 1.1. This simplified circuit can be used to explain the passive 
electrical properties of a given neurone. 
Vm
Rm Cm
Im
 
Figure 1-4 Schematic illustration of simplified model circuit of a neurone.  
Modified from page 7, Biophysics of computation: information processing in single neurons, 
Christof Koch, 1999 (Koch, 1999) From an electrical aspect, lipid bilayers of a neuronal 
membrane confer a classical RC circuit, where membrane resistance (Rm) and membrane 
capacitance (Cm) are in parallel. Membrane ion flow (Im) is driven by resting membrane 
potential (Vm) as a battery.  
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1.4.3 Resting membrane potential 
The resting membrane potential is the difference of electrical potential across 
the membrane due to separation of charge by the lipid bilayer in the absence of 
stimulus. In most cases, neuronal membrane is negatively charged intracellularly, 
and positive charged extracellularly. If the extracellular potential is taken as 
reference as default, the membrane potential of a central neurone in the brain 
is typically about -65mV. Three factors contribute to the establishment of 
resting membrane potential in the central neurones. 1) Disparity of ions 
distribution across inside and outside of neuronal membrane. That is Na+ and Cl- 
are more concentrated outside the cell, whereas K+ and in particular, organic 
anions are much more concentrated inside the cell.  2) Differential permeability 
for ions at resting situation. That is normally, without any stimulation, a 
neurone’s membrane is almost only permeable to K+, but not Na+ due to the 
opening of K+ channels and blockade of Na+ channels. 3) Proper function of Na-K-
ATPase. Na-K-ATPase pumps in two Na+ ions to the plasma and pumps out three 
K+ ions to extracellular fluid during each functional circle. Because Na-K-ATPase 
functions against concentration gradient and generating electrical field, it 
consumes energy which is supplied by ATP. 
 
1.4.4 Action potential 
An action potential (AP) is the ‘signature character’ of neuronal excitation and 
activity. It is also the coding unit of neural processing. An AP is characterised by 
transient alteration and re-establishment of the neuronal membrane potential in 
response to stimulus as illustrated in figure 1.5. The distinctive feature of an AP 
is its all-or-none property (Hodgkin, 1937a, b). That is, the shape and the 
amplitude of an AP do not change in response to the intensity of stimulus as long 
as the stimulus is suprathreshold. If a stimulus is subthreshold, a neurone can 
not generate an AP. In addition, an AP actively propagates across neurone’s axon, 
without compromise of its shape and amplitude. AP’s all-or-none phenomenon is 
in vast contrast with the electrotonic potential, which diminishes with distance. 
However, AP’s all-or-none phenomenon has been complemented by the 
observation that APs can both actively and passively backpropagate into 
dendrites with diminishing amplitude across distance (Stuart et al., 1997). 
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As illustrated in figure 1.5, the mechanism underlying the generation of an AP 
has been rigorously investigated and summarised by Hodgkin and Huxley in 1952 
with the establishment of Hodgkin-Huxley model(Hodgkin & Huxley, 1952b, a, c, 
d). Briefly, the time course of an AP can be divided into five parts: the rising 
phase, the peak phase, the falling phase, and the hyperpolarisation phase. The 
rising phase is mediated by gradual activation of voltage-dependent Na+ channels 
in a positive feedback manner. That is, a suprathreshold stimulus initiates the 
opening of voltage-dependent Na+ channels, resulting in initial Na+ influx. 
Therefore, this Na+ influx depolarises the membrane further and drives more 
voltage-dependent Na+ channels to open. The mass Na+ influx, squeezed by both 
electrical potential and concentration gradient, gives rise to the faster kinetic 
character of the depolarising phase of AP compared to the repolarising phase. 
The opening of voltage-dependent Na+ channels gradually reaches the maximum 
as positive feedback slows. Furthermore, because of the gradual inactivation of 
voltage-dependent Na+ channels and accordingly the activation of voltage 
dependent K+ channels, the AP reaches its peak and begins to decay swiftly. The 
falling phase is determined by the activation of voltage-dependent K+ channels 
together with the inactivation of voltage-dependent Na+ channels. The switch of 
neuronal membrane permeability towards K+ drives efflux of K+ to redepolarise 
membrane potential to restore its resting level. Because the redepolarisation 
reduces the opening of voltage dependent K+ channels in a negative feedback 
manner, the falling phase is kinetically slower compared with the rising phase of 
an AP. The hyperpolarisation phase of an AP is caused by excessive opening of K+ 
channels because the voltage dependent K+ channels do not close immediately 
when membrane potential comes back to its resting level. Hyperpolarisation 
sustains until the normal permeability of K+ is restored. In addition, the 
involvement of hyperpolarisation activated cation channels (Robinson & 
Siegelbaum, 2003), G-protein coupled inwardly rectifying K+ (GIRK) channels and 
Ca2+ activated K+ channels (Lujan et al., 2009) in restoring membrane potential 
after hyperpolarization have been demonstrated. 
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Figure 1-5 Schematic demonstration of an action potential. 
Modified from page 28, Ion channels of excitable membranes, Bertil Hille, 2001 (Hille, 2001a) 
 
1.5 Synaptic transmission 
Neurones make contact with each other, and play the central role of structural 
and functional unit of neural activity within a highly interactive and coordinated 
circuitry. A contact between neurones is termed a ‘synapse’, which originates 
from ‘synaptein’, combing the Greek "syn-" ("together") and "haptein" ("to clasp"), 
first used by British neurophysiologist Charles Sherrington in the early 20th 
century. Interactions among neurones take place at synapses in the form of 
transmitting electrical signals from one neurone to the other. To date, two main 
forms of synaptic transmission are characterised as either electrical or chemical.  
 
1.5.1 Chemical synaptic transmission 
Chemical synaptic transmission is known as classical synaptic transmission. It has 
four phases: 
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1) AP initiated from presynaptic neurone activates voltage-dependent Ca2+ 
channels located within presynaptic terminal, permitting Ca2+ influx. 
2) Ca2+ elevation triggers neurotransmitters released from presynaptic terminal. 
3) Neurotransmitters cross over the synaptic cleft, acting on postsynaptic 
terminal.  
4) The postsynaptic terminal responds with the change of local membrane 
potential. 
 
In this process, the electrical signal coded in the pattern of AP is first 
“translated” into chemical signals carried by neurotransmitters, and “re-
translated” back to electrical signal in the form of membrane potential 
alteration. Therefore, it is also termed as electrical-chemical-electrical 
transmission. 
 
1.5.1.1 Transmitter release 
The critical phase of chemical synaptic transmission is the release of 
neurotransmitters. Features of transmitter release were outlined as following: 
Firstly, transmitter release is characterised by a mechanism involving exocytosis 
and recycling of synaptic vesicles. Transmitter release could be divided into four 
steps: 1) Docking. Vesicles containing neurotransmitters approach and tether the 
active zone of presynaptic terminal. 2) Priming. This step includes all the 
protein and lipid modification and rearrangement in the active zone to make 
synaptic vesicles “readily releasable” and competent to fusion (Lloyd & Bellen, 
2001). 3) Fusion. With the Ca2+ influx triggered by activation of Ca2+ channel, 
synaptic vesicles fuse with presynaptic membrane, leading to release of 
neurotransmitters into synaptic cleft. These three steps discussed above 
comprise the whole process of “excocytosis”. 4) Recycling. Vesicles recycled 
back to presynaptic terminal, reloaded with neurotransmitters, and transported 
back to releasable pool.  
 
Secondly, the process of docking, priming, fusion is tightly regulated by the 
interaction among SNARE complex and other proteins such as complexin, and 
synaptotagmin, which has been postulated as the “SNARE” hypothesis (Sollner et 
al., 1993; Sudhof & Rothman, 2009).  
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Thirdly, the release of neurotransmitters is characterised by quantal release 
theory (Katz, 1971). As described above, neurotransmitters are stored and 
released from synaptic vesicles upon neural impulse. Thus functionally, each 
synaptic vesicle represents a release unit, which is termed as a “quantum”. The 
amount of synaptic vesicles released following one AP is regarded as “quantal 
content”. Likewise, the amount of neurotransmitter molecules loaded in single 
vesicle is described as “quantal size”. From analysis in nerve-muscle synapses, it 
is confirmed that the amount of vesicles released in response to a nerve impulse, 
the “quantal content” vary significantly. However, the amount of 
neurotransmitters in a single vesicle, the “quantal size” is more consistent. 
Therefore, the magnitude of a postsynaptic potential in response to a given 
impulse depends largely on the “quantal content” (Del Castillo & Katz, 1954).  
 
1.5.1.2 Postsynaptic potential 
Neurotransmitters released from presynaptic terminal diffuse through the 
synaptic cleft, and interact with specific receptors located on the postsynaptic 
terminal.  This leads to the conformation change of receptor proteins, which 
subsequently opens ion channels (receptor and ion channel can coexist in the 
same protein complex or not) to change membrane conductivity to specific ions. 
Consequently, the ion influx/efflux results in membrane potential change in 
postsynaptic terminal, namely postsynaptic potential.  
 
Depending on the time course, the postsynaptic potential can be divided into a 
fast or a slow response (Hille, 1994). A fast response, with a latency of 0.5-
1.0ms after presynaptic AP, is mediated by ionotropic receptors, which are 
ligand-gated ion channels with the ability to change membrane conductance 
rapidly by swift conformation modification. In contrast, a slow response, with a 
latency of second to minute scale, is mediated by metabotropic receptors, which 
are not ion channels but indirectly coupled to ion channels on the membrane 
with signal transduction through G-protein-mediated second messenger systems.  
 
Postsynaptic potentials can be excitatory. That is excitatory postsynaptic 
potential (EPSP), where the postsynaptic response depolarises the membrane 
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potential. Postsynaptic potential could also be inhibitory. That is inhibitory 
postsynaptic potential (IPSP), where a hyperpolarising response is observed. 
However, a given neurotransmitter could give rise to either excitatory or 
inhibitory postsynaptic response, depending on which type of receptor is 
activated as well as the resting membrane potential of the postsynaptic neurone 
(Ben-Ari, 2002). Thus, for simplicity, neurotransmitters leading to EPSPs in most 
cases are termed as excitatory neurotransmitters, whereas those resulting in 
IPSPs are classified as inhibitory neurotransmitters. In the brain, most prevalent 
excitatory neurotransmitter is glutamate. And the most important inhibitory 
neurotransmitter is γ–aminobutyric acid (GABA). In the brain, an EPSP is largely 
mediated by the Na+ and/or Ca2+ influx through ligand-gated cation channels, 
such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, 
N-methyl-D-aspartic acid (NMDA) receptors and kainate receptors. A fast IPSP is 
mainly from Cl- influx through opening of GABAA receptors. Opening of K+ 
channels by Gi-coupled GABAB receptors contribute to slow IPSP.  
 
1.5.1.3 Integration of synaptic inputs 
In the brain, where, when and how could a given postsynaptic neurone fire an AP 
depends on where, when and how the postsynaptic potentials it receives, either 
excitatory or inhibitory, are processed in a spatial and temporal manner. This 
process is synaptic integration (London & Hausser, 2005). Synaptic convergence, 
the number of presynaptic neurones innervating a given neurone, and divergence, 
the number of postsynaptic neurones innervated by a particular neurone, lay the 
structural foundation of this tuning (Bartos et al., 2007).  
 
EPSPs and IPSPs are local electrotonic potentials, without “all or none” nature, 
and can be summated. Single EPSP or IPSP generally is about 1mV. In order to 
make a neurone fire AP, the postsynaptic depolarisation must be strong enough 
to overcome threshold, normally around 10mV (depolarisation from -65mV to -
55mV in a healthy neurone). Thus, spatial and temporal summation of EPSPs 
and/or IPSPs decides the magnitude and time course of gross synaptic inputs, 
which in turn dictates the output of postsynaptic neurone in the pattern of AP 
firing.   
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Synaptic summation can be divided into temporal summation and spatial 
summation (Bartos et al., 2007). In case of temporal summation, a series of 
continuous post synaptic potentials come closely after each other before the last 
potential decays at a single synapse, thus the amplitude of a given potential will 
be “added”, either more depolarised with an EPSP or less depolarised with an 
IPSP, into the previous one. On the contrary, spatial summation refers to the 
postsynaptic computation where synaptic potentials originated from multiple 
synapses, arrives simultaneously at a given neurone. Generally, spatial 
summation is linear, as the algebraic summation of post synaptic potentials from 
multiple synapses. Thus, in the spatial summation scenario, the membrane 
potential of postsynaptic neurone equals the algebraic sum of EPSPs and IPSPs. 
However, it must to be noticed that the discussion about spatial summation 
above is based on one assumption that an IPSP is hyperpolarising. Indeed, in 
most cases it is the case. However, IPSP can take its inhibitory function through 
an effect termed shunting inhibition, for instance in inhibitory interneurones in 
the brain (Alger & Nicoll, 1979; Gulledge & Stuart, 2003; Vida et al., 2006). 
Because the reversal potential of Cl- is about -65mV or less in interneurones, if 
the membrane potential is also -65mV, opening of Cl- channels by 
neurotransmitters will not result in Cl- influx with hyperpolarising potential. 
However, if an EPSP coincidently arrives to depolarise the membrane potential 
towards less negative, the opening of Cl- channels will “offset” the magnitude of 
EPSP with Cl- influx. Thus, the IPSP is still inhibitory although not hyperpolari sing 
in the shunting inhibition scenario. This form of spatial summation is non-linear.  
 
To sum up, synaptic integration includes temporal summation and spatial 
summation of synaptic inputs. They coexist and function simultaneously to steer 
a particular neurone to fire APs or not in response to EPSPs and IPSPs in a circuit. 
 
1.5.2 Electrical synaptic transmission 
Unlike electrical-chemical-electrical transduction in classical chemical synpases, 
the information flow among neurones could pass through direct electrical 
coupling established by the electrical synapses in the brain (Eccles, 1982; Jessell 
& Kandel, 1993). Electrical synapse, also know as gap junction, permit charged 
ions, and transmitters to flow freely through gap-junction channel, connexons, 
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between two tightly close neurones with only 2-3nm distance, much shorter 
compared to chemical synapse with 20-40nm (Bennett, 1997; Bennett & Zukin, 
2004).  
 
Compared to chemical synapse, transmission at electrical synapse does not delay, 
but without gain, and in most cases, biderectional. Electrical synapse and 
chemical synapse can coexist at one single synaptic formation (Shapovalov, 
1980). Functionally, electrical synapses are particularly important in local 
inhibitory circuits comprised of GABA-releasing interneurones to generate 
gamma oscillation (Galarreta & Hestrin, 2001). 
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1.6 Synaptic circuits in the hippocampus 
1.6.1 Overview of the hippocampus 
The hippocampus belongs to the ‘limbic system’ in the mammalian brain.  The 
necessity of the hippocampus in storing and retrieving memory as well as 
participating spatial navigation has been extensively documented (Bliss & 
Collingridge, 1993; Wilson & McNaughton, 1993; Malenka & Bear, 2004; 
McNaughton et al., 2006). The hippocampus is one of the most widely 
investigated regions in the brain thanks to its relatively clear principle cell layers 
with their highly organized excitatory output as well as their local domain-
specific inhibitory inputs from interneurones. Experimentally, the hippocampus 
is of readily access for neuroscientists, whose interests range from synaptic 
physiology, neural plasticity, spatial learning and memory and artificial 
remodeling to clinical conditions such as epilepsy, schizophrenia, Alzheimer’ s 
disease, and autism (Bliss & Lomo, 1973; Best & White, 1999; Burke & Barnes, 
2006; Boyer et al., 2007; Squire & Kandel, 2009).    
 
1.6.2 Excitatory circuits in the hippocampus 
A ‘banana shape’ structure located deeply within the medial temporal lobe of 
the mammal’s brain, the hippocampus has three main subdivisions: CA1, CA3 (CA: 
cornus ammonis) and the dentate gyrus (DG). Furthermore, the hippocampus is 
unique in conveying largely unidirectional flow of information through well 
characterised excitatory trisynaptic pathways (Bliss & Gardner-Medwin, 1973; 
Malenka & Nicoll, 1999; Andersen, 2007b). (see figure 1.3). Briefly, considering 
the most simplified scenario, pyramidal cells in the layer II of the entorihnal 
cortex (EC) send axon projections, among many destinations, into the DG. These 
projections are termed as perforant path (PP), which contributes to the major 
hippocampal input. Subsequently, information flows from the DG into the CA3 
area of the hippocampus through mossy fibres (MF), which are axon projections 
from granule cells in the DG into the CA3. Likewise, the pyramidal cells in the 
CA3 innervate the CA1 area of the hippocampus by long axon projections called 
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Schaffer collaterals (SC) to allow information to flow from the CA3 into the CA1. 
To complete this loop, CA1 pyramidal cells project axons into subiculum, which 
directs projections back to the EC. Apart from this trisynaptic pathway, both 
through the PP, the pyramidal cells in layer II of the EC also send direct 
excitatory input into the CA3, and the pyramidal cells in layer III of the EC 
innervate the CA1 directly(Amaral et al., 2007; Andersen, 2007b). Some axons of 
pyramidal cells in the CA1 also terminate directly into deep layers of EC (Amaral 
et al., 2007; Andersen, 2007b). In summary, beginning from the superficial 
layers and finishing in the deep layers of the entorhinal cortex, information flow 
completes a cycle and is processed in the hippocampus through this main 
excitatory EC-DG-CA3-CA1-EC pathway. 
 
Figure 1-6 Classical illustration of the hippocampus showing the excitatory trisynaptic 
pathway.  
Adapted and modified from classical illustration of hippocampal formation showing the 
excitatory trisynaptic pathway as drawn by Santiago Ramon y Cajal (Ramón y Cajal, 1952, 
1955). Insert shows the schematic representation of main excitatory pathways and the 
direction of information flow. Source: http://en.wikipedia.org/wiki/Hippocampus 
  
1.6.3 Inhibitory circuits in the hippocampus 
Although pyramidal cells are the dominant cells in the hippocampus, there are 
indeed a large number of heterogeneous GABAergic interneurones, roughly 10% 
of the total hippocampal neuronal population, located across different 
hippocampal regions and layers, which provide general inhibition and modulate 
network activity (Freund & Buzsaki, 1996; Jonas et al., 2004; Ascoli et al., 2008; 
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Klausberger & Somogyi, 2008). GABAergic interneurones are recognised and 
classified by their firing signature, biochemical markers, morphology, 
innervating pattern, and location in the hippocampus, however overlapping 
among classifications is common (Ascoli et al., 2008; Klausberger & Somogyi, 
2008). Because my project, during its time course, is focused solely in the CA1 
region of the hippocampus, only are interneurones in the CA1 discussed below.  
 
One of the most studied subgroup of interneurones in the CA1 of hippocampus is 
fast-spiking, parvalbumin-expressing basket cells. These basket cells actually are 
pyramidal shape and reside in or close to the pyramidal cell layer. Their short 
range axons innervate mostly the soma and proximal dendrites of thousands of 
pyramidal cells to provide local inhibition. At the same time, a particular basket 
cell receives excitatory input from thousands of pyramidal cells, which indicates 
its high capacity of convergence and potentially critical role in controlling local 
pyramidal cells in feedforward manner and regulating the synchronisation of 
network activity (Cobb et al., 1995; Andersen, 2007a; Bartos et al., 2007; 
Klausberger & Somogyi, 2008). Indeed, it has been demonstrated that basket 
cells are the key factor to ‘phase lock’ AP firing in pyramidal cells to synchronise 
their activity in theta oscillation (Cobb et al., 1995). Further studies have shown 
the fast inhibitory effect of basket cells promotes gamma oscillation (Bartos et 
al., 2002) and shunting inhibition of basket cells consolidates gamma oscillation 
(Vida et al., 2006). 
 
The second group of fast-spiking, parvalbumin-expressing interneurones in the 
CA1 is axo-axonic cells, also termed as chandelier cells, which exclusively 
innervate the initial segment of axons of pyramidal cells. Like basket cells, they 
locate in or adjacent to the pyramidal cell layer. Because the initial segment of 
a axon is critical in generating AP in the pyramidal cells (Stuart et al., 1997), the 
axo-axonic cells are thought to have ultimate control over the output of 
pyramidal cells and involved in the synchronisation of theta and ripple oscillation 
(Howard et al., 2005).  
 
Bistratified cells are also located in the CA1 pyramidal cell layer. In contrast to 
fast-spiking, parvalbumin-expressing basket cells and axo-axonic cells, 
bistratified cells innervate dendrites of pyramidal cells to provide dendritic 
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inhibition (Buhl et al., 1996; Halasy et al., 1996; Klausberger et al., 2004). 
Bistratified cells have been found to fire at a phase when the dendrites of 
pyramidal cells are hyperpolarised (Klausberger et al., 2004). Together with 
basket cells, bistratified cells provide precise ‘phase locking’ of theta oscillation 
in vivo (Klausberger et al., 2004).  
 
Apart from pyramidal cell layer, cell bodies of GABAergic interneurones 
distribute in the stratum oriens, stratum radiatum, and stratum lacunosum-
moleculare of the hippocampus. One distinct group of these interneurones is 
somatostatin-containing O-LM cells, with cell bodies in the stratum oriens, 
dendrites parallel to pyramidal cell layers in the stratum oriens-alveus, axons in 
the stratum lacunosum-moleculare. O-LM cells innervate distal dendrites of CA1 
pyramidal cells. O-LM cells fire preferentially in theta frequency, and are 
important in maintaining gamma oscillation (Tort et al., 2007). Notably, O-LM 
cells has been found to express an “anti-hebbian” form of long term potentiation 
(see more in Chapter 1.7) (Lamsa et al., 2007; Oren et al., 2009). 
 
In conclusion, GABAergic interneurones in the hippocampus provide feedforward 
and feedback inhibition in local circuits in both tonic and phasic means. The 
coherent activity of heterogeneous groups of interneurones in a timing 
dependent manner plays the key role in initiating, maintaining, and 
consolidating network oscillation.  
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1.7 Synaptic plasticity 
It is widely observed that the efficacy of synaptic transmission between 
neurones could be strengthened or weakened depending on a variety of 
electrical or chemical stimuli in a time scale from a few milliseconds to a few 
days in different areas of the brain both in vitro and in vivo (Bliss & Collingridge, 
1993; Bortolotto et al., 1999; Kemp & Bashir, 2001; Zucker & Regehr, 2002; 
Whitlock et al., 2006). This phenomenon has been described as synaptic 
plasticity comprising short-term plasticity (STP), long-term potentiation (LTP) 
and long-term depression (LTD). Synaptic plasticity has been a plausible 
candidate of molecular and cellular basis for learning and memory as 
information maybe stored and retrieved by transforming differential 
spatiotemporal patterns of neural activity into synaptic changes in different 
locations, circuits and neurones in the brain (Bliss & Collingridge, 1993; Martin et 
al., 2000; Holtmaat & Svoboda, 2009; Wang & Morris, 2010). The term “synaptic 
plasticity” was first introduced by Dr. Jerzy Konorski in the late 1940s (Konorski, 
1948). Subsequently refined by Dr. Donald Hebb in 1949 with proposed 
mechanism known widely as Hebb’s postulate (Hebb, 1949): 
 
‘When an axon of cell A is near enough to excite a cell B and repeatedly or 
persistently takes part in firing it, some growth process or metabolic change 
takes place in one or both cells such that A’s efficiency, as one of the cell firing 
B, is increased’. 
 
Since its first introduction, Hebb’s rule has been verified in most types of 
activity-dependent synaptic plasticity in the brain. Hebbian LTP, which typically 
requires the depolarisation of postsynaptic NMDA receptors, has been 
characterised with three dogmas: input specificity, associativity, and 
cooperativity (Bliss & Collingridge, 1993). But exceptions do exist as the non-
Hebbian LTP, where LTP induction is independent of the activation of NMDA 
receptors, and the anti-Hebbian form, where LTP is prevented by postsynaptic 
depolarisation during afferent activity, have been reported (Urban & 
Barrionuevo, 1996; Lamsa et al., 2007; Kullmann & Lamsa, 2008). In the synapse 
made by mossy fibres onto pyramidal neurones in hippocampal CA3 area, non-
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Hebbian LTP was observed as a result of sustained presynaptic activation (Urban 
& Barrionuevo, 1996). In the synapse made by pyramidal cells onto interneurones 
in the oriens of CA1 area, anti-Hebbian LTP was reported in response to 
activation of Ca2+ permeable AMPA receptors during hyperpolarization of 
postsynaptic membrane (Lamsa et al., 2007). 
 
1.7.1 Short-term plasticity 
Short-term plasticity is short-term increase or decrease of synaptic strength that 
lasts for at most a few minutes. Such short lasting changes in synaptic efficacy 
may be expressed in two opposite directions as short-term facilitation or short-
term depression. 
 
1.7.1.1 Short-term facilitation 
Experimentally, short-term facilitation (STF) is easily been observed upon two 
closely paired stimuli paradigm, termed paired-pulse, with an interval of, usually 
among 10ms to 300ms. The synaptic response of the second pulse can be several 
times stronger in relative to the first one at the Schaffer collateral-to-CA1 
synapse.  Short-term facilitation is, by its origin, presyanptic (Zucker & Regehr, 
2002). It reflects an increase in the probability of release of readily vesicles and 
can be attributed to the transient accumulation of presynaptic Ca2+, as Ca2+ 
influx triggered by the second AP is added into the residual Ca2+ which has not 
been depleted after the first pulse (Wu & Saggau, 1994). Another interesting 
observation about short-term facilitation is that the basal level of release 
probability will decide the magnitude of facilitation (McNaughton, 1982). The 
closer the basal release probability to 1, the less scope there is for subsequent 
facilitation. 
1.7.1.2 Short-term depression 
Short-term depression (STD) also occurs upon paired pulse paradigm in some 
synapses. The most widely accepted mechanism for STD is termed as the 
‘depletion model’ (Zucker & Regehr, 2002). That is the STD is the result of a 
decrease of available vesicles in readily releasable pools in presynaptic terminals 
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in response to closely paired stimuli. The desensitization of responsible 
postsynaptic receptors is believed to contribute partially. 
1.7.2 Long-term potentiation 
Long term potentiation (LTP), as long lasting increase of synaptic transmission, 
was first described in the perforant path from entorhinal cortex into the dentate 
gyrus in an anaesthetised rabbit (Bliss & Gardner-Medwin, 1973; Bliss & Lomo, 
1973). Subsequently, it is routinely observed in all excitatory pathways onto 
principal cells in the hippocampus and many other regions in the brain including 
neocortex, striatum, and cerebellum (Wilson & Racine, 1983; Calabresi et al., 
1992; Shibuki & Okada, 1992). Recently, LTP has also been discovered in 
excitatory synapses onto inhibitory interneurones in the hippocampus (Mahanty 
& Sah, 1998; Perez et al., 2001; Kullmann & Lamsa, 2007; Lamsa et al., 2007).  
 
LTP has three distinct properties in input-specificity, associativity, and 
cooperativity (Bliss & Collingridge, 1993). Input-specificity refers to the fact that 
LTP does not spread. Only the pathway that has been activated expresses LTP 
even with other pathways in proximity. Associativity describes that a weak input 
may induce LTP as long as a separate strong input simultaneously stimulate the 
same target neurone. Cooperativity describes the existence of a threshold of 
input intensity for inducing LTP. LTP can be either induced by strong tetanus 
stimulation in a single pathway or by the summation of several small stimuli. 
Among these three LTP properties, input-specificity is relevant to the LTP 
expression, whereas, associativity and cooperativity are within the scope of LTP 
induction.  
 
Based on whether or not NMDA receptor antagonist could block its induction, LTP 
can be classified as NMDA receptor dependent or NMDA receptor independent. In 
the hippocampus, the LTP in the Schaffer collateral-to-CA1 pyramidal cell 
synapses is the most studied type of NMDA receptor dependent LTP (Bliss & 
Collingridge, 1993). On the other hand, the LTP in the mossy fiber synapses onto 
CA3 pyramidal cells are typically NMDA receptor independent (Harris & Cotman, 
1986; Nicoll & Schmitz, 2005). Schaffer collateral LTP is routinely induced by 
tetanus stimulation (100 pulses within 1 second for a tetanus, 1 to 3 tetani) or 
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theta burst stimulation (10 sets of burst of four stimuli in 100Hz, 200ms 
interburst interval). The induction of Schaffer collateral LTP classically follows 
the Hebb’s postulate with the NMDA receptor functioning as a “coincidence 
detector” to pair presynaptic stimulation with postsynaptic depolarisation 
(Collingridge et al., 1988; Kauer et al., 1988; Huang et al., 1992). Associativity, 
and cooperativity could be easily explained by the role of the NMDA receptor in 
Schaffer collateral LTP induction. The voltage dependent Mg2+ blockade of NMDA 
receptors in postsynaptic membrane installs the LTP threshold in cooperativity. 
Associativity is reflected by the fact that the requirement of removing Mg2+ 
blockade of NMDA receptors can be achieved by depolarising postsynaptic 
terminals experimentally by a voltage step or convergent excitatory inputs. 
Apart from NMDA receptor’s voltage dependent Mg2+ blockade, its permeability 
to Ca2+ plays a key role in the Schaffer collateral LTP as Ca2+ influx has been 
confirmed to be necessary for its induction (Lynch et al., 1983).  
 
The time course of LTP can be divided into four phases as post-tetanus 
potentiation (PTP), short-term potentiation (STP), early-LTP, and late-LTP (Bliss 
& Collingridge, 1993; Malenka & Nicoll, 1999). Post-tetanus potentiation (PTP), 
immediately following tetanus stimulation, is believed to be the response of 
enhanced transmitter release corresponding to residual Ca2+ accumulation 
presynaticly during tetanus stimulation. This phase is presynaptic, and NMDA 
receptor independent. Short-term potentiation (STP), usually lasting 30-60 
minutes after tetanus, can be isolated by the presence of protein kinase 
inhibitors or routinely acquired by weak stimulation protocol. Early-LTP with the 
duration of less than 3-6 hours requires protein kinases such as CaMKⅡ and PKC 
(Malinow et al., 1988; Malenka et al., 1989). Late-LTP, usually lasts more than 3 
hours, and is protein synthesis dependent (Frey et al., 1988).  
 
1.7.3 Long-term depression 
Long term depression (LTD) is the long lasting reduction of synaptic transmission 
opposite to LTP. This phenomenon was first recorded in a study that in the CA1 
region of hippocampus, a LTP-inducing stimulation surprisingly resulted in a 
depressed synaptic efficacy in a separate, non-stimulated pathway, a 
phenomenon described later as “heterosynaptic LTD”, by Lynch and co-workers 
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in 1977 (Lynch et al., 1977). Another report in 1980 described that a low 
frequency stimulation effectively reversed established LTP in the hippocampus 
(Barrionuevo et al., 1980) which was later termed as “depotentiation”.  Both 
phenomenon were largely neglected until the early 1990s, that a new form of 
“homosynaptic LTD” was discovered by Mark Bear’s group and confirmed by 
Robert Malenka’s group in 1992 that low frequency stimulation of 900 stimuli in 
1 Hz produced a prolonged reduction of synaptic transmission in the CA1 region 
of hippocampus, without any initial LTP-inducing paradigm (Dudek & Bear, 1992; 
Mulkey & Malenka, 1992).  
 
An intriguing aspect of homosynaptic LTD is its developmental dependency. One 
study showed the standard low frequency stimulation (LFS) protocol, 900 stimuli 
in 1 Hz, routinely produced LTD in the CA1 region of hippocampal slices from 2 
weeks old animal, whereas LTD magnitude decreased by half in 5 weeks old 
animals (Dudek & Bear, 1993). This age-dependency was reproducible as another 
group independently showed LTD can be induced by LFS in animals younger than 
40 days, however no LTD was acquired in animals between 40 days to 16 weeks 
(Kemp et al., 2000). The loss of LTD induced by LFS is not likely due to the lack 
of ability to depress the Schaffer collateral-to-CA1 synapse as paired-pulse low 
frequency stimulation produced LTD in aged animals (Kemp et al., 2000) as well 
as stimuli of 5-10Hz for 15 mins (Berretta & Cherubini, 1998). In summary, these 
data suggest LTD induction may require differential machineries responsible for 
LTD induction over development and upon stimulation protocols.   
 
1.7.3.1 NMDA receptor dependent LTD 
LTD can be classified as NMDA receptor-dependent or not depending on whether 
or not DL-AP5 or other NMDA receptor antagonists block its induction. The LTD 
induced by LFS (900 stimuli, 1Hz) in CA1 region of hippocampus has been 
confirmed as NMDA receptor dependent (Dudek & Bear, 1992; Mulkey & Malenka, 
1992). NMDA receptor dependent LTD is also found in visual cortex (Kirkwood & 
Bear, 1994), perirhinal cortex (Ziakopoulos et al., 1999), and barrel cortex 
(Feldman et al., 1998).  
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It has been confirmed the induction of NMDA receptor dependent LTD requires a 
rise of postsynaptic Ca2+ concentration. Chelating Ca2+ postsynaptically by 
ethylene glycol tetraacetic acid (EGTA) or 1,2-bis (o-aminophenoxy) ethane-
N,N,N',N'-tetraacetic acid (BAPTA) blocked LTD induction (Brocher et al., 1992; 
Mulkey & Malenka, 1992). In addition, Mulkey and Malenka also demonstrated 
that reducing extracellular Ca2+ resulted in the induction of LTD by a LTP-
inducing paradigm (Mulkey & Malenka, 1992). Theses data suggest both LTD and 
LTP induction requires a rise of postsynaptic Ca2+ concentration. Lisman’s study 
further proposed that because the postsynaptic enzymes such as phosphatases 
and protein kinases have differential affinity for Ca2+, low level of Ca2+ may 
activate phosphatases to induce LTD, whereas, high level of Ca2+ may activate 
protein kinases to yield LTP (Lisman, 1989). To conclude these observations, it is 
further hypothesized that the spatiotemporal distribution and/or magnitude of 
Ca2+ transient postsynapticly may confer the polarity of long lasting changes of 
synaptic strength (Bliss & Collingridge, 1993; Bliss et al., 2007).  
 
As LFS-induced LTD in the hippocampal CA1 region has been shown to be NMDA 
receptor dependent, it is therefore, of interest to look into if the feature of 
developmental dependency of LFS-induced LTD in the CA1 is a result of the 
composition shift of NMDA subunits during development (Dudek & Bear, 1993; 
Monyer et al., 1994; Kemp et al., 2000). Evidence supporting this hypothesis 
came as one report discovered that overexpression of embryonic dominant NR2D 
subunit resulted in a loss of LTD in juvenile mice (Okabe et al., 1998). 
Furthermore, an interdependency of NR2D and NR2B was noticed in this study 
with downregulation of NR2B accompanied with NR2D overexpression in 2 to 3 
weeks mice (Okabe et al., 1998), suggesting a potential role of NR2B in LFS-
induced LTD in juvenile mice. 
 
Subsequently, more studies investigated the possibility that specific NMDA 
receptor subunit is responsible for LTD. The critical role for NR2B subunit is 
demonstrated by a knockout-mice study that mice lacking the NR2B subunit- 
containing NMDA receptors did not express LTD (Kutsuwada et al., 1996). 
However, pharmacological experiments provide conflicting data that one report 
using NR2B selective inhibitor, ifenprodil, enhances LTD (Hendricson et al., 
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2002), whereas, another report, using the same drug, shows blockade of LTD (Liu 
et al., 2004).  
 
1.7.3.2 mGlu receptor dependent LTD 
The involvement of mGlu receptors in LTD was first evidenced by the discovery 
that the group I/II mGluR antagonist, MCPG, blocked the induction of 
depotentiation by LFS protocol (900 stimuli, 1 Hz) following established LTP in 
the CA1 region of hippocampus (Bashir et al., 1993; Bashir & Collingridge, 1994). 
Furthermore, several studies have demonstrated the requirement of activation 
of mGluRs in de novo LTD in the CA1 region of the hippocampus under certain 
conditions. In one study, MCPG also blocks the induction of LTD in hippocampal 
CA1 pyramidal neurones in neonatal rats induced by a stimulation of 5Hz for 3 
minutes (Bolshakov & Siegelbaum, 1994). In another study, MCPG blocked de 
novo LTD following the same stimulation of 5Hz for 3 minutes in hippocampal 
CA1 region from both neonatal (6-7 days old) and juvenile (11-35 days old) rats 
(Oliet et al., 1997). Subsequent studies demonstrate more evidence of mGluR 
involvement in LTD. A potent non-selective mGluR antagonist, LY341495 blocked 
depotentiation but not de novo LTD, suggesting they may not share a common 
induction mechanism (Fitzjohn et al., 1998). LTD induced by low frequency 
stimulation of paired-pulse at 1Hz (PP-LFS) in adult (Kemp & Bashir, 1999) and 
juvenile anmimals (Huber et al., 2000) were shown to require mGluRs.  
 
Interestingly, NMDA receptor-dependent LTD induced by LFS is also present in 
the same synapses in the hippocampal CA1 but these two forms of LTD have 
been suggested to utilise distinct induction pathways: mGluR dependent LTD 
requires the Ca2+ influx from T-type Ca2+ channel, and protein kinase C, whereas, 
NMDA receptor dependent LTD requires Ca2+ influx through NMDA receptors and 
the activity of protein phosphatases (Oliet et al., 1997). It has been further 
suggested that the requirement of NMDA receptors and mGlu receptors in 
induction of LTD may be mutually exclusive as where there is a role for NMDA 
receptors, there is no role for mGluRs and vice versa (Bortolotto et al., 1999; 
Kemp & Bashir, 2001).  
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In addition to mGluR dependent LTD induced by synaptic activity, there is 
another form of long lasting depression of synaptic transmission caused by 
groupⅠmGluR agonist DHPG in areas such as CA1 (Palmer et al., 1997; Fitzjohn 
et al., 1999; Fitzjohn et al., 2001) and DG (Camodeca et al., 1999). This form of 
chemically-induced LTD is blocked by group I or broad-spectrum mGluR 
antagonists but not by NMDA receptor antagonists (Palmer et al., 1997; Fitzjohn 
et al., 1999; Fitzjohn et al., 2001). The induction of DHPG-induced LTD is Ca2+-
independent with a postsynaptic locus. Inhibiting postsynaptic G proteins activity 
by loading a G protein inhibitor into CA1 pyramidal cells prevents the induction 
of DHPG-induced LTD (Watabe et al., 2002), suggesting a postsynaptic induction. 
Furthermore, chelating Ca2+ postsynaptically with BAPTA does not block DHPG-
induced LTD induction, suggesting a Ca2+-independent mechanism (Fitzjohn et 
al., 2001). A rapid protein synthesis in postsynaptic dendrites has also attributed 
to the induction of DHPG-induced LTD (Huber et al., 2000). The locus of 
expression of DHPG-induced LTD is debatable. Several evidences have indicated 
a presynaptic locus. Fitzjohn and co-workers demonstrated that paired-pulse 
facilitation and the coefficient of variation of EPSCs were increased, with the 
reduction of frequency of miniature EPSCs but not amplitude (Fitzjohn et al., 
2001). Furthermore, DHPG-induced LTD is also not associated with changes in 
sensitivity to focally uncaged L-glutamate (Rammes et al., 2003). These data 
support the argument that the locus of expression of DHPG-induced LTD is 
presynaptic. However, there is also evidence that removal of AMPA and NMDA 
receptors in postsynaptic terminal is responsible for the expression of DHPG-
induced LTD, indicating a postsynaptic mechanism (Snyder et al., 2001), 
indicating a postsynaptic expression locus. 
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1.8 Neurone-astrocyte interaction 
Astrocytes are traditionally regarded as chemical and physiological insulators in 
the central nervous system, facilitating AP propagation, buffering glutamate 
induced neurotoxicity, and releasing neurotrophins to support neuronal growth 
(Galambos, 1961; Barres, 2008; Allen & Barres, 2009). This doctrine has been 
challenged by increasing evidence that astrocytes could not only respond to 
synaptic activity in their own right but also modulate synaptic communication 
actively both in culture and in intact brain slices (Agulhon et al., 2008; Perea et 
al., 2009; Hamilton & Attwell, 2010). 
 
Astrocytes are passive cells without the ability to generate APs. However, 
temporal fluctuation of intracellular Ca2+ concentration has been widely 
accepted as a “signature” of excitability in astrocytes (Cornell-Bell et al., 1990; 
Perea et al., 2009). The elevation of Ca2+ could be evoked by at least three 
means (Agulhon et al., 2010). Firstly, Ca2+ elevation can be induced as a result 
of the mobilisation of intracellular Ca2+ store by the binding of the second 
messenger IP3 with IP3 receptors located in the ER in response to stimulation or 
spontaneously (Pasti et al., 1997; Bezzi et al., 1998; Kang et al., 1998; Kulik et 
al., 1999; Araque et al., 2002). Secondly, upon repetitive depolarisation of the 
astrocytic membrane, intracellular Ca2+ concentration elevates as a result of 
Ca2+ influx through voltage dependent Ca2+ channels or transient receptor 
potential (TRP) channels which are both confirmed to be expressed on the 
astrocytic membrane (Cahoy et al., 2008). Thirdly, mechanical stimulation gives 
rise to Ca2+ elevation, possibly through mechanically sensitive receptors (Koizumi 
et al., 2003). Among these mechanisms, nevertheless, Ca2+ elevation in response 
to the mobilisation of intracellular Ca2+ store is by far the most studied 
mechanism underlying the ‘glial excitability’ (Perea et al., 2009). This 
mechanism is morphologically supported by the fact that astrocytes express most 
of the GPCRs expressed in neurones which are mostly receptors for 
neurotransmitters and Gq-coupled GPCRs(Porter & McCarthy, 1997).  
 
The neurone-astrocyte communication is in fact bidirectional. On the one hand, 
several studies have demonstrated that astrocytes vividly respond to synaptic 
activities by transient intracellular Ca2+ fluctuation both in culture and in intact 
  69 
brain slices. It has been confirmed that the firing of glutamatergic neuronal 
afferents triggers Ca2+ waves in acute and cultured organotypic slices of rat 
hippocampus (Dani et al., 1992; Pasti et al., 1997). Furthermore, intracellular 
Ca2+ was shown to increase upon stimulation at the Schaffer collaterals, and this 
effect was blocked by TTX as well as MCPG, suggesting a neuronal origin and 
mGluR dependency (Porter & McCarthy, 1996). More recently, Perea and Araque 
demonstrated that Ca2+ elevations were evoked by glutamate released from 
Schaffer collaterals and by acetylcholine, but not glutamate, released by alveus 
stimulation (Perea & Araque, 2005). In addition, neurotransmitters other than 
glutamate, such as acetylcholine and noradrenaline were also confirmed to 
evoke astrocytic Ca2+ signal (Kulik et al., 1999; Araque et al., 2002). These data 
confirm astrocytes could answer synaptic activity in a fashion of Ca2+ fluctuation 
in intact tissue. On the other hand, astrocytes could modulate the 
communication among neurones directly. Astrocytes release several neuroactive 
molecules such as glutamate, ATP, and D-serine, which can influence synaptic 
transmission (Agulhon et al., 2008; Perea et al., 2009).  
 
Several studies showed glutamate release from astrocytes in a Ca2+-dependent 
manner. An early study confirmed that astrocytes released glutamate in a Ca2+ -
dependent manner in response to coactivation of the AMPA/kainate and mGluRs 
on astrocytic membrane both in culture and slices (Bezzi et al., 1998). In 
another study direct stimulation of astrocytes potentiated miniature inhibitory 
postsynaptic currents (mIPSCs) in pyramidal neurons, and this effect was 
abolished by chelating astrocytic Ca2+ with BAPTA or by antagonists of the 
ionotropic glutamate receptors, suggesting a mechanism of Ca2+-dependent 
glutamate release from astrocytes (Kang et al., 1998). Furthermore, when 
astrocytes within the immediate vicinity of CA1 pyramidal cells were stimulated 
in hippocampal slices, the intracellular astrocytic Ca2+ wave coincided with a 
significant increase in the frequency of AMPA spontaneous EPSCs, and the 
increased frequency of AMPAR currents was sensitive to the group I mGluR 
antagonists, suggesting Ca2+-dependent glutamate released from astrocytes 
activated presynaptic group I mGluRs to facilitate glutamatergic transmission 
(Fiacco et al., 2007). Similarly, NMDA receptor-mediated slow inward currents 
(SICs) were recorded from CA1 pyramidal cells when DHPG was used, in the 
presence of TTX, to activate Gq-coupled group 1 metabotropic glutamate 
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receptors on astrocytes to elevate astrocytic Ca2+ concentration (Fellin et al., 
2004) Recently, Lee and co-workers reported activation of P2Y receptor, 
bradykinin receptors and PAR-1, all stimulated glutamate release from 
astrocytes, potentiating NMDA current in neurons in proximity (Lee et al., 2007). 
Using PAR-1 as a model system, they further demonstrated that PAR-1 mediated 
glutamate release from astrocytes was Ca2+-dependent in vitro, and astrocytic 
PAR-1 activation activated NMDA receptors on neurones in proximity in culture 
and induced APV-sensitive SICs in brain slices (Lee et al., 2007). Collectively, 
these evidences strongly support the growing acceptance of Ca2+-dependent 
release of glutamate from astrocytes. 
 
However, conflicting results were also reported favouring the argument that the 
glutamate release from astrocytes was not Ca2+-dependent. Different mouse 
models have been genetically engineered to allow astrocyte-specific 
manipulation of intracellular Ca2+ concentrations (Fiacco et al., 2007; Petravicz 
et al., 2008; Agulhon et al., 2010). In one mouse model, the transgenic mice 
were introduced a Gq-coupled receptor MrgA1, which is normally not expressed 
in the brain, selectively into astrocytes (Fiacco et al., 2007). Specifically 
elevating intracellular astrocytic Ca2+ concentration did not increase neuronal 
Ca2+, produce neuronal SICs, or affect excitatory synaptic activity, which 
questioned the developing consensus that glutamate release by astrocytes in 
vivo is Ca2+-dependent (Fiacco et al., 2007). In addtion, in another mouse model 
where IP3 mediated Ca2+ mobilisation was selectively prevented in astrocytes by 
deletion the gene PP3R2, which encodes the only astrocytic IP3 receptor on the 
ER, spontaneous EPSCs and tonic NMDA-mediated currents recorded from CA1 
pyramidal cells were unaffected, suggesting the removal of astrocytic Ca2+ 
increases did not affect excitatory neuronal activity and ambient glutamate 
levels (Petravicz et al., 2008). Recently, utilising these two mouse lines, it was 
further demonstrated that neither increasing nor obliterating astrocytic Ca2+ 
fluxes affected spontaneous and evoked excitatory synaptic transmission 
together with short- or long-term synaptic plasticity at the Schaffer collateral-
to-CA1 synapse (Agulhon et al., 2010). Collectively, these data strongly 
challenge the developing general acceptance of the Ca2+ dependency of 
glutamate release from astrocytes. 
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How could this starkly contrasting conclusion among different labs be reconciled 
(Hamilton & Attwell, 2010; Kirchhoff, 2010)? Differences in experimental setups 
or method-induced artifacts may be responsible for the diverging results. For 
example, the introduction of an exogeneous Gq-coupled receptor MrgA1 in 
astrocytes (Fiacco et al., 2007) would not necessarily overlap with the 
endogenous astrocytes signalling pathways. But rather focus on methodological 
reasons, it is perhaps more reasonable to consider the possibility of differential 
release mechanisms for glutamate may exist within potentially different groups 
of astrocytes. Moreover, it is also possible that within a given astrocyte, the 
requirement of Ca2+ in releasing glutamate or other gliotransmitters would vary 
in different subcellular regions of the cell (Kirchhoff, 2010). In other words, 
there could be more than one mechanism within a given astrocyte in governing 
the gliotransmitter release. Interestingly, one recent study has demonstrated 
the possible existence of two forms of astrocytic calcium excitability, whereby 
the activation of astrocytic PAR-1 receptors but not P2Y1 receptors, although 
both elevated astrocytic Ca2+, resulted in glutamate release, as APV-sensitive-
NMDA-mediated SICs were recorded (Shigetomi et al., 2008).  
 
Apart from glutamate, D-serine, which is exclusively released from astrocytes 
has been demonstrated to modulate synaptic transmission and plasticity, and 
postulated as the endogenous ligand for the glycine site of NMDA receptors 
(Schell et al., 1995; Mothet et al., 2000; Panatier et al., 2006). Recent 
literature further suggested that tonic D-serine release enhanced NMDA receptor 
activity in neurones, and the binding of D-serine to glycine site in NMDA receptor 
was required in LTP induction in cultured hippocampal neurones (Yang et al., 
2003). In addition, the degree of glycine site occupancy in NMDA receptors by D-
serine affected the activation of NMDA receptor, thereby affecting long term 
synaptic plasticity (Panatier et al., 2006). The concept that astrocytic release of 
D-serine regulates normal synaptic function was strongly boosted by a very 
recent paper reporting that the release of D-serine from astrocytes was required 
for establishing LTP at the Schaffer collateral-to-CA1 synapse (Henneberger et 
al., 2010). Collectively, these data support the hypothesis that astrocytic 
release of D-serine is important in regulating synaptic transmission and plasticity. 
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ATP has also been demonstrated as a key player in astrocyte-to-neurone 
communication, inducing heterosynatpic depression of excitatory transmission 
(Koizumi et al., 2003; Zhang et al., 2003; Pascual et al., 2005; Serrano et al., 
2006). It was first shown in hippocampal cultures that the activation of 
presynaptic P2 receptors depressed glutamatergic synaptic transmission in an 
ATP-dependent manner as a result of astrocytic Ca2+ wave in response to 
mechanical stimulation (Koizumi et al., 2003). This discovery was independently 
confirmed by the following report that neuronal activity activated astrocytes to 
tonically release ATP, thus suppressing glutamatergic synapses via presynaptic 
P2Y receptors in culture and slices (Zhang et al., 2003). The adenosine, the 
product of ATP degradation, was also found in modulating heterosynaptic 
depression in hippocampal slices by activating presynaptic A1 receptors (Serrano 
et al., 2006). The involvement of ATP in mediating tonic heterosynaptic 
depression was further evidenced by using transgenic mice to selectively impair 
gliotransmitter release by inducing a dominant-negative SNARE domain (Pascual 
et al., 2005). Collectively, these data demonstrated that astrocytic released ATP 
or its degradation product, adenosine, depresses glutamatergic synaptic 
transmission by activating presynaptic P2 or A1 receptors in the hippocampus. 
 
In summary, as presented in figure 1.7, it appears that astrocytes not only listen 
to, and respond to synaptic activity but also bear the ability to release 
“gliotransmitters” to modulate synaptic activity. This bidirectional glia-neurone 
interaction has given rise to the concept of “tripartite synapses”, where in 
addition to pre and post synaptic neurones, there is a functional component of 
astrocytes. The functional cross talk among these three parties shed light on 
synaptic transmission and plasticity (Agulhon et al., 2008; Perea et al., 2009; 
Hamilton & Attwell, 2010).  
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Figure 1-7 Schematic illustration of the concept of tripartite synapse. 
 (Adapted and modified from Agulhon C, et al., 2008 (Agulhon et al., 2008)) 
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1.9 Conclusion and aims 
Albeit low level, PAR-2 is extensively expressed in normal and pathological brain, 
including the hippocampus. During pathological conditions, an increase of PAR-2 
expression has been documented in diseases such as ischaemia, Parkinson’s 
disease, HIV-associated dementia, Alzheimer’s disease, and multiple sclerosis, 
suggesting that PAR-2 plays important roles in pathophysiological processes in 
the brain. Depending on the cell type in which increased PAR-2 expression is 
observed, PAR-2 has been proposed to play ‘dual face’ role, either degenerative 
(glial) or protective (neuronal). The hippocampus is the most studied region in 
the brain with detailed elucidation of its highly organized neural circuits. Acute 
slice preparation and primary hippocampal culture are well established 
experimental models in investigating neuronal and synaptic functions in the 
hippocampus in vitro with readily accessibility. Therefore, based on the fact 
that PAR-2 is indeed expressed in the hippocampus as verified independently by 
a number of groups, and given the functional roles that it plays in a variety of 
pathological conditions in the brain, it is reasonable to examine whether PAR-2 
contributes to normal neuronal signalling under physiological conditions in the 
hippocampus, and if so, how this modulation behaves in terms of cellular and 
synaptic physiology. Furthermore, does PARs activation exert same or 
differential modulation of cellular neurophysiology in different neuronal circuits 
or neuronal types in the brain? 
 
In conclusion, the central hypothesis of my PhD is that PAR-2 serves as 
‘molecular switches’ in normal neural signalling in the hippocampus, modulating 
neuronal excitability, basal synaptic transmission and plasticity, as well as 
network activities.  
 
Therefore, the specific aim of my PhD research is to investigate: 
 
1. HOW DOES PAR-2 ACTIVATION AFFECT EXCITABILITY OF HIPPOCAMPAL 
NEURONES?  
2. HOW DOES PAR-2 ACTIVATION MODULATE SYNAPTIC TRANSMISSION AND 
SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS?  
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3. HOW DOSE PAR-2 ACTIVATION INFLUENCE ACTIVITIES AND GROSS 
EXCITABILITY OF NEURAL NETWORKS IN THE HIPPOCAMPUS? 
4. HOW DOSE PAR-2 MEDIATE MODULATORY ACTIONS IN THE HIPPOCAMPUS AT 
THE CELLULAR AND SYNAPTIC LEVELS? 
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2 Materials and Methods 
2.1 Primary hippocampal culture experiments 
2.1.1 Preparation of primary culture of hippocampal neurones 
Cultured hippocampal neurones were prepared as previously described 
(Greenwood et al., 2007). As presented in figure 2.1, 1-2 days old, male and 
female, Sprague Dawley rat pups were killed by cervical dislocation according to 
U.K. Home Office Schedule 1 guidelines under the authority of U.K. Animals 
(Scientific Procedures) Act, 1986. At least 3 rat pups were sacrificed in each 
culture preparation. The skull was opened through the midline by a sterilised No. 
22 scalpel blade (Swann Morton Limited, UK). The whole brain was rapidly 
removed by a spatula, placed on a piece of sterilised filter paper and bisected 
by a sterilised No.11 blade (Swann Morton Limited, UK). Hippocampi were 
carefully dissected away from surrounding brain tissue from both hemispheres 
and submerged into a sterilised preparation buffer filtered by 0.2m pore 
diameter syringe filter unit (Cronus, UK) of the following composition: 
NaCl (116mM) 
KCl (5.4mM) 
NaHCO3 (26mM) 
NaH2PO4 (1.3mM) 
MgSO4·7H2O (1mM) 
CaCl2·2H2O (1mM) 
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Ethylenediaminetetraacetic acid (EDTA)  (0.5mM) 
Glucose (25mM) 
PH was adjusted to 7.4 
Hippocampi were then, transferred onto a sterilised lid of a 35mm diameter cell 
culture dish (BDbiosciences, UK), and finely chopped into pieces by a sterilised 
No.11 scalpel blade to increase surface area. Processed tissue was transferred 
into a 15ml centrifuge tube (Cronus, UK) filled with 5ml fresh preparation buffer 
supplemented with 1.5mg/ml papain (Sigma, UK) at 37 degree Centigrade for 20 
minutes to allow enzymatical dissociation of cells. The tissue was then 
transferred to 6ml fresh preparation buffer supplemented with 10mg/ml bovine 
serum albumin (BSA) (Sigma, UK), to stop papain’s digesting activity, and 
triturated with three flame-polished glass Pasteur pipettes of decreasing 
diameter from 3mm to 1mm. The tissue suspension was then centrifuged at 
2000rpm for 3 minutes. A small pellet formed in the bottom of centrifuge tube 
following centrifuge, and was removed by a pipette (Gilson, UK) with minimal 
preparation buffer, and resuspended in a fresh 15ml centrifuge tube filled with 
Neurobasal-A media (Invitrogen, UK) supplemented by 2% (volume) B-27 
(Invitrogen, UK) and 2mM L-glutamine (Invitrogen, UK) with a cell density of 5 X 
105 cells/ml.   
Following enzymatical and mechanical dissociation, cells were plated onto 
sterilised 13mm diameter glass coverslips coated with L-Lysine (200g/ml, at 
least 1 hour to ensure good cell adhesion) at a density of 3.5X105 cells/ml. 
Coverslips with cell suspension were maintained in 35mm diameter cell culture 
dishes (3 coverslips in 1 culture dish) in an incubator with an environment of 95% 
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O2/ 5% CO2 at 37 degree Centigrade for at least 1 hour to allow cells to settle 
down. After this period, each culture dish was supplied by 2ml Neurobasal-A 
media supplemented by B-27 and L-glutamine with same concentrations 
described above. No antibiotic agent was employed in all culture preparations. 
After 5 days in culture, cytosine-D-arabinofuranoside was added with 10M final 
concentration to inhibit glial proliferation.  
Cultures were monitored daily with any culture infected by bacteria or fungi as 
indicated by the change of media colour from pink to yellow being disregarded. 
Health conditions of neurones were examined under microscope in terms of gross 
morphology, processes branching pattern, and cell settlement status (clustered 
or scattered). Unhealthy cultures were excluded in the following experiments.  
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Figure 2-1 Schematic flow chart of primary hippocampal culture preparation. 
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2.1.2 Patch clamp recordings in cultured hippocampal neurones 
2.1.2.1 Patch clamp recording setup 
As shown in figure 2.2, a recording platform (Gibraltar Burleigh, Canada) was 
mounted with a submerged recording chamber (Custom design), a 
micromanipulator (EXFO Burleigh PCS-6000-150, Canada) and an upright 
microscope (Olympus, USA). This itself was fixed on an anti-vibration table 
(Intracel system 2000). A faraday cage covered the whole recording system to 
protect it from external electrical noises. All electrical equipment including the 
amplifier (Axoclamp 200B, Axon instrument, USA), the digitizer (Digidata 1322A, 
Axon instrument, USA), and the micromanipulator power supply (EXFO Burleigh 
PCS-6000-150, Canada) were secured in an equipment rig and commonly 
grounded from the anti-vibration table.  
Filled glass pipettes were mounted into a head stage (Axon instrument, USA) 
with the intracellular solution making electrical contact with the silver chloride 
electrode. A silver chloride bath reference electrode was also connected to the 
head stage. Subsequently, the head stage was connected to the Axoclamp 200B 
amplifier. Neuronal activities in the experiments were captured by the amplifier 
and filtered by a built-in low pass Bessel filter at 2 KHz, digitised by a digitizer 
(Digidata 1322A, Axon instrument, USA) at 10 KHz and stored in a personal 
computer (Dell, USA).  
2.1.2.2 Recording procedure 
Both voltage clamp and current clamp recording were performed in DIV (days in 
vitro) 13-16 days cultured neurones because of their matured status with stable 
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intrinsic properties. Glass micropipettes (1.5mm O.D. x 0.86mm I.D. Harvard 
Apparatus, UK)  were pulled by an electrode puller (DMZ-Universal, Germany), 
and filled with an intracellular solution with the following composition with a 
final resistance of 3-5MΩ: 
KCl (150mM) 
MgCl2 (1mM) 
CaCl2 (1mM) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (10mM) 
EGTA (0.5mM)  
Mg-ATP (3mM) 
GTP (0.3mM) 
pH was adjusted to 7.2 
Osmolarity was adjusted to 290mOsm 
Cultured neurones were continuously perfused by a HEPES based saline solution 
with the following composition: 
NaCl (140mM) 
KCl (5mM) 
MgCl2 (2mM) 
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CaCl2 (2mM) 
HEPES (10mM) 
D-Glucose (10mM) 
pH was adjusted to 7.4 
Osmolarity was adjusted to 310mOsm. 
Whole cell voltage and current clamp recordings were obtained from cultured 
hippocampal neurones under microscopic visualization. Briefly, a healthy 
neurone was chosen by its shiny, smooth cell surface. No positive pressure was 
employed during advancing the electrode towards the targeted cell. A 10mV 
voltage step was applied through the pipette to generate a current pulse to 
calculate the electrode resistance. Once the electrode tip touched the cell 
membrane (seen by a robust reduction of the amplitude of the current pulse), a 
slight negative pressure was applied to the pipette to form a high resistance seal. 
A further application of -70mV voltage command facilitated the formation of 
‘gigoseal’. Once the ‘gigoseal’ was achieved, short suctions were given to 
rupture the membrane patch but leaving the ‘gigoseal’ intact to obtain the 
whole cell patch clamp configuration.  
During pharmacological manipulation, chemical agents were supplied through 
the perfusate. Either whole cell voltage or current clamp mode was chosen 
according to experimental design. In voltage clamp mode, holding currents and 
spontaneous synaptic currents were recorded, whereas in current clamp mode, 
membrane potential and spontaneous synaptic potentials were monitored. 
During each experiment, fast capacitance was fully compensated. No slow 
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capacitance and series resistance compensation were applied. Input resistance 
was not monitored throughout the recording process.  
Upright 
microscope
Submerged 
recording chamber Micromanipulator Headstage
Anti-vibration
table
Manipulator 
power
Digitizer Amplifier Personal Computer
Faraday 
Cage
Recording
platform
 
Figure 2-2 Photograph showing the actual setup used in patch-clamp experiments. 
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2.2 Acute hippocampal slice experiments 
2.2.1 Preparation of acute hippocampal slices 
Male and female Wistar rats (16-24 days old) were killed by cervical dislocation, 
followed by decapitation in accordance with U.K. Home Office Schedule 1 
guidelines under the authority of the U.K. Animals (Scientific Procedures) Act, 
1986. 
The brain was removed quickly and immersed in ice-cold (0-4 degree Centigrade) 
oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (ACSF) solution of the 
following composition (in mM): NaCl,124; KCl, 3; NaHCO3, 26; NaH2PO4, 1.25; 
MgSO4 1; D-glucose, 10; CaCl2, 2 (McNair et al., 2006). As shown in figure 2.3, 
the brain was further hemisected, and each part was glued to the stage of a 
vibrating microtome (Campden Instruments Ltd). Transverse whole brain slices 
(400m) were cut in the parasagittal plane and hippocampal regions dissected 
free from surrounding brain tissue before being transferred to an interface 
holding chamber in a humidified and oxygen-enriched (95% O2, 5% CO2) 
atmosphere for at least 1 hour for equilibrium from slicing trauma. Subsequently, 
slices were transferred into a humidified and oxygen-enriched (95% O2, 5% CO2) 
atmosphere interface recording chamber maintanined at 28-32 degree 
Centigrade and perfused by ACSF oxygenated by 95% O2 and 5% CO2 at a flow 
rate of 6-8ml/minute powered by a peristaltic pump (Minipuls 3, Gilson, France) 
for subsequent recording.  
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Figure 2-3 Process and orientation of parasagittal slice preparation. 
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2.2.2 Extracellular recording in acute hippocampal slice 
preparations 
2.2.2.1 Extracellular recording setup 
An interface recording chamber (HAAS-type, Berlin), a binocular (Zeiss, 
Germany), two micromanipulators (Narishige, Japan; Leica, Germany) and a 
lamp were secured on an anti-vibration table (Intracel, UK). Alongside, an 
amplifier (AxoClamp 2B, Axon instrument, USA), a digitizer (Digidata 1320A, 
Axon instrument), a 50Hz line noise eliminator (Hum Bug, Quest scientific), an 
instrumental amplifier (Model 440, Brownlee precision) and a PC were secured 
into a rig. A photo of this setup is presented in figure 2.4. 
The experimental design is as described previously (McNair et al., 2006). 
Stimulating current was delivered through a bipolar tungsten stimulating 
electrode of 3.5MΩ resistance (World Precision Instruments, USA) using an 
isolated constant current stimulator (Model D52A, Digitimer Ltd., UK). The 
current range is from 0-30mA. Pulse duration is 0.1ms. Recording electrodes 
were made from standard walled (1.2mm O.D. X 0.69 I.D.) borosilicate glass 
capillaries (Harvard Apparatus, UK) on a Flaming/Brown micropipette puller 
(Model P-87, Sutter Instrument Co., USA). The electrodes (3-5MΩ) were filled 
with ACSF solution and were connected via a silver chloride pellet containing 
electrode holder to a headstage (HS2A, Axon Instrumental).  
Pre-amplification (x100) was carried out by AxoClamp 2B amplifier (Axon 
instruments, USA). Further amplification (x20) was carried out by a Brownlee 
instrumentation amplifier (Model 440, Brownlee Precision, USA) giving a total 
amplification of x2000. A Hum Bug 50/60Hz noise eliminator (Quest Scientific, 
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UK) was used to eliminate 50Hz line frequency noise where necessary. Data were 
captured by Digidata 1320A analogue-to-digital acquisition board (Axon 
Instrument) and transferred directly to the hard-disc of a PC (Viglen Pentium 4) 
at a rate of 10 KHz. 
Amplifier Isolated stimulator Micromanipulators Pump
Instrumental
amplifier
Hum Bug HeadstageInterface recording
chamber
Personal
computer
 
Figure 2-4 Photograph showing the actual setup used in extracellular recording experiments. 
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2.2.2.2 Extracellular recording procedure 
After at least 1 hour equilibration time for hippocampal slices, a single recording 
electrode was placed on the stratum radiatum in the CA1 region of hippocampal 
slice. A single stimulating electrode was placed in stratum radiatum of either 
side of recording electrode to stimulate Schaffer collateral pathway. Small 
stimulating current pulses (0-30mA, 0.5ms) were administrated to test for the 
presence of field excitatory postsynaptic potentials (fEPSP) responses. Once 
synaptic potentials were observed, input-output (I/O) curve was obtained by 
gradually increasing stimulating current and monitoring fEPSP responses (see 
figure 2.5). The stimulating current which gave the half maximum fEPSP 
response was then used for the remainder of experiment. Measurements of 
synaptic response were typically monitored in terms of initial slope. The window 
for slope measurement was typically in the range of 2 to 6 ms following 
stimulation.  
As shown in figure 2.6, fEPSPs were evoked at frequency of 0.05 Hz in the 
stratum radiatum of area CA1. Paired-pulse facilitation (PPF) was investigated 
at 50ms intersimulus interval. High-frequency stimulation paradigm of 100Hz 
high frequency stimulation (HFS) for 1 second was used to induce long term 
potentiation (LTP). Synaptic efficacy was monitored at least 20 minutes before 
and 60 minutes after induction by recording fEPSP responses every 20s (traces 
were averaged for every minute interval). Slices that did not exhibit stable 
fEPSP slopes during 20 minutes baseline recording were excluded from the study. 
For studies to investigate the action of PARs activation during in vitro 
epileptiform activity, field epileptiform activities were recorded from in stratum 
pyramidale of area CA3 in response to the application of the potassium channel 
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blocker 4-aminopyridine (4-AP, 100M) & 0 Mg2+ or GABAA receptor antagonist 
bicuculline (20 M) via the perfusate.  
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Figure 2-5 Glutamatergic synaptic transmission in the CA1 region of rat hippocampus. 
A.   Example of an excitatory post synaptic potential (EPSP) recorded  
      in the stratum radiatum of area CA1 of rat hippocampus. Arrow  
      represents time of stimulation. Note the dashed line indicates slope measurement. 
B    A representative Input-output curve recorded in the same experiment. 
      Note the recorded pathway required approximately 28A to reach a half 
      maximum response (dotted line). 
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Figure 2-6 Schematic diagram illustrating the positions of electrodes for extracellular field 
recordings.  
  
2.3 Data analysis 
All data from patch-clamp recording in primary culture was analysed online and 
offline using the software package pClamp9 (Axon Instrument, USA). All data 
from extracellular recordings in acute hippocampal slices were analysed online 
and offline using the software packages WinLTP (Anderson & Collingridge, 2007), 
Excel 2003 (Microsoft, USA) and pClamp9 (Axon Instrument, USA). Epileptiform 
activities in chapter 5 were analysed using threshold based detection mode in 
pClamp9 (Axon Instrument, USA). All data were graphically illustrated using 
GraphPad Prism 5.0 (GraphPad Software, USA).  Data are presented as means ± 
standard error of the mean (SEM). The n value refers to the number of times a 
particular experiment was performed. 
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Statistical significance was determined by Student t-test, paired Student t-test. 
Statistical test was performed using Graph Pad 5.0 (GraphPad Software, USA). If 
not indicated in the context, in chapter 3, either mean (for bar charts) or peak 
values (for time plots) of drug effect were compared with controls. In chapter 4 
and 5, either mean values (for bar charts) or values from the last minute of drug 
application period (for time plots) were tested with controls. A probability value 
of less than 0.05 was taken as indicating statistical significance.  
2.4 Drugs and Chemicals 
PAR peptides, namely, PAR-2-APs, SLIGRL-NH2  and 2-furoyl-LIGRL-NH2, PAR-2 
inactive peptide (PAR-2-IP), LRGILS-NH2, PAR-1 activating peptide (PAR-1-AP), 
TFFLRL-NH2, and PAR-4 activating peptide (PAR-4-AP), AYPGKF-NH2 were 
purchased from either the Peptides Synthesis Facility at the University of Calgary 
(Canada) (http://wcm2.ucalgary.ca/peptides) or Peptides Synthetics (UK) 
(www.peptidesynthetics.co.uk). All the other chemicals employed in this thesis 
were obtained from Ascent Scientific (UK), Sigma-Aldrich (UK) or VWR (UK).  
All drugs were dissolved in physiological saline employed according to 
experimental design (ACSF or HEPES based buffer). PAR peptides solutions were 
made fresh immediately before each experiment. All the other drugs were 
prepared in physiological saline by 1 in 1000 dilution from stock aliquots to the 
final working concentration.    
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3 The action of PAR activation on neuronal 
excitability and synaptic transmission in 
cultured hippocampal neurones 
3.1 Introduction and aims 
As described in Chapter 1, PARs are expressed widely throughout the central 
nervous system. In the hippocampus, PARs have been confirmed to be expressed 
in neurones, astrocytes, oligodendrocytes, and microglia (Striggow et al., 2001; 
Noorbakhsh et al., 2003; Bushell et al., 2006; Luo et al., 2007). In recent years, 
PAR involvement during pathological conditions in the brain have been 
extensively described (Noorbakhsh et al., 2003; Luo et al., 2007), however, their 
potential modulatory roles in regulating intrinsic neuronal and synaptic 
properties during physiological conditions are only partially understood. Indeed, 
cellular level study has shown PAR-1 involvement in normal neuronal signalling in 
the brain (Almonte et al., 2007). However, much less is known about PAR-2 
receptors in this context. 
Primary hippocampal cultured neurones are extensively utilised as an in vitro 
system to investigate neuronal and synaptic properties of glutamatergic and 
GABAergic neurones. Despite obvious shortcomings of this system in terms of a 
lack of normal patterns of brain connectivity and the need to obtain samples 
from immature tissues, the system nevertheless has many technical benefits. For 
instance, it is easy to identify and patch or image single neurone or glia. Being a 
reduced system, it is also readily accessible to pharmacological and other 
manipulations. Due to these factors, I decide to utilise this culture system in my 
experiments to provide an initial characterisation of PAR-2 receptor actions in 
central neurones.  
The specific aim of the experiments described in this chapter was to evaluate 
the possibility that PARs activation modulates neuronal excitability and synaptic 
transmission in cultured neurones. For this, I utilised whole cell patch clamp 
recording technique in dissociated hippocampal neurones. 
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3.2 Characterisation of spontaneous activities in cultured 
hippocampal neurones under whole-cell voltage 
clamp configuration 
In order to evaluate whether PAR-2 activation has modulatory effect on synaptic 
transmission in the network formed by cultured hippocampal neurones,  whole-
cell voltage clamp recordings were made initially in 10 cultured hippocampal 
neurones from 5 separate culture preparations (~3-4 rats for each) to monitor 
spontaneous synaptic activities. Upon obtaining whole-cell recording 
configuration, membrane potentials of neurones was first monitored before the 
cell was voltage-clamped at -70mV. All neurones with a resting membrane 
potential more positive to -55mV were disregarded. Mean holding current in 
these experiments was -32.52 ± 11.52pA (n=10). As shown in one representative 
recording (Fig 3.1), the spontaneous whole cell synaptic currents consisted of 
two major activities. 1) Subthreshold excitatory post synaptic currents (EPSCs). 2) 
Superthreshold EPSCs compounded with AP discharges. This activity was 
characterised with the spatiotemporal summation of several EPSCs, which broke 
in the threshold, resulting in AP firing.  
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Figure 3-1 Characterisation of spontaneous activities in cultured hippocampal neurones 
under voltage clamp. 
A. Representative current trace from a cultured hippocampal neurone (cell number 170507/1) 
clamped at -70mV. Note the presence of both spontaneous inward synaptic currents* 
(EPSCs) and large events representing unclamped action potentials**. B. Excerpts of trace 
showing (B) a representative subthreshold EPSC and (C) a representative action potential 
event. D. Current trace showing summation of EPSCs (arrows) leading to an action potential 
event and loss of voltage clamp***. 
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3.3 Trypsin increases holding current and spontaneous 
activity in cultured hippocampal neurone under 
voltage clamp 
PAR-2 is preferentially activated by the proteinase, trypsin (Macfarlane et al., 
2001; Ossovskaya & Bunnett, 2004). Thus, trypsin was used as a PAR-2 activator 
to test the effect of PAR-2 activation on cultured hippocampal neurones in initial 
experiments. Whole-cell voltage clamp recordings were carried out on 10 
cultured hippocampal neurones from 5 separate preparations. As presented in 
Fig 3.2B, application of 100nM trypsin of 5 minutes duration induced a significant 
yet reversible increase of holding current value from -27.84 ± 11.65pA to -548.62 
± 160.40pA (P=0.0055, n=10). Upon washout, the holding current recovered back 
to -58.13 ± 13.54pA. The sustained inward current upon trypsin application 
would be consistent with a membrane depolarisation where the cells were held 
under physiological current clamp conditions. The recordings also revealed a 
significant yet reversible increase of the frequency of spontaneous synaptic 
activities in these neurones from 5.51 ± 0.86Hz to 8.24 ± 1.05Hz (P=0.0092, n=10) 
in response to 100nM trypsin application as presented in Fig 3.2C. These data 
suggest that trypsin gives rise to an increase of frequency of synaptic inputs 
experienced by the recorded neurone.  
One interpretation of this result is that the membrane depolarisation and 
increased EPSC frequency is due to activation of PAR-2 receptors in response to 
trypsin application. However, whilst trypin shows relative selectivity towards 
PAR-2, it has been shown to activate other PARs, albeit at higher concentrations 
(Noorbakhsh et al., 2003; Ossovskaya & Bunnett, 2004). Moreover, the 
proteolytic action of trypsin on the cell membrane could lead to bioactive 
processes other than PARs activation. For instance, proteolytic action may  
release soluble ligands, activate enzyme precursors, and inactivate agonists 
(Ossovskaya & Bunnett, 2004). Thirdly, trypsin is potentially a stressor for the 
cultured neurones given its nature of digesting activity. Therefore, these data 
from the initial experiments suggest that the trypsin-induced membrane 
depolarisation and enhanced synaptic activities in cultured neurones may be 
partially mediated by PAR-2 activation, but the alternative explanations 
  96 
described above can not be ruled out. In subsequent experiments, I therefore 
switched to the use of PAR-2-AP, SLIGRL.  
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Figure 3-2 Action of trypsin on cultured hippocampal neurones. 
A. Representative recording (cell number 200607/3) illustrating the effect of 100nM trypsin 
on holding current and spontaneous activities. Excerpts before and during trypsin 
application as shown on an expanded time scale below. Note an increase of the holding 
current immediately following trypsin (100nM) application and the substantial increase in 
the occurrence of subthreshold inward synaptic currents. B. Bar chart summarising 
quantitative analysis of holding current before and after trypsin application. Note that 
100nM trypsin results in a significant but reversible increase in holding current (n=10, 
P=0.0055). C. Bar chart showing a significant increase in the frequency of spontaneous 
inward synaptic currents following 100nM trypsin application (n=10, P=0.0092). 
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3.4 Characterisation of spontaneous activities in cultured 
hippocampal neurones under whole-cell current 
clamp configuration 
The high levels of spontaneous APs observed in the cultured neurones recorded 
previously under voltage clamp conditions demonstrated space clamp problems 
and specifically, an inability to adequately clamp neurones sufficient to avoid AP 
discharge. I therefore switched recording configuration in all subsequent cellular 
studies to current clamp mode. This had the added advantage of maintaining the 
neurones under more physiological conditions.  
All neurones, with membrane potential more positive than -55mV, were 
excluded from the data set. Initially, 7 cultured hippocampal neurones from 4 
separate preparations were recorded to characterise the electrical properties 
and the spontaneous activities in these cells. The mean resting membrane 
potentials of these neurones was -61.31 ± 0.56mV (n=7). As demonstrated by a 
representative voltage trace in Fig. 3.3, the cells recorded under baseline 
conditions displayed spontaneous activities consisted of two major events: 1) 
Subthreshold excitatory postsynaptic potentials (EPSPs), which had a mean 
amplitude of 8.46mV ± 0.58mV with a mean frequency of 0.72 ± 0.25 Hz (n=7) 2) 
Spontaneous overshooting APs with a mean amplitude of 88.12 ± 4.72mV with a 
mean frequency of 1.45 ± 0.25 Hz (n=7).  
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Figure 3-3 Characterisation of spontaneous activities in cultured hippocampal neurones 
under current clamp. 
A. Representative voltage trace from a cultured hippocampal neurone (cell number 210607/2) 
at resting membrane potential (zero current injection). Note the presence of both 
spontaneous subthreshold excitatory postsynaptic potentials (EPSPs) and suprathreshold 
EPSPs giving rise to action potentials**. B. Excerpts of trace above showing (B) a 
representative subthreshold EPSP and C. a representative suprathreshold EPSP / action 
potential.  
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3.5 Trypsin depolarises cultured hippocampal neurones 
and increases the occurrence of spontaneous action 
potentials 
Initially, trypsin was used to repeat the experiments conducted previously under 
voltage clamp conditions. Bath application of trypsin (100nM) significantly 
depolarised the membrane potential of the recorded neurones with the mean 
magnitude of 15.50 ± 5.29mV (n=7, P=0.026, figure 3.4C). An increase of AP 
frequency was also noticed following trypsin application. However, due to the 
high variance, this effect did not achieve statistical significance (251.11 ± 
81.52% of control level, n=7, P=0.11, figure 3.4D). Given trypsin is reported to 
irreversiblely cleave and activate the functional PAR-2s on the cell membrane, a 
further application of trypsin was introduced to test whether the second 
application was able to evoke further membrane depolarisation and / or increase 
AP discharge. In contrast to the first application in which all cell respond with a 
depolarisation, overtly, the second application resulted in neither significant 
depolarisation (8.10 ± 4.90mV, n=7, P=0.1497, figure 3.4E) nor increase of AP 
frequency (174.14 ± 56.98% of control, n=7, P=0.2375, figure 3.4F). Dissecting 
into these cells more closely, only 3 of 7 cells responded to a second application 
with 4 out of all 7 neurones showing no detectable change in membrane 
potential (0.63 ± 0.99mV, n=4, figure 3.4B) or change in firing frequency (110.15 
± 26.77% of control, n=4, figure 3.4B). However, in 3 of 7 neurones examined, 
the second application of trypsin (100nM) produced a similar magnitude of 
depolarisation (mean magnitude = 19.72 ± 6.92mV, n=3) and increase in AP 
frequency (260.86 ± 121.66%, n=3). Again however, these effects did not achieve 
statistical significance, presumably due to low replicate numbers. 
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Figure 3-4 Effect of repeated trypsin application on membrane potential and action potential 
frequency. 
A. Representative current clamp recording upon application of 10nM trypsin and showing 
the characteristic depolarisation and increase in EPSP and action potential frequency. B.  
Following a 10 minute washout period, a second application of 100nM trypsin did not 
produce any detectable response. C-E. Bar chart showing pooled data. Note that a 
significant membrane depolarisation was observed (C) yet increase of firing frequency (D) 
did not achieve significant upon 1st trypsin application. 2nd application of trypsin did not 
cause significant membrane depolarisation (E) and increase of AP frequency (F). 
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3.6 PAR-2 activating peptide, but not PAR-2 inactive 
peptide depolarises neuronal membrane and 
depresses spontaneous action potential firings 
In order to refine the experimental approach and discriminate the involvement 
of PAR-2 receptors over other PAR subtypes, the synthetic PAR-2 activating 
peptide (PAR-2-AP), SLIGRL-NH2, was used. This peptide agent has been 
confirmed previously to possess high selectivity for murine PAR-2 (EC50=5M) 
(Nystedt et al., 1994; al-Ani et al., 1995; Nystedt et al., 1995b; Saifeddine et al., 
1996). It is utilised to overcome the disadvantage of lack of selectivity and the 
potential ‘off-target’ effect in previous experiments with trypsin. 100μM 
concentration, which has been used in expression system to evoke maximal 
response of PAR-2 (Nystedt et al., 1995b), and was similar to previous study in 
investigating Ca2+ mobilisation by PAR-2 activation in cultured hippocampal 
neurones and astrocytes (Bushell et al., 2006),  was selected initially to test the 
effect of PAR-2 activation in cultured hippocampal neurones. Under current 
clamp recording, as presented in figure 3.5, bath application of PAR-2-AP 
significantly depolarised the neuronal membrane with the mean magnitude of 
9.19 ± 1.22mV (n=5, P=0.0016). Furthermore, alongside the membrane 
depolarisation, a significant depression of spontaneous AP firings was observed 
(65.72 ± 4.62% compared to control level, n=5, P=0.013). These data suggested 
PAR-2 activation depolarised neuronal membrane in hippocampal culture under 
autonomous resting membrane potential conditions. However, the quantification 
of this depolarisation was hampered by the fact that the neurones being tested 
were of differential resting membrane potentials (range = -70mV to -60mV). To 
eliminate this variable, neurones were monitored under an equal baseline 
membrane potential of -65mV (close to the recognised physiological value), by 
tonic current injection (<200pA). Under these conditions, three concentrations 
of PAR-2-AP were tested. Interestingly, bath application of PAR-2-AP (1, 10, and 
100M) induced depolarisation of neuronal membrane in a concentration-
dependent manner with the mean magnitude of 0.62 ± 0.86mV (1M, n=12, 
P=0.4872), 1.39 ± 0.58mV (10M, n=11, P=0.038), and 5.52 ± 1.48mV (100M, 
n=16, P=0.026) respectively as shown in figure 3.6B. This was accompanied by a 
concentration-dependent depression of spontaneous APs to 85.36 ± 11.84% (1M, 
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n=7, P=0.9314), 75.79 ± 6.11% (10M, n=6, P=0.1403) and 29.63 ± 5.03% (100M, 
n=13, P=0.0001) of control (drug free) conditions respectively as shown in figure 
3.6C.  
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Figure 3-5 Action of the PAR-2-AP, SLIGRL, on cultured hippocampal neurones under 
autonomous membrane potential. 
A. Representative recording (cell number 141107/1) illustrating the effect of 100M PAR-2-
AP on the holding current and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before and during PAR-2-AP application as shown on an expanded time scale 
below. Note the sustained depolarisation immediately following PAR-2-AP (100M) 
application and the substantial decrease in the occurrence of spontaneous action potentials. 
B. Bar chart summarising quantitative analysis of membrane potential before and after PAR-
2-AP application (n=5, P=0.0016). C. Bar chart showing a significant decrease in the 
frequency of spontaneous action potentials following 100M PAR-2-AP application (n=5, 
P=0.013).  
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Figure 3-6 Action of the PAR-2-AP, SLIGRL on cultured hippocampal neurones clamped at -
65mV. 
A. Representative recording (cell number 121108/2) illustrating the effect of 100M PAR-2-
AP on holding current and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before and during PAR-2-AP application as shown on an expanded time scale 
below. Note that all cells received somatic current injection to set the membrane potential to 
-65mV prior to drug application. B. Time plot showing the action of 1, 10 and 100M PAR-2-
AP on mean membrane potential. Quantitative analysis revealed a concentration-dependent 
depolarisation (1M, n=12, P=0.4872; 10M, n=11, P=0.038; 100M, n=16, P=0.026). C. Time 
plot showing a concentration-dependent decrease in the frequency of spontaneous action 
potentials following the application of 1, 10 and 100M PAR-2-AP application (1M, n=7, 
P=0.9314; 10M, n=6, P=0.1403; 100M, n=13, P=0.0001).  
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To further verify the membrane depolarisation and depression of spontaneous 
APs were indeed a result of selective PAR-2 activation rather an artefact 
introduced by the chemical nature of synthetic peptide, synthetic PAR-2 inactive 
peptide (PAR-2-IP), LRGILS-NH2, which has a scrambled (reversed) amino acid 
sequence compared to PAR-2-AP was applied as a ‘negative control’. Again, 
these experiments were conducted both under resting membrane conditions and 
with the cells maintained at -65mV through somatic current injections. As 
expected, bath application of 100μM PAR-2-IP did not depolarise neurones 
maintained at resting membrane potential (control: -63.04 ± 1.53mV, upon PAR-
2-IP: -59.98 ± 2.64mV, n=10, P=0.16, figure 3.7B). Furthermore, no significant 
change in the frequency of spontaneous APs was observed (117.05 ± 10.62% 
compared to control level, n=9, P=0.15, figure 3.7C). Similarly, PAR-2-IP applied 
to neurones maintained at -65mV showed no change in membrane potential 
(0.61 ± 0.31mV, n=8, P=0.0915, figure 3.8B) or AP frequency (91.55 ± 7.63%, n=8, 
P=0.3049, figure 3.8C). 
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Figure 3-7 Action of the PAR-2-IP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 200308/2) illustrating the effect of 100M PAR-2-IP 
on holding current and spontaneous activities in a cultured hippocampal neurone. Excerpts 
before and during PAR-2-IP application as shown on an expanded time scale below. Note 
absence of any detectable change in membrane potential or spontaneous action potential 
frequency following PAR-2-IP application. B. Bar chart summarising quantitative analysis of 
membrane potential before and after PAR-2-IP application (n=10, P=0.16C. Bar chart of 
pooled data showing no significant change in the frequency of spontaneous action 
potentials following 100M PAR-2-IP application (n=9, P=0.15).  
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Figure 3-8 Action of the PAR-2-IP on cultured hippocampal neurones normalised to 
membrane potential of -65mV. 
A. Representative recording (cell number 080409/1) illustrating the effect of 100M PAR-2-IP 
on holding current and spontaneous activities in a cultured hippocampal neurone. Excerpts 
before and during PAR-2-IP application as shown on an expanded time scale below. Note 
that all cells received somatic current injection to set the membrane potential to -65mV prior 
to drug application. B. Time plot showing the action of 100M PAR-2-IP on mean membrane 
potential. Quantitative analysis revealed no significant change in membrane potential (n=8, 
P=0.09, cf. robust depolarisation following PAR-2-AP, blue symbols). C. Time plot showing  
no significant change in the frequency of spontaneous action potentials following the 
application of 100M PAR-2-IP application (n=8, P=0.30, cf. robust decrease of action 
potential frequency following PAR-2-AP, blue symbols).  
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3.7 PAR-1 and PAR-4 activating peptides depolarise 
membrane of cultured hippocampal neurones. 
After establishing the fact that PAR-2 activation induced membrane 
depolarisation and depressed spontaneous AP firings in cultured neurones, my 
investigation extended to assess whether the other two functional PAR family 
members, PAR-1 and PAR-4, have modulatory roles in cultured hippocampal 
neurones. To this end, 100μM PAR-1 activating peptide (PAR-1-AP), TFLLR-NH2, 
was applied to cultured neurones under identical recording conditions. As 
presented in figure 3.9, a significant membrane depolarisation was observed 
(11.61±1.50mV, n=8, P=0.0078). However, unlike that seen with PAR-2-AP, the 
PAR-1-AP did not cause any significant change in the frequency of spontaneous 
APs (103.90±9.08%, n=8, P=0.68). This clear membrane depolarisation but lack of 
effect of AP frequency was apparent both when cells where maintained at 
resting membrane potential and at -65mV (membrane depolarisation: 
3.26±0.27mV, n=12, P=0.0006, figure 3.10B; change of firing frequency: 
105.89±14.06%, n=10, P=0.7301, figure 3.10C).  
Finally, we also assessed the action of the PAR-4-AP, AYPGKF-NH2. These studies 
were hampered by the very limited availability of the peptide but preliminary 
data showed a depolarisation (8.35±5.07mV, n=4, P=0.19, 100μM) but this did 
not achieve statistical significance. Similar to PAR-1 response, no change was 
detected in frequency of spontaneous APs upon PAR-4-AP application 
(110.68±13.80%, n=4, P=0.49).  
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Figure 3-9 Action of the PAR-1-AP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 111107/3) illustrating the effect of 100M PAR-1-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before and during PAR-1-AP application as shown on an expanded time scale 
below. Note the depolarisation and transient decrease in the occurrence of spontaneous 
action potentials immediately following PAR-1-AP (100M). B. Bar chart showing a 
significant membrane depolarisation following PAR-1-AP application (n=8, P=0.0078). C. In 
contrast, changes in the frequency of spontaneous action potentials following 100M PAR-
1-AP application did not achieve statistical significance (n=8, P=0.68).  
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Figure 3-10 Action of the PAR-1-AP on cultured hippocampal neurones normalised to 
membrane potential of -65mV. 
A. Representative recording (cell number 140609/1) illustrating the effect of 100M PAR-1-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before and during PAR-1-AP application as shown on an expanded time scale 
below. Note that all cells received somatic current injection to set the membrane potential to 
-65mV prior to drug application. B. Time plot showing the action of 100M PAR-1-AP on 
mean membrane potential. Quantitative analysis revealed significant depolarisation upon 
drug application (n=12, P=0.0006). C. Time plot showing no significant change in the 
frequency of spontaneous action potentials following the application of 100M PAR-1-AP 
application (n=10, P=0.73).  
  110 
20mV
20s
A
B C
PAR-4-AP
Control PAR-4-AP Washout
-60
-40
-20
0
M
em
br
an
e 
po
te
nt
ia
l (
m
V)
20mV
1s
Co
ntr
ol
PA
R-
4-A
P
Wa
sh
ou
t
0
50
100
150
N
or
m
al
iz
ed
 A
P 
fr
eq
ue
nc
y 
%
 
Figure 3-11 Action of the PAR-4-AP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 090807/1) illustrating the effect of 100M PAR-4-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before and during PAR-4-AP application as shown on an expanded time scale 
below. Note the depolarisation and transient decrease in the occurrence of spontaneous 
action potentials immediately following PAR-4-AP (100M). B. Bar chart showing no 
significant membrane depolarisation following PAR-4-AP application (n=4, P=0.19). C. In 
contrast, changes in the frequency of spontaneous action potentials following 100M PAR-
4-AP application did not achieve statistical significance (n=4, P=0.49).  
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3.8 Mechanism underlying PAR-2 activation-induced 
membrane depolarisation in cultured hippocampal 
neurones   
3.8.1 PAR-2 activation-induced neuronal membrane 
depolarisation is dependent on glutamate 
Previous report suggests that PAR-1 receptors in the brain may signal via 
astrocytes rather than direct neuronal mechanisms (Lee et al., 2007). To test 
this hypothesis, the PAR-2-AP experiments were repeated in the presence of a 
cocktail of ionotropic and metabotropic glutamate receptor antagonists (20M 
NBQX, 100M DL-APV, and 500M MCPG). Current clamp recordings from 
cultured hippocampal neurones held at -65mV and bathed in a cocktail of these 
glutamate antagonists revealed that application of 100M PAR-2-AP, SLIGRL, was 
no longer able to induce any distinguishable membrane depolarisation in any 
neurones tested. (Control: -64.28±0.26mV, PAR-2-AP: -64.39±0.44, n=8, mean 
difference=-0.1±0.42mV, P=0.8157). These data are presented in figure 3.12 and 
suggest that glutamate is indeed required to achieve a PAR-2-AP-induced 
neuronal depolarisation. 
After establishing this glutamate dependency, we dissected further into which 
class of glutamate receptors, either ionotropic or metabotropic, was 
contributing to the effect. Therefore, the nonselective group I/II metabotropic 
glutamate receptor antagonist, MCPG was first omitted from the glutamate 
antagonists cocktail. As shown in figure 3.13, application of 100M PAR-2-AP, 
SLIGRL, did not cause significant depolarisation of neuronal membrane in 
present of ionotropic glutamate receptor blockade alone (Control: -65.26 ± 
0.07mV, PAR-2-AP: -65.10 ± 0.18mV, n=8, mean difference=0.16 ± 0.06mV, 
P=0.4678). This data indicated that the PAR-2 modulation of neuroexcitability 
observed in current experimental model was dependent on iontropic glutamate 
receptors.  
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Figure 3-12 Glutamate receptor antagonism prevents PAR-2-induced depolarisation. 
A. Representative current clamp recording showing a lack of membrane response to 100M 
PAR-2-AP in a cell bathed in a cocktail of AMPA/Kainate, NMDA and metabotropic glutamate 
receptor antagonist. B. Pooled data showing a lack of any significant membrane 
depolarisation (n=8, P=0.82). C. Same data represented as a time plot. Horizontal bars in A 
and C represent time of drug administration. 
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Figure 3-13 Iontropic glutamate receptor antagonism prevents PAR-2-induced 
depolarisation. 
A. Representative current clamp recording showing a lack of membrane response to 100M 
PAR-2-AP in a cell bathed in a cocktail of AMPA/Kainate, NMDA glutamate receptor 
antagonist. B. Pooled data showing lack of any significant membrane depolarisation (n=8, 
P=0.47). C. Same data represented as a time plot. Horizonal bars in A and C represent time 
of drug administration. 
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3.8.2 PAR-2 activation-induced neuronal membrane 
depolarisation requires normal astrocytic function 
As glutamate was required for the modulation of neuroexcitability by PAR-2 
activation in current experimental model, a natural question was to investigate 
further the possible source of glutamate. Given that glutamate could be 
released during normal synaptic transmission, experiments were carried out to 
test whether synaptically released glutamate was responsible for this 
dependency. Therefore, current clamp recordings were conducted in neurones 
normalised at -65mV in the presence of the sodium channel blocker tetrodotoxin 
(TTX), which was employed to prevent AP-dependent synaptic transmission. As 
shown in figure 3.14, 0.5M TTX completely abolished the spontaneous AP 
activity as expected. However, surprisingly, application of 100M PAR-2-AP, 
SLIGRL, was still able to produce a significant membrane depolarisation (3.3 ± 
0.62mV, n=8, P=0.0011) in cultured neurones as presented in figure 3.14. 
Considering the fact that PAR-2-induced neuronal depolarisation was glutamate 
dependent, this data strongly suggested that synaptically released glutamate 
was not responsible for PAR-2-induced neuronal depolarisation.  
 
After ruling out the involvement of AP-dependent release of glutamate, the 
possibility of astrocytically released glutamate was next investigated. Several 
studies have demonstrated that activation of GPCRs on astrocytes induce the 
release of gliotransmitters, including glutamate (Araque, 2008; Fiacco et al., 
2009; Santello & Volterra, 2009). Furthermore, recent publication has proposed 
that activation of PAR-1 in astrocytes led to astrocytic release of glutamate (Lee 
et al., 2007). To test the possible involvement of astrocytically released 
glutamate in our experiments we suppressed the metabolic function of 
astrocytes using fluoroacetate (FAc) (Fonnum et al., 1997). This strategy has 
been successfully utilised and verified to depress astrocytic functions in a range 
of culture and slice preparations (Swanson & Graham, 1994; Zhang et al., 2003; 
Gordon et al., 2005; Shigetomi et al., 2008; Henneberger et al., 2010). 
  115 
A
10mV
20s
TTX
PAR-2-AP
B
Control PAR-2-AP Washout
-66
-63
-60
-57
TTX
**
M
em
br
an
e 
po
te
nt
ia
l (
m
V)
 
Figure 3-14 Blockage of action potential-dependent synaptic transmission failes to prevent 
PAR-2-induced depolarisation. 
A. Representative current clamp recording showing a depolarising membrane response to 
100M PAR-2-AP in a cell bathed in the sodium channel blocker, Tetrodotoxin (500nM). B. 
Pooled data showing modest yet significant membrane depolarisation (n=8, P=0.0011).  
  116 
Whole-cell current clamp recordings were carried out as described previously in 
neurones that had been preincubated with 10M FAc for 3 hours. As shown in 
figure 3.15B, application of 100M PAR-2-AP, SLIGRL, to such cells failed to 
induce any significant depolarisation of neuronal membrane (0.19 ± 0.32mV, 
n=10, P=0.5742) In contrast, neurones from the same culture preparation but 
which had not received FAc treatment continued to display a robust depolarising 
response upon 100M SLIGRL application (mean depolarisation = 3.40 ± 0.43mV, 
n=6, P=0.0005). Furthermore, as shown in figure 3.16, no significant change of 
basal spontaneous AP frequency was observed between naïve neurones and FAc 
treated cells (drug free: 1.23 ± 0.08Hz, n=6; FAc treated: 1.30±0.10Hz, n=10, 
P=0.6030), which suggests that the 3 hours incubation with 10M FAc did not 
cause overt physiological damage in cultured neurones.  
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Figure 3-15 Inhibition of astrocytic function prevents PAR-2-AP-induced membrane 
depolarisation. 
A. Representative current clamp recordings form FAc treated (upper trace) or naïve (lower 
trace) neurones obtained from the same culture preparation. Note the presence of a 
membrane depolarisation in the control but not in the FAc-treated cell. B. Time plot 
summarising pooled data confirms 100M PAR-2-AP to produce a depolarisation in naïve 
neurones but not in those treated with FAc (FAc treated, n=10, P=0.57; Naïve, n=6, P=0.0005) 
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Figure 3-16 No significant difference in the frequency of basal spontaneous AP firings from 
naïve neurones and those treated with 10M FAc. 
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3.9 Mechanism underling PAR-2 activation-induced 
depression of the frequency of spontaneous AP 
firings in cultured neurones 
As shown in figure 3.5, PAR-2 activation-induced neuronal membrane 
depolarisation was associated with a profound but paradoxical depression of the 
frequency of spontaneous APs. To examine this phenomenon further, we 
investigated the mechanisms underlying the generation of APs in the dissociated 
culture preparation. 
3.9.1 Spontaneous APs are synaptically driven in nature 
It was first noticed that the spontaneous APs were significantly abolished (10.75 
± 2.97% of control, n=7) in the presence of the cocktail of glutamate receptor 
antagonists (20M NBQX, 100M DL-APV, and 500M MCPG) as showed in figure 
3.17. This observation suggested the occurrence of AP firings in these cultured 
neurones was largely dependent on glutamatergic synaptic transmission within 
the network of cultured neurones. Indeed, on closer inspection, recorded 
cultured neurones were found to receive a constant barrage of EPSPs, many of 
which were suprathreshold for the generation of APs (see figure 3.3). In order to 
further confirm that the majority of spontaneously occurring APs were 
synaptically driven, current-induced depolarisation was first applied by current 
injection through micropipette during current-clamp recording to the magnitude 
similar to that seen with PAR-2 activation (from -65mV to -60mV). In contrast to 
the decrease in firing rate caused by PAR-2 activation, this procedure resulted in 
a predicable and significant increase of the frequency of AP firings (220.85 ± 
24.92% of control, n=15, P=0.0003, figure 3.18). This data supported the 
interpretation that the depression of AP firings seen associated with PAR-2 
receptor activation was not due to a membrane depolarisation per se. We also 
calculated the frequency of sub-threshold EPSPs before and after the application 
of SLIGRL (100M), as shown in figure 3.19. There was a significant reduction of 
sub-threshold EPSP (27.80 ± 5.57% of control, n=7, P=0.0006) occurrence in the 
presence of SLIGRL (100M), suggesting there was indeed a reduction in the 
activity of neurones innervating the recorded neurone. Taken together, these 
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data suggest that the majority of spontaneous APs in the cultured neurones were 
synaptically driven, and furthermore the reduction of the frequency of 
spontaneous AP firings reflected that PAR-2 activation depressed synaptic 
transmission in the cultured neurones. This question is addressed further in the 
next chapter. 
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Figure 3-17 The occurrence of spontaneous APs is prevented in the presence of glutamate 
antagonism. 
A. Representative recording of experiment B. Real time summary and C. pooled data show 
frequency of APs is depressed upon glutamate antagonism (NBQX+APV+MCPG) 
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Figure 3-18 Control experiments showing membrane depolarisation in response to somatic 
current injection is associated with an increased frequency of action potentials. 
A. Representative current clamp recording showing current injection to mimic PAR-2-AP-
induced depolarisation results in increased action potential dischage (cf. the reduced 
frequency seen in figure 3.6). B. Bar plot of pooled data showing a significant increase of 
spontaneous AP frequency following current injection to shift membrane potential from -
65mV to -60mV (n=15, P=0.0003). 
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Figure 3-19 PAR-2-AP depresses frequency of EPSPs. 
A. Representative traces of one experiment. Stars represent EPSPs and large positive 
deflections are APs. B. Real time summary of depression of EPSPs upon PAR-2-AP 
application (n=7, P=0.0006) 
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3.9.2 Glial-neuronal signalling contributes to the PAR-2 activation 
induced depression of the frequency of spontaneous AP 
firing in cultured neurones 
As discussed in 3.8.2, FAc, the selective astrocytic function inhibitor, was 
employed to test if glial-neuoronal signalling was involved in the PAR-2 
activation induced depolarisation. Apart from the fact that 3 hours incubation of 
10M FAc completely abolished the PAR-2 activation-induced depolarisation in 
neurones, it was also noticed that the suppression of frequency of spontaneous 
APs was reduced. As shown in figure 3.20, the maximal reduction of AP 
suppression observed at the time point of 480 second (67.23 ± 9.12% of control, 
n=8), compared to neurones from naïve cultures (41.63 ± 11.5% of control, n=6), 
was statistically significant (P=0.0308). However, the gross pattern of the 
reduction of AP suppression following FAc treatment was nevertheless modest. 
These data suggest that PAR-2 activation, in addtion to its roles on glial cells, 
may have direct influence on neurones over their intrinsic properties, which are 
responsible for generating APs.          
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Figure 3-20 Depression of the frequency of spontaneous AP firings is modestly reduced in 
neurones treated with FAc. 
Star point shows the time point of statistical significance. 
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3.10 Discussion 
In this chapter, I show, for the first time, that the PAR-2 receptor activation 
modulates neuroexcitability and depresses spontaneous APs in cultured 
hippocampal neurones. Furthermore, this PAR-2-mediated regulation is 
dependent on iontropic glutamate receptor activation and normal astrocytic 
function. This latter result suggests that glial-neuronal signalling may be an 
important element in PAR-2-mediated actions in the nervous system. 
In this chapter, I first demonstrate that trypsin, which at the similar 
concentration (80nM) used is reported to preferentially activate PAR-2 (Bushell 
et al., 2006), induced significant depolarisation of neuronal membrane and 
increased spontaneous activities (APs and spontaneous synaptic events under 
both voltage clamp and current clamp configurations (See figure 3.2 and 3.4)). 
These data support our hypothesis that PAR-2 has a modulatory role in central 
neurones under non-disease conditions. These results are distinct from previous 
studies which have tended to focus upon PAR-2 actions being solely related to 
disease conditions (Striggow et al., 2001; Jin et al., 2005; Noorbakhsh et al., 
2005; Afkhami-Goli et al., 2007; Lohman et al., 2008). However, this 
interpretation could be compromised by serious concerns over the selectivity of 
trypsin for activating PARs and its ‘off target’ effects in terms of digesting other 
surface proteins. It has been reported, at high concentrations (mM range), 
trypsin could activate PAR-1 and PAR-4, although it is more selective to PAR-2 at 
low concentration (EC50=1nM in Xenopus oocytes (Macfarlane et al., 2001)). 
Therefore, it is difficult to rule out the possible activation of PAR-1 and PAR-4, 
albeit at low levels, in the experiments using 100nM trypsin. In addition to its 
action on PARs, trypsin is a potent digesting enzyme for very many proteins with 
80% of proteins possessing at least one trypsin-like proteinase cleavage site 
(Southan, 2001; Puente et al., 2003). Taking this into account, the suspicion that 
observed depolarisation upon trypsin application could be due to cleavage of 
other membrane proteins important in regulating membrane potential and 
cellular excitability is credible. In the current clamp recording, overtly, second 
application of 100nM did not cause significant depolarisation in neurones tested 
as shown in figure 3.4E, F. This is consistent with a cleavage of PAR2 receptors 
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(a ‘one hit’ stimuli) and corresponding membrane depolarisation. However, it is 
possible that cleavage of off-target proteins could produce a similar one-hit 
response. Interesting, 3 out of 7 neurones did indeed responded to the 2nd 
trypsin application but this was typically smaller and overall did not achieve 
statistical significance. However, this can be explained in terms of the initial 
application causing a partial cleavage of the PAR2 population. Given that the 
second application was 10 minutes following the initial response, this might be 
explained by a number of mechanisms including 1) receptor desensitisation, 2) 
trafficking of new PAR2 receptors to the membrane surface or to downregulation 
of the signalling processes. These possibilities have been considered previously 
for PAR2-induced calcium signalling responses (Bushell et al., 2006). Overall, it 
is concluded from the trypsin experiments that the membrane depolarisation 
and increased synaptic activities observed upon trypsin treatment are partially 
mediated by PAR-2 activation. However, to confirm this suspicion, all further 
experiments were conducted using more selective PAR-2-AP, SLIGRL and its 
inactive negative controls, PAR-2-IP, LRGILS.  
The neuronal depolarisation observed upon SLIGRL application is consistent with 
previous trypsin experiments. Taken together, these experiments support the 
interpretation that PAR-2 activation leads to membrane depolarisation in 
cultured hippocampal neurones. Whilst the finding that PAR-2 induces neuronal 
depolarisation in central neurones is completely novel, it nevertheless mirrors 
previous reports that PAR-2 receptor activation excites dorsal root ganglia (DRG) 
neurones (Kayssi et al., 2007). It also mirrors reports that PAR-1 receptor 
activation excite hippocampal neurones (Kayssi et al., 2007; Lee et al., 2007). 
Kayssi and co-workers demonstrated that membrane depolarisation in colonic 
DRG neurone was attributed to PAR-2-induced suppression of delayed rectifier K+ 
currents (Kayssi et al., 2007). In the current investigation, our primary focus was 
to characterise the overt actions of PAR2 activation on membrane excitability 
(membrane potential) and synaptic transmission and I did not investigate 
possible intracellular or ion channel signalling processes. Nevertheless, a 
reduction in potassium conductance as seen in the Kayssi paper would be 
consistent with the depolarising responses observed in the current studies.  
In the study by Lee and co-authors, the authors proposed that the membrane 
depolarisation in CA1 hippocampal neurone was in response to glutamate release 
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from astrocytes upon astrocytic activation by PAR-1 (Lee et al., 2007). In this 
chapter, I demonstrated glutamate is also required during PAR-2-mediated 
depolarisation in cultured hippocampal neurones. Specifically, as ionotropic 
glutamate receptors blockade alone sufficiently prevented this depolarisation, it 
is highly likely that mGluRs are not required under current experimental 
condition and in contrast, this modulation is dependent on signalling through 
iontropic glutamate receptors. Furthermore, when it comes to the origin of 
glutamate, the hypothesis that astrocytically released glutamate is underlying 
this glutamate dependency is suggested by the fact that TTX (to block neuronal 
AP- dependent glutamate release) does not block PAR-2-mediated depolarisation. 
This hypothesis is strengthened by the result that PAR-2-induced neuronal 
depolarisation is abolished when normal astrocytic function is inhibited in 
hippocampal cultures. In summary, these results are consistent with a 
dependency for astrocytic (but not neuronal) release of glutamate. 
When PAR-1 is investigated, the result that a significant depolarisation was 
observed upon PAR-1-AP, TFLLR, is consistent with that previously reported (Lee 
et al., 2007) and also consistent with the PAR-2-AP induced responses reported 
for the first time here. Taken together, these data suggest that the membrane 
depolarisation induced by activation of PAR-1 and PAR-2 receptors may share a 
common glial-dependent mechanism. In terms of cellular signalling as a result of 
PAR-1/PAR-2 activation, although PAR-2 and PAR-1 are activated differentially 
by distinct proteinases (both experimentally and presumably under endogenous 
conditions) there could be a common downstream mechanism which underlies 
the way they modulate neuroexcitability in the central neurones. However, it 
was also noticed the depression of spontaneous APs firings associated with PAR-2 
activation, was not seen with PAR-1 activation, suggesting although PAR-1 and 
PAR-2 are in the same receptor family and have potentially common downstream 
modulatory target and mechanism in neuroexcitability, there may also be 
important differences in the way they control network excitability (see also 
chapter 5).  
In addition to membrane depolarisation brought about by PAR-2 activation, it is 
of special interest to note the paradoxical decrease in the frequency of 
spontaneous APs. This was not observed upon trypsin treatment or upon 
selective activation of PAR-1. The reduction in AP frequency is unexpected 
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because a depolarisation usually gives rise to increased APs. Indeed, simulation 
of PAR2-induced depolarisation through intracellular current injection did cause 
an increase in AP frequency. However, it seems that in the cultured neuronal 
preparation, the vast majority of spontaneously generated APs are in fact driven 
by ongoing synaptic activity. This is confirmed by the finding that most 
spontaneous APs are prevented upon application of a cocktail of glutamate 
receptor antagonists shown in figure 3.17. Taken together, data from these two 
series of experiments suggest that the depression of APs seen associated with 
PAR-2 receptor activation was not due to a membrane depolarisation but instead 
the action of PAR-2 receptor activation on synaptic transmission. This is 
addressed experimentally in the following chapter. The finding that inhibiting 
astrocytic function modestly reduced the magnitude of SLIGRL-induced 
depression of spontaneous APs, as shown in figure 3.20, suggests that astrocytic-
neuronal signalling partially contribute to the reduction of APs upon PAR-2 
activation. Considering the fact that glutamate-dependent PAR-2-induced 
depolarisation is abolished during astrocytic blockade, this may suggest 
astrocytically released glutamate at least partially contribute to PAR-2-mediated 
depression of APs in cultured hippocampal neurones. Alternatively, other 
gliaotransmitters, such as ATP, may be involved (Koizumi et al., 2003; Zhang et 
al., 2003). However, the dependency of glutamate receptor activation as shown 
in figure 3.12 in PAR-2-induced neuronal depolarisation suggests that glutamate 
from astrocytes is the most likely the primary source of the modulation. 
However, it is also acknowledged that the astrocytic blockade did not abolish 
the PAR-2-mediated depression of APs in cultured neurones (figure 3.20). This 
indicates PAR-2 activation may have direct influence over neuronal intrinsic 
properties by modulating, for instance, ion channels. It has been well 
established that the activation of GPCRs has direct modulatory effect on ion 
channel conductances such as two-pore-domain K+ channels (Mathie, 2007) and 
GIRK channels (Luscher & Slesinger, 2010), which modulate neuronal intrinsic 
properties and ultimately finetune the generation of APs. Moreover, it has been 
demonstrated that PAR-2 activation modulates neuronal K+ channel conductances 
(Kayssi et al., 2007). Therefore, in order to test this possibility, the input 
resistance of the recorded neurone has to be monitored before and after the 
PAR-2 activator is applied. This input resistance measurement could give a clue 
that whether channel conductances on the neuronal membrane are altered upon 
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PAR-2 activation. If so, a series of screening experiments could be performed to 
identify which ion channels are likely to be modulated directly by PAR-2 
activation. 
In summary, in this chapter, I demonstrated for the first time that the activation 
of PAR-2 receptor depolarises membrane and depresses spontaneous APs in 
cultured hippocampal neurones. Furthermore, this PAR-2-mediated regulation of 
neuroexcitability is dependent on iontropic glutamate receptor activation and 
normal astrocytic function.  It is also suggested that PAR-2-mediated depression 
of spontaneous APs is the consequence of reduced synaptic transmission within 
the network which is modulated by astrocytes.  
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4 Actions of PAR-2 activation on synaptic 
transmission in acute hippocampal slice 
preparations 
4.1 Introduction 
In addition to its expression in neurones as well as astrocytes in primary 
hippocampal culture, PAR-2 has also been demonstrated to be present in 
neurones of the mature nervous system (Bushell et al., 2006). Specifically, 
immunocytochemistry has revealed PAR-2-immunoreactivity at both excitatory 
(glutamatergic) and interneuronal (GABAergic) cell populations in the 
hippocampus (Bushell et al., 2006) as well as GFAP-positive astrocytes. Neuronal 
immunostaining revealed strong dendritic labelling suggesting PAR-2 receptors 
may modulate aspects of synaptic signalling in addition to the intracellular Ca2+ 
signalling in the cell body reported previously (Bushell et al., 2006). However, 
direct investigation of the actions of PAR-2 receptor activation on synaptic 
transmission in intact brain slices has not previously been investigated. 
Having conducted initial experiments (chapter 3) in a cultured system, 
subsequent experiments to assess the action of PAR-2 on synaptic transmission 
was conducted in the acute hippocampal slice preparation. Acute hippocampal 
slices have been extensively employed as an in vitro model in studying neuronal 
and synaptic properties in the CNS thanks to many advantages such as the ability 
for direct visualization of neuronal layers to allow precise manipulation of 
stimulating or/and recording electrode at defined synapses. Moreover, synapses 
in the acute slice have developed normally and are likely to reflect more 
accurately the properties of synapses in the intact brain. 
Therefore, the specific aim of this chapter was to investigate the actions of PAR-
2 activation on synaptic transmission at the Schaffer  collateral-to-CA1 synapse in 
acute hippocampal slices using established extracellular recording technique. 
This synapse was chosen as it represents a well studied and well characterised 
connection in the brain. It is also a relatively straightforward synapse to isolate 
and stimulate. Finally, our earlier immunocytochemistry data suggested that 
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PAR-2 receptors are expressed both within the dendritic zone in area CA1 as well 
as in CA3 pyramidal cells providing the efferent output. 
 
4.2 PAR-2 activation depresses synaptic transmission at 
the Schaffer collateral-to-CA1 synapse 
To examine the consequences of PAR-2 activation on synaptic transmission, 
standard extracellular recordings were carried out in parasagittal slices of 
400m thickness prepared from 16-24 days old Wistar rats. fEPSPs were evoked 
by single stimulus at a frequency of 0.05Hz through a stimulating electrode 
positioned 2-3mm adjacent to a recording electrode positioned within stratum 
radiatum (see methods chapter). Electrical stimulation of the Schaffer collateral 
afferent evoked a characteristic fEPSP which, when recorded in mid stratum 
radiatum, comprised of a 1) stimulus artefact, 2) presynaptic volley, 3) negative 
deflecting EPSP (Figure 4.1A). Slices were deemed acceptable if they produced a 
clear fEPSP that was stable (in amplitude or slope measurement) over a 20 
minutes period. Following 20 minutes of stable baseline measurements, drugs 
would then be applied to the bath via the perfusion media. Our initial studies 
attempted to use low concentrations of trypsin as a selective PAR-2 activator. 
However, pilot studies revealed unacceptable toxicity associated with the use of 
trypsin (100nM-10M) in which synaptic responses were completely and 
irreversibly abolished (data not shown). This may have been due to digestion of 
glutamate receptors (Grosshans et al., 2002) or other essential membrane 
proteins. However, in light of the pilot experiments it was decided to focus all 
further experiments on the use of non-proteolytic activators of PAR-2. 
As presented in figure 4.1B, 100M SLIGRL applied via the perfusate for 30 
minutes resulted in a slow but profound depression in the slope of fEPSPs to 
80.75 ± 2.54% of control (n=12, P=0.0008). These data suggest that PAR-2 
activation depresses basal glutamatergic synaptic transmission at the Schaffer 
collateral-to-CA1 synapse. However, it was also apparent that the SLIGRL-
induced synaptic depression did not recover upon washout of drug, suggesting 
PAR-2 activation provoked a long lasting plasticity (depression) of synaptic 
transmission. An alternative possibility was that SLIGRL was neurotoxic to the 
acute slices. To discriminate between these possibilities, a reanalysis of the data 
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was conducted. Specifically, analysis of the fibre volley, a direct indicator of 
presynaptic input integrity, was conducted in SLIGRL-treated slices to establish 
whether the integrity of axonal / synaptic terminal function was impaired by 
SLIGRL treatment. Overt and unambiguous presynaptic volleys were observed 7 
of 12 slices and were used for subsequent analysis. As presented in figure 4.1B, 
no significant change of fibre volley was noticed (to 101.38 ± 4.82% of control at 
30 minute, n=7, P=0.5334), suggesting SLIGRL-induced long lasting synaptic 
depression was not a consequence of slice deterioration.  
 
To strengthen this argument, one high frequency stimulation (HFS, 100 stimuli at 
1s) was delivered through the stimulating electrode to produce LTP after SLIGRL-
induced long lasting depression was established. As shown in figure 4.2, the time 
course and the amplitude of responses following HFS were indistinguishable to 
those obtained upon HFS from naïve slices (naïve slices: 148.82 ± 9.39% of 
baseline, n=9; PAR-2-AP treatment: 142.64 ± 7.43% of baseline, n=10, at 60 
minute following HFS, P=0.6090), suggesting the synaptic structure and 
mechanism underlying LTP in the Schaffer collateral-to-CA1 synapse were intact 
in acute hippocampal slices after SLIGRL treatment. 
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Figure 4-1 SLIGRL depresses synaptic transmission at the Schaffer collateral-to-CA1 
synapse in acute hippocampal slices. 
A. Representative raw traces of extracellular field EPSPs recorded from stratum radiatum in 
are CA1. Note the presence of a presynaptic volley following the stimulus (artefact removed 
for clarity purposes) which is preceded by a negatively deflecting field EPSP. In all 
experiments, the magnitude of the response was quantified by measuring the initial slope of 
the fEPSPB using the LTP software.  B. Time plot of pooled data showing the effect of 
PAP2-AP (SLIGRL, 100M, n=12, period indicated by horizontal bar) on fEPSP slope (red 
symbols). Note the gradual reduction in fEPSP slope following SLIGRL application. 
Corresponding measurement of presynaptic fibre volleys (blue symbols, n=7) confirm no 
significant change in the integrity of presynaptic stimulation/input. 
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Figure 4-2 Preincubation of slices with PAR-2-AP does not affect the induction of LTP. 
A. Representative control (drug-free) fEPSPs before and 60 minutes following high 
frequency stimulation (HFS). B. Similar traces in a slice preincubated with the PAR2-AP 
SLIGRL (100M) produces a similar robust LTP following HFS. C. Pooled time series data 
showing LTP in control (blue symbols, n=9) and SLIGRL treated (red symbols, n=12) slices 
and revealing no significant difference in the propensity for LTP induction between groups.  
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In light of the relatively high concentration (100M) of SLIGRL used in the study, 
control experiments were conducted to exclude the possibly of ‘off-target’ 
effect of this peptide. Thus, the biologically inactive reverse peptide, PAR-2-IP, 
LRGILS, which had been successfully used in previous study in primary culture 
(Bushell et al., 2006), was employed as a negative control. As presented in 
figure 4.3, application of 100M LRGILS for 30 minutes did not a cause significant 
change in the slope of fEPSPs (100.87 ± 0.88% of baseline at 30 minute, n=9, 
P=0.8751), suggesting LRGILS has no effect on synaptic transmission at the 
Schaffer collateral-to-CA1 synapse. This data is consistent with SLIGRL having a 
discrete and specific action on synaptic transmission in the acute slice. 
To further address the concern over selectivity of SLIGRL, we utilised a recently 
reported potent peptide agonist, 2-furoylated-LIRL-NH2 (2f-LIGRL) (Kawabata et 
al., 2004; Kawabata et al., 2005; Kanke et al., 2009). 2f-LIGRL has been 
demonstrated to be 10 times more potent relative to the native SLIGRL peptide 
by Ca2+ signalling assays in cultured cell lines (2f-LIGRL EC50 =1M) (Kawabata et 
al., 2004). In the salivation bioassay in anesthetized mice, 2f -LIGRL was found to 
be approximately 100 times more potent than SLIGRL (2f-LIGRL 
ED50=0.15mol/kg) (Kawabata et al., 2004). The higher potency of 2f-LIGRL 
might be explained by its resistance to the degrading enzyme, aminopeptidase 
by virtue of its furoylated C-terminus (Kawabata et al., 2004). As presented in 
figure 4.4, 100M 2f-LIGRL was applied in the perfusate after 20 minutes stable 
baseline was obtained. Interestingly, the application of 2f-LIGRL for 30 minutes 
produced a slow and profound depression of the slope of fEPSPs (82.07 ± 2.42% 
of control at 30 minute, n=9, P=0.0026), suggesting glutamatergic synaptic 
transmission was depressed. This data was in agreement with the experiments 
employing the native PAR-2-AP, SLIGRL, and further demonstrated PAR-2 
activation induced a long lasting depression of the Schaffer collateral-to-CA1 
synapse. However, it was also noticed that the prolonged synaptic depression 
produced by 2f-LIGRL had similar time course and magnitude of response 
compared with that of SLIGRL-induced depression. In contrast to previous studies 
that 2f-LIGRL was shown 10-100 times more potent than SLIGRL (Kawabata et al., 
2004; Kawabata et al., 2005; Kanke et al., 2009), our data suggest that at the 
concentration tested (100M), 2f-LIGRL and SLIGRL were equally efficacious in 
suppressing synaptic transmission. 
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Figure 4-3 The PAR-2-IP LRGILS does not depresses synaptic transmission at the Schaffer 
collateral-to-CA1 synapse. 
A. Representative raw traces of extracellular field EPSPs before (black) and following (blue) 
LRGILS (100M) application. B. Time plot of pooled data showing the effect of PAP2-IP 
(period indicated by horizontal bar, n=9) on fEPSP slope (blue symbols). Note the absence 
of any significant change in fEPSP slope following LRGILS application.  
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Figure 4-4 2f-LIGRL depresses synaptic transmission at the Schaffer collateral-to-CA1 
synapse in acute hippocampal slices. 
A. Representative raw traces of extracellular field EPSPs recorded from stratum radiatum in 
are CA1 before (black) and following (red) 2f-LIGRL application. B. Time plot of pooled data 
showing the effect of PAP2-AP (2f-LIGRL, 100M, n= 9, period indicated by horizontal bar) 
on fEPSP slope (red symbols). Note the gradual reduction in fEPSP slope following peptide 
application. 
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To sum up, in the current study, two independent PAR-2-APs, SLIGRL and 2f-
LIGRL, induced a similar long lasting depression of glutamatergic synaptic 
transmission at the Schaffer collateral-to-CA1 synapse in acute hippocampal 
slices. This effect was unlikely due to slice deterioration. Furthermore, PAR-2-IP, 
the negative control, did not produce any measurable effect, consistent with the 
PAR-2-APs producing a discrete and specific suppressant action.  
 
4.3 PAR-1 activation does not modulate synaptic 
transmission at the Schaffer collateral-to-CA1 
synapse 
After establishing that PAR-2 activation induced synaptic depression in the acute 
slices, my investigation extended further to assess whether the activation of 
another widely studied member of PAR family, namely, PAR-1, would display a 
role in modulating synaptic transmission in acute hippocampal slices. Therefore, 
the same extracellular recording configuration was used to investigate the 
actions of PAR-1 activation. Application of the selective PAR-1-AP, TFLLR 
(100M), for 30 minutes did not cause any significant change of the slope of 
fEPSPs recorded at the Schaffer collateral-to-CA1 synapse in acute hippocampal 
slices (103.10 ± 0.98% of baseline at 30 minute, n=11, P=0.0578, Figure 4.5), 
suggesting PAR-1 did not modulate glutamatergic synaptic transmission at this 
synapse under our experimental conditions.   
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Figure 4-5 The PAR-1-AP, TFLLR, does not depresses synaptic transmission at the Schaffer 
collateral-to-CA1 synapse. 
A. Representative raw traces of extracellular field EPSPs before (black) and following (red) 
TFLLR (100M) application. B. Time plot of pooled data showing the effect of PAP1-AP 
(n=11, period indicated by horizontal bar) on fEPSP slope (red symbols). Note the absence 
of any significant change in fEPSP slope following TFLLR application.  
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4.4 Mechanisms underlying the PAR-2-induced long term 
depression of synaptic transmission. 
In the following experiments, I investigated further the potential mechanisms 
underlying PAR-2 activation-induced long lasting synaptic depression at the 
Schaffer collateral-to-CA1 synapse. 
 
4.4.1 Paired-pulse facilitation is enhanced during PAR-2 
activation-induced long lasting synaptic depression 
To dissect whether the induction of this novel form of long lasting synaptic 
depression triggered by PAR-2 activation was of presynaptic or postsynaptic 
locus, I examined paired pulse facilitation (PPF) at the Schaffer collateral-to-CA1 
synapse under first naïve (drug-free) conditions and subsequently in the 
presence of 100M SLIGRL. PPF was tested by measuring fEPSP responses 
following two stimuli delivered at short intervals (50 ms). PPF is a commonly 
used paradigm to test presynaptic function, where the response to the second 
stimulus is enhanced due to the residual calcium in the presynaptic terminal 
following the first stimulus (Malinow & Malenka, 2002). I examined PPF in 
response to a 50ms interval as described previously (Asaka et al., 2006; Moretti 
et al., 2006). Whilst the response to the 1st stimulus was consistently smaller in 
the drug-treated group, the degree of potentiation seen following the 2nd 
stimulus was in fact enhanced in the presence of SLIGRL. As presented in figure 
4.6, the ratios of PPF was significantly increased in the presence of 100M 
SLIGRL, compared to naïve control baseline (Baseline: 1.41 ± 0.02, n=7; SLIGRL-
LTD: 1.48 ± 0.03, n=7, P=0.0044). However, the absolute value of this change is 
modest. These data may suggest a presynaptic locus of SLIGRL-induced changes 
in synaptic signalling. 
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Figure 4-6 SLIGRL-induced long lasting synaptic depression is associated with an 
increased short term plasticity as revealed by paired-pulse facilitation. 
A. Representative extracellular recordings showing paired synaptic responses at 50 ms 
inter-stimulus interval. Note the presence of paired-pulse facilitation as shown by the 
increased amplitude of the second pulse in both naïve and SLIGRL treated slices.  
B. Bar chart of pooled data reveals a modest but significant enhancement in paired-pulse 
facilitation following SLIGRL treatment (Control: n=7, SLIGRL treatment: n=7).  
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4.4.2 mGluRs are not involved in the PAR-2-mediated synaptic 
depression 
mGluRs have been suggested to mediate a variety of chemically-induced forms 
of long term depression at the Schaffer collateral-to-CA1 synapse (Palmer et al., 
1997; Fitzjohn et al., 1999; Fitzjohn et al., 2001). Thus, in the following 
experiments, I examined whether mGluR activation was implicated in the PAR-2 
activation-induced synaptic depression. As presented in figure 4.7, the non-
selective group I/II mGluR antagonist, MCPG (500M), did not prevent LTD 
induced by SLIGRL (100M) at these synapses (81.62 ± 2.18% of baseline at 30 
minute, n=8, P=0.0043). And this reduction is not significantly different from 
that observed in SLIGRL-induced LTD in the absence of MCPG (80.75 ± 2.54% of 
control at 30 minutes, n=12, see figure 4.1, P>0.05). Furthermore, as shown in 
figure 4.8, following the establishment of well-characterised form of LTD 
induced by group I mGluRs agonist, DHPG at 50M (50.99 ± 6.12% of baseline at 
20 minute, n=4, P=0.0041), the application of 100M SLIGRL was still able to 
elicit further synaptic depression with time course and magnitude similar to that 
observed in naïve slices. (80.64 ± 3.35% of baseline at 30 minute, n=4, P=0.0383, 
figure 4.8 and 4.9). Taken these two sets of experiments together, these results 
strongly suggest that mGluRs are unlikely to be directly involved or required in 
PAR-2 activation-induced LTD.  
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Figure 4-7 MCPG does not block SLIGRL-induced synaptic depression at the Schaffer 
collateral-to-CA1 synapse. 
A. Representative fEPSPs before and following SLIGRL treatment in slices preincubated 
with the non-selective group I/II mGluR antagonist MCPG (500M). Colour code: Black-drug 
free, Red: SLIGRL+MCPG B. Time plot of pooled data showing that MCPG does not prevent 
SLIGRL-induced depression (n=8).  
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Figure 4-8 DHPG-induced LTD does not occlude SLIGRL-induced synaptic depression at the 
Schaffer collateral-to-CA1 synapse. 
A. Representative extracellular recordings from a single experiment in which DHPG 
produces a robust synaptic depression which can increased by subsequent SLIGRL 
application. Colour code: Black-drug free, Blue-DHPG, Red-SLIGRL 
B. Time plot of pooled data showing summation of synaptic depression by sequential DHPG 
(n=4) and SLIGRL (n=4) application. Note there is no evidence for occlusion of synaptic 
depression by DHPG and indeed the relative depressant action of SLIGRL following DHPG 
treatment is equal to that seen in naïve slices (see text).  
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Figure 4-9 Time course and magnitude of SLIGRL-induced LTD following DHPG-LTD (n=4) 
(B) is similar to that observed in naïve tissue (n=12) (A). 
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4.4.3 PAR-2-mediated synaptic depression is dependent on NR2B 
subunit containing-NMDA receptors 
As NMDA receptor dependency has been found to be a common mechanism in the 
induction of several forms of LTD (Dudek & Bear, 1992; Mulkey & Malenka, 1992), 
after ruling out the involvement of mGluRs in PAR-2 activation-induced LTD, I 
further tested whether NMDA receptors were involved in PAR-2 activation 
induced LTD. Surprisingly, as presented in figure 4.10, application of 100M 
SLIGRL failed to produce any significant depression at the Schaffer collateral-to-
CA1 synapse when applied in the presence of the selective NMDA receptor 
antagonist DL-APV (100M, 99.20±1.97% of baseline at 30 minute, n=9, P=0.7852). 
These initial experiments suggest NMDA receptor activation to be an essential 
requirement for PAR-2-induced synaptic depression. To investigate this further, 
100M SLIGRL was co-applied in the presence of the selective NR2B-containing 
NMDA receptor antagonist, Ro 25-6981(3M)(Fischer et al., 1997). Again, under 
these conditions, I observed no detectable or significant change in the slope of 
fEPSPs (100.24±2.35 of baseline at 30 minute, n=5, P=0.9257, figure 4.11). These 
data are consistent with NMDA, and specifically NR2B-subunit containing NMDA 
receptors being an absolute requirement for PAR-2 activation-induced LTD.  
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Figure 4-10 DL-APV blocks SLIGRL-induced LTD at the Schaffer collateral-to-CA1 synapse. 
A. Representative fEPSPs before (black)  and following SLIGRL application (100M, red 
trace) in the presence of the NMDA receptor antagonist D-AP5. B. Time plot of pooled data 
showing PAR2 activation fails to elicit synaptic depression when co-applied in the presence 
of DL-APV (100M, n=9) and suggesting the requirement for NMDA receptor activation in 
PAR-2-induced LTD 
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Figure 4-11 Ro 25-6981 blocks SLIGRL-induced LTD at the Schaffer collateral-to-CA1 
synapse. 
A. Representative fEPSPs before (black) and following SLIGRL application (100mM, red 
trace) in the presence of the NR2B subunit containing NMDA receptor antagonist Ro 25-
6981 (3M) B. Time plot of pooled data showing PAR2 activation fails to elicit synaptic 
depression when co-applied in the presence of Ro 25-6981 (3M, n=5) and suggesting the 
requirement for NR2B-contaning NMDA receptor activation in PAR2-induced LTD. 
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4.4.4 Glial-neuronal signalling contributes to the PAR-2-mediated 
synaptic depression 
It has been demonstrated in previous chapter that glial-neuronal signalling was 
contributing to the PAR-2 activation-induced depression of synaptic transmission 
in the cultured hippocampal neurones. Here, I examined, under more 
physiological conditions, whether glial mechanisms also contribute to the PAR-2- 
induced synaptic depression in acute hippocampal systems. To this end, 
hippocampal slices were preincubated with the selective glial function inhibitor 
FAc (10M) for 3 hours. Initially, in order to test whether this procedure would 
be detrimental to the health of hippocampal slices, I examined the general 
properties of neurotransmission in naïve and FAc treated slices. Thus, 
experiments were performed to record synaptic responses at the Schaffer 
collateral-to-CA1 synapse to varying intensities of single electrical stimulation so 
that an input-output relationship could be established. Increasing stimulating 
intensity resulted in the expected accompanying increase in fEPSP slope (Figure 
2.5). However, as also shown in figure 4.12, no significant difference in input-
output curve was observed between naïve (drug-free) slices and those treated 
with FAc (naïve: n=12, FAc treated: n=9. stimulus intensity: 30A, P=0.7095; 
60A, P=0.6659; 90A, P=0.9440), suggesting basal integrity of synaptic 
transmission was not altered by 3 hours treatment of 10M FAc.  
 
After confirming the synaptic integrity in slices treated by FAc, extracellular 
recording was repeated as previous described. As shown in figure 4.13, the 
SLIGRL-induced LTD was significantly reduced in FAc treated slices compared to 
those recorded from naïve slices (naïve: 78.48 ± 3.14% of baseline at 30 minute, 
n=4; FAc treated: 94.11 ± 1.48% of baseline at 30 minute, n=6, P=0.0287), 
suggesting glial-neuronal signalling was indeed contributing to PAR-2 activation-
induced LTD in hippocampal slices.  
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Figure 4-12 Input-output curve in naïve and FAc treated slices. 
A. Representative fEPSPs in response to increasing stimulation (arrowhead) intensity. B. 
Similar experiment in performed in slice preincubated with the astrocyte inhibitor FAc.  
B. Pooled input-output plot showing the characteristic relationship between stimulation 
intensity and fEPSP magnitude. Note there is no significant difference between control (blue 
symbols, n=12) and FAc treated slices (red, n=9).  
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Figure 4-13 SLIGRL-induced LTD is significantly reduced in FAc treated slices. 
A. Representative fEPSP recordings before and after SLIGRL treatment in naïve slices (blue 
symbols) and in slices preincubtated in FAc (Red symbols). B. Time plot of pooled data 
showing actions of SLIGRL on naïve slices (blue, n=4) and FAc treated slices (n=6). Note a 
significant reduction of the magnitude of SLIGRL-induced LTD in FAc treated slices 
(P=0.0287) 
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4.5 Discussion 
In this chapter, I demonstrated, for the first time, that activation of PAR-2 
induced a novel form of long lasting depression of glutamatergic synaptic 
transmission at the Schaffer collateral-to-CA1 synapse in acute hippocampal 
slices. Furthermore, I provided evidences that this PAR-2 activation-induced LTD 
is dependent on NR2B subunit-containing NMDA receptors and suppressed by 
disrupting glial cell function. 
 
In this chapter, I first demonstrate that 100M PAR-2-AP, SLIGRL, which at the 
concentration used is reported to elicit the maximal Ca2+ mobilisation in 
expression system (Nystedt et al., 1995b), and was similar to previous study in 
investigating Ca2+ mobilisation by PAR-2 activation in cultured hippocampal 
neurones and astrocytes (Bushell et al., 2006), induced a novel form of long 
lasting depression of glutamatergic transmission at the Schaffer collateral-to-
CA1 synapse (see figure 4.1). The specific nature of the PAR-2-mediated 
response is confirmed by the lack of effect using the control peptide, 100M 
LRGILS (see figure 4.3). This selectivity is further strengthened by the fact that 
another independent PAR-2-AP, 2f-LIGRL, induces similar LTD at the same 
synapses under equivalent conditions (see figure 4.4). Thus, these data support 
our hypothesis that PAR-2 activation modulates basal synaptic transmission and 
agree with the indication discussed in chapter 3 that PAR-2 activation induces a 
reduction of synaptic transmission in the cultured hippocampal neurone network 
(see figure 3.18 and 3.19).  
 
However, this interpretation could be hampered by the concern that the 
irreversibility of PAR-2-induced LTD may be the consequence of the 
deterioration of the integrity of presynaptic terminals perhaps due to the 
neurotoxic effect of the chemical nature of these peptides. Therefore, this 
concern is addressed by the reanalysis of presynaptic fibre volley amplitude, 
which is an indicator of integrity of presynaptic terminals. My data demonstrated 
no significant change of presynaptic fibre volley amplitude during PAR-2-
mediated LTD (see figure 4.1B), which confirms the integrity of presynaptic 
input. Furthermore, intact LTP induced by HFS in slices conditioned with 100M 
SLIGRL incubation (see figure 4.2C) provides further evidence to support this 
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interpretation. Thus, the PAR-2-mediated LTD is not due to the deterioration of 
slice quality. 
 
It was recently reported that PAR-2 activation caused a temporary deficit in the 
formation and/or recollection of experience-dependent learning and memory in 
a strain of rat (Lohman et al., 2009). Considering the long term plasticity in the 
brain is well recognised cellular basis for learning and memory (Bliss & 
Collingridge, 1993; Martin et al., 2000), it is of special interest to investigate 
into if PAR-2 activation in acute hippocampal slices would modulate long term 
plasticity. Interestingly, my data show that in the slices preconditioned with 
100M PAR-2-AP, SLIGRL, the LTP is indistinguishable from that elicited from 
naïve slices (see figure 4.2). Furthermore, this LTP is induced upon previously 
established synaptic depression by PAR-2-AP application. Thus, on one hand, this 
data suggest that the LTD induced by 100M PAR-2-AP is reversible, confirming 
the integrity of the synapses after the concerns over potential neurotoxic effect 
of relatively high concentration of PAR-2-AP. On the other hand, this result 
suggests that the activation of PAR-2 before the input-postsynaptic association, 
as given by the HFS, has no disruption on the mechanisms underlying the 
induction and expression of NMDA-receptor dependent LTP at the Schaffer 
collateral-to-CA1 synapse. However, it is acknowledged that in order to address 
the question whether PAR-2 activation modulates hippocampal long term 
plasticity more convincingly, a better solution is to investigate LTP induction and 
expression in the presence of PAR-2-AP. But this was rather unfeasible in my 
hand, because PAR-2-AP depresses basal synaptic transmission (see figure 4.1). 
Alternatively, LTP could be thoroughly investigated utilising the PAR-2 knockout 
animals (Ferrell et al., 2003) and their littermate controls. However, due to the 
time limit of my PhD, this is the subject of further experimentation.  
 
An unexpected finding in this chapter is, in my hand, the PAR-1 activation has no 
modulatory role in the basal transmission of glutamatergic transmission at the 
Schaffer collateral-to-CA1 synapse in acute hippocampal slices (see figure 4.5). 
This result is in contrast to a previous report which showed the PAR-1-AP, 
SFLLRN (15M), induced a gradual robust increase (50% increase of baseline) of 
fEPSPs recorded at the Schaffer collateral-to-CA1 synapse, which reach a 
plateau after 40 minutes, in rat hippocampal slices (Maggio et al., 2008). The 
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disagreement between these two investigations could be explained by firstly, 
different PAR-1-APs employed in these studies. In my study, I used the TFLLR 
rather than SFLLRN as the PAR-1-AP because the substitution of threonine for 
serine prevents the cross-activation or desensitisation of PAR-2 (Hollenberg et 
al., 1997). Thus, because of the lack of selectivity for PAR-1, theoretically, the 
robust increase of fEPSPs observed by Maggio and co-workers using SFLLRN could 
be a synergy effect of activation of both PAR-1 and PAR-2. If this is the case, 
combining my results, these data suggest the synergy consequence on synaptic 
transmission by dual activation of both PAR-1 and PAR-2 is distinct from that 
upon activation of individual PARs. Secondly, the concentration of PAR-1-AP 
utilised is different. Maggio and co-workers used 15M as working concentration, 
which is close to the concentration used (10M) in investigating PAR-1 action in 
acute hippocampal slices (Gingrich et al., 2000) and slightly higher than the EC50 
of SFLLRN (0.5-6M) (Macfarlane et al., 2001). In contrast, I used a relatively 
high concentration of TFLLR of 100M although the peptide itself is more 
selective than SFLLRN. To reconcile the disagreement, it is possible that PAR-1 
potentiates synaptic transmission under relatively modest activation upon low 
concentration of activator, whereas, this modulation of basal transmission could 
be masked upon strong activation of the receptor itself through an unknown 
mechanism involving perhaps feedback inhibition. Considering that in disease 
conditions, modest activation of PAR-1 tends to be protective and strong 
activation of PAR-1 is degenerative (see Chapter 1.3.7.4), it is reasonable to 
speculate a scenario that ‘multi-face’ modulation of synaptic transmission by 
PAR-1 is upon the magnitude of its activation under normal brain physiology. 
 
In this chapter, I investigated further into whether the presynaptic mechanism is 
involved in the expression of the PAR-2-mediated LTD at the Schaffer collateral-
to-CA1 synapse. I demonstrate that the paired-pulse ratio, which is an indicator 
of presynaptic involvement, is increased during the PAR-2 activation-induced 
LTD, suggesting a presynaptic locus. However, the change of absolute value of 
paired pulse ratio from 1.41 to 1.48 (see figure 4.6), though statistically 
significant, is relatively very modest to support a strong presynaptic contribution 
to the PAR-2-mediated LTD. On the contrary, another interpretation of this data 
is that because the synaptic transmission is reduced during the PAR-2-mediated 
LTD at the first place, the small increase in the paired pulse ratio could be 
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attributed to a reduced transmitter release probability at presynaptic terminals 
in agreement with the depressed synaptic transmission, which in turn results in 
an increase of fEPSP amplitude upon second stimulus as a result of increased 
residual Ca2+ in the presynaptic terminals in response to the first stimulus 
corresponding to the paired-pulse paradigm. Nevertheless, in order to clarify the 
presynaptic contribution for PAR-2-mediated LTD, a positive control experiment 
employing, for instance baclofen (1M), the agonist for GABAB receptors which 
locate presynaptically, could be introduced to test the magnitude of paired 
pulse ratio under identical recording conditions. This experiment will give some 
clues that whether this established presynaptic inhibition (Mott & Lewis, 1994; 
Misgeld et al., 1995) elicits comparable increase of paired pulse ratio as what 
was observed in PAR-2-induced synaptic inhibition.  
 
Finally, in this chapter, I investigated further into the cellular mechanism 
underlying PAR-2 activation-induced LTD. LTD at the Shaffer collateral-to-CA1 
synapse has been demonstrated to be NMDA-receptor dependent or NMDA-
receptor independent (Dudek & Bear, 1992; Mulkey & Malenka, 1992; Bashir et 
al., 1993; Bashir & Collingridge, 1994; Fitzjohn et al., 1998; Citri & Malenka, 
2008; Rebola et al., 2010). Especially to our interest, a widely reported form of 
chemically-induced LTD expresses at this synapse in response to group I mGluRs 
agonist, DHPG (Palmer et al., 1997; Fitzjohn et al., 1999; Fitzjohn et al., 2001; 
Gladding et al., 2009; Luscher & Huber, 2010). To differentiate whether PAR-2 
activation-induced LTD is dependent on mGluRs, I used two strategies. Firstly, I 
demonstrated 500M MCPG, a non-selective antagonist of group I/II mGluRs, has 
no effect on PAR-2 activation-induced LTD (see figure 4.7). Secondly, 100M 
SLIGRL still produced a further long lasting depression following LTD induced by 
the group I mGluR agonist, DHPG (50M) (see figure 4.8) with the amplitude of 
this further synaptic depression being similar to that induced in naïve slices (see 
figure 4.9). Taken together, these data strongly suggest at least group I/II 
mGluRs are not involved in the PAR-2 activation-induced LTD at the Schaffer 
collateral-to-CA1 synapse. Therefore, I tested whether this novel form of LTD is 
NMDA receptor dependent. Surprisingly, the NMDA receptor antagonist DL-APV 
(100M) completely abolished the SLIGRL-induced LTD (see figure 4.10). In 
addition, a specific NR2B subunit-containing NMDA receptor antagonist, Ro 25-
6981(3M) (Fischer et al., 1997) also prevented the SLIGRL-induced LTD (see 
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figure 4.11). These data suggest the NR2B subunit-containing NMDA receptor is 
required during the PAR-2 activation-induced LTD. Previous studies showed 
conflicting data regarding the role of NR2B subunit-containing NMDA receptors in 
the induction of LTD (Kutsuwada et al., 1996; Hendricson et al., 2002; Liu et al., 
2004). However, my results here suggest that the NR2B subunit-containing NMDA 
receptors may be important in governing at least PAR-2 activation-induced LTD 
in the hippocampus. As PAR-2-induced LTD is suggested to be NMDA receptor 
dependent, it is possible that PAR-2-mediated LTD may utilise a common 
induction mechanism that has been observed in other forms of NMDA receptor 
dependent LTD. Clearly dinstinct from mGlu receptor dependent LTD, NMDA 
receptor dependent LTD requires intracellular Ca2+ singal (Gladding et al., 2009; 
Collingridge et al., 2010). The Ca2+ sensor protein, calmodulin, detects the entry 
of extracellular Ca2+ through NMDA receptors. The binding of Ca2+ with 
calmodulin activates protein phosphatase 2B, which in turn dephosphorylates 
inhibitor-1 to activate protein phosphatase 1 (Mulkey et al., 1993). Protein 
phosphatase 1 is the key enzyme in NMDA receptor dependent LTD, as it 
dephosphorylates Ser845 on the AMPA receptor subunit GluR1, to initiate 
clathrin-mediated endocytosis of AMPA receptors (Collingridge et al., 2004), 
which leads to LTD. Therefore, it is of special interest to further test whether 
employing protein phosphatase 1 inhibitors, for instance, okadaic acid (1M) or 
calyculin A (1M) (Mulkey et al., 1993), could prevent the synaptic depression 
induced by PAR-2 activation in identical preparations. These experiments are 
likely to give futher evidences for the NMDA receptor dependency of PAR-2-
mediated LTD and to shed light on its induction mechanisms. 
 
Based on the suggestion from Chapter 3 that neurone-glial signalling may be 
important in the modulation of neuronal excitability and synaptic transmission 
upon PAR-2 activation in hippocampal cultures, I further investigated into the 
whether this signalling is also contributing the PAR-2 activation-induced LTD in 
acute hippocampal slices. Selective blockade of glial metabolism in acute slices 
by FAc (10M) incubation significantly attenuated the magnitude of SLIGRL-
induced LTD (see figure 4.13). In addition, the indistinguishable input-output 
curves obtained from FAc-treated and naïve slices confirmed no significant 
neuronal damage was brought in during the FAc incubation (see figure 4.12). 
These data are in agreement with my observation that neurone-glial signalling 
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was important in hippocampal cultures as discussed in chapter 3. They also 
demonstrated that neurone-glial signalling we observed in culture system was 
not a culture artefact that due to in vitro manipulations.   
 
In conclusion, in chapter 4, I demonstrated for the first time that the activation 
of PAR-2 in acute hippocampal slices induces a novel form of LTD at the Schaffer 
collateral-to-CA1 synapse. Furthermore, the PAR-2-mediated LTD is dependent 
on NR2B subunit-containing NMDA receptor activation as well as normal glial-
neuronal signalling.   
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5 Modulation of epileptiform activity in the 
hippocampus by PARs activation 
5.1 Introduction 
PARs are confirmed to be expressed in a variety of cell types, including neurones 
and astrocytes, in the CNS (Bushell et al., 2006; Bushell, 2007; Luo et al., 2007), 
and their involvement in the pathology of the brain has been widely reported 
(Noorbakhsh et al., 2003; Luo et al., 2007). In particular, recent evidences 
suggest PARs are crucial players in modulating epileptogenesis both in vivo and 
in vitro. One in vivo study demonstrated that intravenous application of the 
selective PAR-2-AP, SLIGRL protected rats against kindling-induced seizures 
(Lohman et al., 2008). This led the authors to conclude that PAR-2 may have a 
protective role during epileptogenesis. This is in contrast with a recent in vitro 
study showing PAR-1 activation to facilitate epilileptogenesis in rat hippocampal 
slices (Maggio et al., 2008), advocating a pro-epilepicactivity role for this PAR 
subtype. These studies suggest, despite being within the same receptor family 
and activation by common mechanisms, though possibly they are activated under 
different conditions, PARs may have differential modulatory effect on cortical 
network activity such as epilepsy. Moreover, the potential underlying 
mechanisms for this differential regulation are unclear. In this regard, this 
chapter makes an initial attempt to assess the influence of both PAR-2 and PAR-1 
on epileptiform activity in vitro in the hope of gaining a better understanding of 
how PAR-2 and PAR-1 modulate cortical networks.  
Acute hippocampal slice preparations have been extensively utilised to develop 
a range of different in vitro pharmacology-based models of experimental 
epileptogenesis (Jefferys, 1994, 2003). These have been invaluable for 
investigating some of the mechanisms underlying the genesis and control of 
epilepsy-like behaviours in hippocampal circuits (Rutecki et al., 1985; Voskuyl & 
Albus, 1985; Tancredi et al., 1990). Epileptiform activity can be induced in acute 
hippocampal slices by changing the ion composition of the perfusate, or applying 
convulsant agents such as ion channel blockers or modulators of excitatory or 
inhibitory synaptic transmission. Two models of epileptiform activity used in the 
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current investigations were 1. application of 4-aminopyridine (4-AP)/ low 
magnesium perfusate and 2. application of bicuculline. Both models produce 
robust and stereotyped patterns of epileptiform activity (rhythmical 
synchronised field potentials) over long periods. 4-AP is a non-selective K+ 
channel blocker, which is used clinically in treating demyelinating disorders 
(Hayes, 2004; Judge & Bever, 2006) and used widely as an experimental tool in 
studying K+ channels (Storm, 1987; Lesage, 2003). It has also be used widely to 
produce epilepsy in vivo (Morales-Villagran et al., 1996; Pena et al., 2002) and 
epilepsy-like activities in acute hippocampal slices (Voskuyl & Albus, 1985; 
Roshan-Milani et al., 2003). At least two main factors contribute to 4-AP-induced 
epileptiform activity: firstly, by blocking K+ channels in soma-dendritic 
membrane in postsynaptic neurone to depolarise the cells and drive it closer to 
AP threshold (Roshan-Milani, 2004). Secondly, by blocking K+ channels in 
presynaptic axon terminals, 4-AP enhances neurotransmitter release by 
prolonging AP duration (Molgo et al., 1977). Omitting Mg2+ from the perfusate 
removes the voltage-dependent Mg2+ blockade of NMDA receptors, which in turn 
allows free Na+, Ca2+ and K+ to move through the channels in response to 
glutamate and subsequent hyperexcitability. A unique feature of 4-AP-induced 
epileptiform activity is that synchronisation of firings occurs despite normal even 
enhanced inhibitory inputs (Rutecki et al., 1987). In contrast, the GABAA 
receptor antagonist, bicuculline, produces eplileptiform activity in hippocampal 
slices by simple disinhibition of hippocampal microcircuits which then results in 
synchronised and unchecked firing of cells in area CA3 through recurrent 
excitatory collaterals. This enhancement is maintained by strengthening 
recurrent excitatory synapses among CA3 pyramidal neurones (plasticity) 
following disinhibition (Miles & Wong, 1983, 1987). As these two models induce 
in vitro epilepsy-like activities by either enhancing gross excitation (4-AP/low 
Mg2+) or depressing overt inhibition (bicuculline), their combination provides a 
unique approach to assess whether PAR-2 activation modulates epilepsy-like 
activities differentially through these two opposite mechanisms.  
To sum up, the specific aims of this chapter were to assess whether PAR-2 and 
PAR-1 exert any modulatory influence over pathological network activities under 
conditions where network excitation is enhanced (4-AP/0 Mg2+ model) or when 
synaptic inhibition is compromised (bicuculline model). 
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5.2 Characterisation of epileptiform activity in 4-AP/0 
Mg2+ model 
Extracellular recordings were obtained from the CA3 stratum pyramidale in 
hippocampal slices prepared from 16-24 days old Wistar rats. No detectable 
spontaneous field events were recorded during control period (drug free, normal 
ACSF) in all slices tested (n=33). Subsequent perfusion with 0 Mg2+ ACSF 
supplemented with 4-AP (100M) resulted in the gradual appearance of 
intermittent, large amplitude, rhythmical field events (see figure 5.1A, B). 
These intermittent events of short burst duration mirrored the inter-ictal-like 
activity described in previous reports (Avoli et al., 1993; Mattia et al., 1994; 
Roshan-Milani et al., 2003).  
Individual inter-ictal-like events (see figure 5.1C) comprised of (1) a large, fast 
negative deflection followed by (2) an initial fast and later slower positive 
potential, which overshot baseline to reach peak amplitude and then (3) a slow 
negative potential, some of which were nested by a high frequency oscillatory 
burst component (see figure 5.1). The application of 4-AP with 0 Mg2+ACSF 
resulted in the occurrence of inter-ictal-like events within 10-20 minutes. The 
instantaneous frequency of these events increased to eventually plateau at a 
stable and stereotyped discharge with a mean instantaneous frequency of 1.51 ± 
0.16Hz (n=33). The mean amplitude of these events was 2.03 ± 0.27mV 
(measured baseline to positive peak; n=33). However, the amplitude was rather 
variable and exquisitely sensitive to the precise placement of the recording 
electrode. Therefore, all subsequent analyses focused on the temporal domain 
rather and response amplitude.   
The occasional appearance of prolonged seizure-like discharges or ‘ictal-like’ 
events was observed only in a small minority of experiments (7 in 33 slices) (see 
figure 5.2). Because the occurrence of ictal-like activity was rare, inconsistent 
and irregular across this set of experiments, the following analysis of 
epileptiform activity focused on the inter-ictal-like activity. 
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Figure 5-1 4-AP/ 0 Mg2+-induced epileptiform activity in the CA3 area of acute hippocampal 
slices. 
A. Representative extracellular recording upon bath application of the 0 Mg2+ ACSF 
supplemented with convulsant compound, 4-AP (100M) as indicated by the solid bar. Note 
the appearance of rhythmical field events within 10 minutes of 4-AP/0 Mg2+ application. B. 
Expanded trace of the same recording shows intermittent and coherent inter-ictal-like 
events. C. Further expansion of trace to resolve the waveform of individual spontaneous 
field events show then to comprise of: (1) a fast negative potential followed by a (2) a series 
of fast positive potentials (extracellular action potential burst) followed by a (3)slow 
negative potential. 
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Figure 5-2 Examples of two types of 4-AP/0 Mg2+-induced epileptiform activity in the CA3 
area of acute hippocampal slices. 
A. Representative trace of intermittent regular inter-ictal-like activity (spontaneous field 
bursts) which was the most dominant form of epileptiform activity induced by 4-AP/0 Mg2+ 
application (seen in all 33 slices). B. Example of ictal-like discharge pattern which was 
observed (in addition to inter-ictal bursts) in 7 of 33 slices recorded. Note the prolonged 
burst discharge separated by periods of relative network quiescence. Note that the initial 
response resembles a burst-like response but activity is thereafter on terminated but shows 
a prolonged discharge pattern consistent with a breakdown of inhibition.  
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5.3 PAR-2 activation depresses the frequency of 4-AP/0 
Mg2+-induced epileptiform activities in acute 
hippocampal slices 
Sustained and regular inter-ictal-like activities were recorded in the CA3 cell 
body layer following the application of 0 Mg2+ ACSF supplemented with 4-AP 
(100M). 10 minutes baseline of inter-ictal-like activities with stable bursting 
frequency was required before 100M PAR-2-AP, SLIGRL, was applied through 
the perfusate. As presented in figure 5.3B, application of SLIGRL for 30 minutes 
significantly depressed the bursting frequency of inter-ictal-like activities from 
1.53 ± 0.21Hz to 1.18 ± 0.17Hz (n=13, P=0.0006). Individual experiment time 
plots revealed a gradual yet profound SLIGRL-induced depression of the bursting 
frequency with slow time course resembling that seen for the depression of 
evoked synaptic responses reported in chapter 4 (see figure 4.1), (normalised 
burst frequency, control: 100.98 ± 0.90%, drug: 80.46 ± 4.40%, n=13, P=0.0004, 
figure 5.3C). Furthermore, this depression of epileptiform burst frequency 
persisted following the washout of SLIGRL as was also seen with the synaptic 
depression experiments (chapter 4, see figure 4.1). In contrast, the application 
of negative control, 100M PAR-2-IP, LRGILS, for 30 minutes, did not lead to any 
significant change in 4-AP/0 Mg2+-induced bursting activities (control: 1.60 ± 
0.40Hz, drug:1.71 ± 0.40Hz, n=6, P=0.1721,figure 5.4B). This trend is also seen 
in the normalised pooled data sample as shown in (figure 5.4C, normalised burst 
frequency, control: 98.40 ± 2.46%, drug: 106.73 ± 6.14%, p=0.2043, n=6). 
Together, these data suggesting the depression of bursting frequency was indeed 
a specific action of PAR-2 activation. 
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Figure 5-3 PAR-2 activation reduces the frequency of 4-AP/0 Mg2+-induced epileptiform 
activity in the CA3 area of acute hippocampal slices. 
A. Representative traces (20080805/2) show the occurrence of inter-ictal-like activities 
during baseline period (upper trace) and after the PAR-2-AP, SLIGRL (100M) is applied 
(lower trace). Note the frequency of inter-ictal-like events is reduced upon SLIGRL 
application. B. Bar chart summarising quantitative analysis of instantaneous frequency 
before and during SLIGRL application (n=13, P=0.0006). C. Time plot of the same pooled 
experiments normalised to baseline frequency show the gradual but robust reduction of 
epileptiform burst frequency upon SLIGRL application (n=13, P=0.0004, measured at last 
minute of baseline and SLIGRL application).  
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Figure 5-4 The PAR-2-IP, LRGILS has no effect on the frequency of 4-AP/0 Mg2+-induced 
epileptiform activity in hippocampal area CA3. 
A. Representative traces (20080729/1) show the occurrence of inter-ictal-like activities 
during baseline period (upper trace) and after the PAR-2-IP, LRGILS (100M) is applied 
(lower trace). Note the absence of any detectable change in burst frequency upon LRGILS 
application. B. Bar chart summarising quantitative analysis of instantaneous frequency 
before and after LRGILS application (n=6, P=0.1721) C. Time plot showing no significant 
change in mean burst frequency over time as the LRGILS is applied (n=6, P=0.2043). 
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5.4 PAR-1 activation does not affect the frequency of 4-
AP/0 Mg2+-induced epileptiform activities in acute 
hippocampal slices 
In order to assess whether PAR-1 activation may have a modulatory role on 4-
AP/0 Mg2+-induced epileptiform activities, extracellular recording was repeated 
in the CA3 stratum pyramidale in acute hippocampal slices. 10 minutes stable 
inter-ictal-like bursting activities was monitored before 100M PAR-1-AP, TFLLR, 
was applied. As shown in figure 5.5B, no detectable change in bursting frequency 
was observed following TFLLR application (control: 1.10 ± 0.13Hz, drug: 1.14 ± 
0.11Hz, n=13, P=0.3730). Time plot analysis confirmed the same observation 
(normalised burst frequency: control: 101.65 ± 1.19%, drug: 104.30 ± 3.52%, 
n=13, P=0.3781, figure 5.5C). Overall, this experiment using the selective 
activator of PAR-1 did not modulate the frequency of 4-AP/0 Mg2+-induced 
epileptiform bursting. 
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Figure 5-5 The PAR-1-IP, TFLLR, has no effect on the frequency of 4-AP/0 Mg2+-induced 
epileptiform activity in hippocampal area CA3. 
A. Representative traces (20080819/1) show the occurrence of inter-ictal-like activities 
during baseline period (upper trace) and after the PAR-1-IP, TFLLR (100M) is applied (lower 
trace). Note the absence of any detectable change in burst frequency upon TFLLR 
application. B. Bar chart summarising quantitative analysis of instantaneous frequency 
before and after TFLLR application (n=13, P=0.373) C. Time plot showing no significant 
change in mean burst frequency over time as TFLLR is applied (n=13, P=0.378). 
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5.5 Characterisation of epileptiform activity in bicuculline 
model 
Extracellular recordings were obtained from the CA3 stratum pyramidale in 
hippocampal slices prepared from 16-24 days old Wistar rats. No detectable 
spontaneous field events were recorded during control period (drug free, normal 
ACSF) in all slices tested (n=10). Subsequent disinhibition by the bath application 
of GABAA receptor antagonist, bicuculline (20M), resulted in a gradual 
appearance of intermittent rhythmical field events. These inter-ictal-like events 
occurred every 9.7±1.1s (n=10) and were 100 times less frequent compared to 
those observed in 4-AP/0 Mg2+ model (interevent interval: 0.10 ± 0.01s for 4-
AP/0 Mg2+ model, n=33, 9.7 ± 1.1s for bicuculline model, n=10). 
Bicuculline-induced inter-ictal-like events observed (shown in figure 5.6) were 
different in waveform from those seen in 4-AP/0 Mg2+ model. They were 
typically characterised by a primary large inter-ictal-like event with triphasic 
waveform: (1) a fast negative deflection followed by (2) a fast positive 
deflection which overshot baseline to reach peak amplitude (3) slow negative 
decay phase. This was followed by another burst or a train of repetitive smaller 
and shorter bursts. Bicuculline-induced epileptiform events occurred with a 
mean instantaneous frequency of 0.40 ± 0.27Hz (n=10) and the mean peak 
amplitude (measured from baseline to positive peak) of these events was 2.56 ± 
0.43mV. (n=10). 
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Figure 5-6 Bicuculline-induced epileptiform activity in the CA3 area of acute hippocampal 
slices. 
A. Representative extracellular recording upon bath application of the GABAA receptor 
antagonist bicuculline (20M) as indicated by the solid bar. Note the appearance of 
rhythmical field events within 10 minutes of bicuculline application. B. Expanded trace of 
the same recording shows intermittent and coherent inter-ictal-like events. C. Further 
expansion of trace to resolve the waveform of individual spontaneous field events show 
then to comprise of: (1) a fast negative potential followed by a (2) a series of fast positive 
potentials (extracellular action potential burst) on top on a (3)slow negative potential. 
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5.6 Both PAR-2 and PAR-1 activation have no effect on 
the frequency or occurrence of bicuculline-induced 
epileptiform activities in hippocampal slices  
Once sustained and regular inter-ictal-like activities were recorded from the CA3 
cell body layer following the application of 20M bicuculline, 10 minutes 
baseline of inter-ictal-like activities with stable bursting frequency was recorded 
as control period before either the PAR-2-AP (SLIGRL, 100M) or the PAR-1-AP 
(TFLLR, 100M) was applied through the perfusate. Application of SLIGRL or 
TFLLR for 30 minutes induced no significant or detectable change in the 
frequency of inter-ictal-like activities (0.14 ± 0.03Hz to 0.13 ± 0.03Hz, n=6, 
P=0.5282, figure 5.7B for PAR2-AP) (0.13 ± 0.02Hz to 0.13 ± 0.02Hz, n=4, 
P=0.9893, figure 5.8B for PAR1-AP) respectively. Time plot summary confirmed 
the absence of any detectable drug effect over the period of drug application 
(normalised burst frequency, PAR-2-AP: from 98.01 ± 3.21% to 99.85 ± 4.60%, 
n=6, P=0.6043, figure 5.7C; PAR-1-AP: from 96.59 ± 0.35% to 89.28 ± 8.73 n=4, 
P=0.5385, figure 5.8C). These data suggest PAR-2 and PAR-1 activation had no 
modulatory influences on bicuculline-induced epileptiform activities, at lease in 
terms of overt changes in burst frequency. 
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Figure 5-7 The PAR-2-AP, SLIGRL, has no effect on the frequency of bicuculline-induced 
epileptiform activity in hippocampal area CA3. 
A. Representative traces (20080812/1) show the occurrence of inter-ictal-like activities 
during baseline period (upper trace) and after the PAR-2-AP, SLIGRL (100M) is applied 
(lower trace). Note the absence of any detectable change in burst frequency upon SLIGRL 
application. Stippled indicated matching of traces indicative of no change in burst 
frequency. B. Bar chart summarising quantitative analysis of instantaneous frequency 
before and after SLIGRL application (n=6, P=0.5281) C. Time plot showing no significant 
change in mean burst frequency over time as the SLIGRL is applied (n=6, P=0.604). 
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Figure 5-8 The PAR-1-AP, TFLLR has no effect on the frequency of bicuculline-induced 
epileptiform activity in hippocampal area CA3. 
A. Representative traces (20081017/1) show the occurrence of inter-ictal-like activities 
during baseline period (upper trace) and after the PAR-1-AP, TFLLR (100M) is applied 
(lower trace). Note the absence of any detectable change in burst frequency upon TFLLR 
application. Stippled indicated matching of traces indicative of no change in burst 
frequency. B. Bar chart summarising quantitative analysis of instantaneous frequency 
before and after TFLLR application (n=4, P=0.989) C. Time plot showing no significant 
change in mean burst frequency over time as the TFLLR is applied (n=4, P=0.539). 
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5.7 Discussion 
In this chapter, I demonstrated, for the first time, that activation of PAR-2 
significantly depresses the frequency of epileptiform activities induced by 4-
AP/0 Mg2+ in acute hippocampal slices, suggesting that PAR-2 activation exerts 
an anti-epileptic effect in the 4-AP/0 Mg2+-induced epilepsy model. In contrast, 
PAR-1 activation is ineffective. Furthermore, neither PAR-2 nor PAR-1 activation 
changes the frequency of epileptiform activities induced by bicuculline.  
 
In this chapter, I first demonstrate that PAR-2 activation depresses the 
frequency of epileptiform activities in 4-AP/0 Mg2+ induced epilepsy (see figure 
5.3). This result is in agreement with previous report that PAR-2 activation is 
protective against seizure in vivo (Lohman et al., 2008). Considering the fact 
that enhanced excitatory input in the network is the main driving force to the 
epileptogenesis in 4-AP/0 Mg2+-induced epileptiform activities in slices, the 
observed depression of epileptiform activities may reflect the nature that PAR-2 
activation reduces excitatory synaptic transmission, which has been 
demonstrated in chapter 3, and 4 (see figure 3.17,3.19 and 4.1). Therefore, one 
rational interpretation based on this result is PAR-2 activation weakens 
excitatory synaptic transmission, which in turn reduces excitatory driving force, 
and thus depresses the frequency of epileptiform activity in 4-AP/0 Mg2+ model. 
In stark contrast, PAR-2 activation has no detectable effect on the frequency of 
bursting in bicuculline-induced epileptiform activities. This inconsistency may be 
explained by considering the mechanism underlying bicuculline-induced 
epileptiform activity. In this model, epileptiform activity is induced as a result 
of the collapsed balance of excitation and inhibition due to silenced inhibition by 
GABAA receptor blockade. Thus, as the disinhibition dominates the driving force 
for epileptogenesis in bicuculline model, a modest reduction of excitatory input 
as expected from PAR-2 activation (about 20%, see figure 5.3 and figure 4.1) may 
not be able to compensate the gross loss of inhibition. Therefore, no observable 
effect by PAR-2 activation could be rationalised.  
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It is surprising to notice in this chapter that PAR-1 activation has no detectable 
effect on the frequency of epileptiform activity in either 4-AP/Mg2+ or 
bicuculline model. Although this observation is consistent with the results 
reported in Chapter 4 (see figure 4.5) that PAR-1-AP, TFFLR (100M) has no 
detectable effect on synaptic transmission at the Schaffer collateral-to-CA1 
synapse, it is, at first glance, inconsistent with the previous report that PAR-1 
activation facilitates epileptogenesis in hippocampal slices (Maggio et al., 2008).  
This disagreement could be reconciled by the following consideration. Maggio 
and co-workers investigated the frequency of spontaneous spikes under normal 
saline solution and the threshold of seizures by elevating extracellular K+ 
concentration (Maggio et al., 2008). Therefore, the interpretation from their 
results is PAR-1 may facilitate the occurrence of epileptiform activity. However, 
in their report, it remains void that whether PAR-1 modulates the epileptiform 
activity once it is established. My result, on the other hand, suggests PAR-1 has 
no regulatory role after the establishment of epileptiform activity. To conclude, 
PAR-1 activation may facilitate epileptogenesis, but it may not have modulatory 
role in established epilepsy. 
Taken together, in chapter 5, I demonstrate that PAR-2 may suppress 
epileptiform activities in the area of CA3 in acute hippocampal slices due to 
heightened excitation but does not regulate epileptiform activities as a result of 
disinhibition of hippocampal circuits.  
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6 General discussion 
The main purpose of this thesis was to investigate whether activation of PAR-2 in 
the hippocampus under non-diseased conditions modulates neuronal intrinsic 
properties, synaptic transmission and plasticity as well as network activities. The 
central hypothesis of this investigation was that PAR-2, by its unique activation 
mechanism, may serve as ‘molecular switch’ in tuning neuronal signalling in the 
hippocampus, a brain structure important in aspects of learning and memory. It 
was hoped that by examining neuronal excitability and synaptic transmission in 
primary hippocampal culture and acute hippocampal slice preparations, such in 
vitro investigations would provide valuable insights about the action of PAR-2 
activation in the cells of the CNS. It was hoped that these experiments might 
ultimately provide experimental evidence to whether PAR-2 is a plausible 
candidate for therapeutic interventions. Thus, in the final chapter, I will firstly 
summarise the major findings of this investigation with highlighted novel 
discoveries. Then, I will discuss the significance of this investigation, in 
particular in relation to established knowledge of PARs in the CNS as well as 
modulators of neural transmission and plasticity. Furthermore, I will reflect the 
limitations of this project in terms of methodology, data interpretation, and 
completeness. Finally, I will make suggestions to directions that future studies 
could take based on my current data. 
6.1 Major findings 
The major findings reported in the thesis are the following: 
Firstly, from primary hippocampal culture experiments 
1. Trypsin depolarises cultured hippocampal neurones and increases the 
occurrence of spontaneous APs. 
2. Spontaneous APs are synaptically driven in nature. 
3. The PAR-2-AP (SLIGRL) but not PAR-2-IP (LRGILS) depolarises cultured 
hippocampal neurones and depresses spontaneous occurring APs. 
4. The PAR-1-AP (TFLLR) and PAR-4-AP (AYPGKF) depolarises cultured 
hippocampal neurones. However, neither PAR-1-AP nor PAR-4-AP 
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significantly changes the frequency of spontaneous AP firings. 
5. SLIGRL-induced neuronal depolarisation is dependent on glutamate. 
6. SLIGRL-induced neuronal depolarisation requires normal astrocytic 
function. 
7. Astrocytic-neuronal signalling contributes to SLIGRL-induced depression 
of spontaneous AP firing. 
 
Secondly, from acute hippocampal slice experiments 
 
1. Two independent PAR-2-APs, SLIGRL and 2f-LIGRL, but not the PAR-2-IP 
(LRGILS) induce LTD of glutamatergic synaptic transmission at the 
Schaffer collateral-to-CA1 synapse. 
2. mGluRs are not required in the induction of PAR-2 activation-induced LTD 
3. PAR-2 activation-induced LTD is dependent on NR2B subunit-containing 
NMDA receptors 
4. Glial-neuronal signalling contributes to PAR-2-mediated LTD. 
5. The PAR-1-AP (TFLLR) has no effect on basal glutamatergic synaptic 
transmission at the Schaffer collateral-to-CA1 synapse. 
 
Finally, from pilot study investigating PAR-1 and PAR-2 actions in in vitro 
models of epilepsy 
 
1. The PAR-2-AP (SLIGRL) but not the PAR-2-IP (LRGILS) depresses the 
frequency of 4-AP/0 Mg2+-induced epileptiform activity in the CA3 of 
acute rat hippocampal slices. 
2. The PAR-1-AP (TFLLR) has no effect on the frequency of 4-AP/0 Mg2+-
induced epileptiform activity in the CA3 of acute hippocampal slices. 
3. Neither PAR-2-AP (SLIGRL) nor PAR-1-AP (TFLLR) has any effect on the 
frequency of bicuculline-induced epileptiform events in the area CA3 of 
acute rat hippocampal slices. 
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6.1.1 PAR-2-mediated neuronal depolarisation in hippocampal 
culture 
In my thesis, firstly, I demonstrate that activation of PAR-2 leads to membrane 
depolarisation of cultured hippocampal neurones. To my knowledge, this is the 
first report that a member of PAR family modulates the excitability (membrane 
potential) of a central neurone. However, the data is nevertheless consistant 
with previous studies showing PAR-2 activation to depolarise membrane of 
submucosal neurones (Reed et al., 2003), colonic DRG neurones (Kayssi et al., 
2007) in the digestive tract as well as nociceptive DRG neurones (Amadesi et al., 
2004) in the spinal cord, in response to 50 to 100M PAR-2-AP, SLIGRL, 
application. In addition, the average magnitude of depolarisation reported in 
these studies is all in the range between 5 to 10mV (from normal resting 
conditions), which is comparable to that I observe in my preparation. Thus, my 
result reported here is in agreement with previous observations in other 
neuronal types. Furthermore, considering PAR-2-mediated neuronal 
depolarisation is independently verified in four neuronal types in three systems 
(submucosal neurones, colonic DRG neurones in the digesting tract, nociceptive 
DRG neurones in the spinal cord, and hippocampal neurones in the brain), it is 
suggesting that the modulation of neuronal excitability is perhaps a common 
regulatory role that PAR-2 plays in tuning neuronal function. However, it is also 
noticed that the proposed mechanism underlying neuronal depolarisation 
mediated by PAR-2 activation in all four types of neurones may not be the same. 
Reed and co-workers showed the depolarisation observed in submucosal 
neurones were associated with an increase of input resistant of the recorded 
neurone (Reed et al., 2003), and this association was also apparent when colonic 
DRG neurones were tested (Kayssi et al., 2007). In the later study, it was 
demonstrated that PAR-2-mediated depolarisation together with the increase of 
input resistance was due the blockade of delayed rectifier K+ channels (Kayssi et 
al., 2007), arguing a direct channel-modulating effect by the activation of 
neuronal PAR-2. In contrast, my results suggest PAR-2-mediated neuronal 
depolarisation in the cultured hippocampal neurones is dependent on glutamate 
release from nearby astrocytes, favouring an indirect effect from the activation 
of astrocytic PAR-2. Indeed the phenomena that gliotransmitters release, 
including glutamate, in response to GPCR activation on glial cells is very well 
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established (see Chapter 1.8). Notably, several recent publications reported that 
PAR-1, another member of PAR family, produced neuronal activity (enhancing 
neuronal NMDA receptor mediated component of mEPSCs (Lee et al., 2007), 
eliciting NMDA receptor mediated SIC (Shigetomi et al., 2008), and evoking Ca2+ 
signal in neurones from the nucleus of the solitary tract (Hermann et al., 2009) 
respectively) through its activation on astrocytes in diverse experimental 
preparations, including hippocampal culture as well as hippocampal and 
medullary slice preparations. Thus, in terms of the mechanism underlying PAR-2-
mediated neuronal depolarisation, my result is in agreement with the previously 
established astrocytic PAR-1-to neurone pathway. However, regarding 
neuroexcitability, it has to be acknowledged that the possibility that a direct 
influence on neuronal ion channels following neuronal or/and astrocytic PAR-2 
activation, which is not examined in the current study, has to be considered. 
Ca2+ imaging experiments have demonstrated a small yet significant rise of 
intracellular Ca2+ upon SLIGRL application in the cultured hippocampal neurones 
(Dr. Sam Greenwood, unpublished data), suggesting a possible modulation of 
channels whose activation may need the Ca2+ signal, for instance the Ca2+-
activated K+ channels.  
Therefore, taking all these considerations into account, it is reasonable to make 
a general suggestion that neuronal depolarisation is maybe a common feature of 
PAR-2-mediated modulation of neuronal excitability. But at lease two 
independent or overlapping mechanisms could underlie this, either a direct 
effect of neuronal PAR-2 activation (via ion channels) or/and an indirect effect 
of astrocytic PAR-2 activation (via glutamate receptors).  
6.1.2 PAR-2-mediated depression of the frequency of 
spontaneous firings 
Another novel finding from my thesis is that in the cultured hippocampal 
neurones, a transient modest depolarisation is associated with paradoxically 
reduction of AP firing frequency upon PAR-2 activation (see figure 3.6). This 
observation is unusual because a membrane depolarisation normally results in 
increased excitability, therefore facilitating the occurrence of APs. Thus, in 
order to address the mechanism underlying this paradox. I first demonstrate that 
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the AP firing is largely dependent on glutamatergic synaptic transmission 
because a cocktail of glutamate receptor antagonists totally prevents the 
generation of APs (see figure 3.17). Secondly, I confirm the recorded neurone 
receives a constant barrage of EPSPs, many of which are suprathreshold for the 
generation of APs (see figure 3.3). Moreover, within closer inspection, I show the 
frequency of sub-threshold EPSPs are significantly reduced following PAR-2 
activation (see figure 3.19). Thirdly, when somatic current injection is applied to 
depolarise neuronal membrane from -65mV to -60mV, the magnitude similar to 
that seen upon PAR-2 activation, a predictable and significant increase of APs is 
observed (see figure 3.18). Taken together, these data from my thesis, although 
indirect, suggest the occurrence of APs in the cultured hippocampal neurone is 
largely not intrinsic, but synaptically driven. Therefore, the reduction of 
spontaneous AP firings may be as a result of significant reduction of 
glutamatergic synaptic transmission onto the recorded cell. To combine the 
observed depolarisation data, this paradox that depolarisation associated with a 
reduction of AP firings could be rationalised by dissecting this simultaneously 
occurring event by separate mechanisms. That is PAR-2-mediated neuronal 
depolarisation is due to astrocytic release of glutamate, whereby, at the same 
time, PAR-2 activation depresses glutamatergic synaptic transmission in the 
network formed within the cultured hippocampal neurones.  
 
The precise mechanisms underlying the PAR-2-mediated depression of 
glutamatergic synaptic transmission in the cultures was not established in 
unequivocal terms during the course of this thesis. Nevertheless, my data in 
Chapter 3 again favours an indirect action of PAR-2 activation whereby 
glutamate of astrocytic origin results in the suppression of fast glutamatergic 
synaptic transmission. Consistent with this, glutamate released from astrocytes 
have been demonstrated to depress excitatory synaptic transmission in 
hippocampal culture following activation by a number of other G-protein 
coupled receptors including presynaptic MAP-4 sensitive group III mGluRs 
(Araque et al., 1998). Group I (Gereau & Conn, 1995) and group II mGluRs 
(Bushell et al., 1996) can also be potential candidates as their involvement have 
been confirmed depending on types of synapses, animal age and species. Thus, it 
is of special interest to examine if presynaptic mGluRs are contributing to this 
PAR-2-mediated synaptic depression in culture using selective mGluR antagonists. 
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Moreover, as the rise of intracellular Ca2+ is confirmed in astrocytes in our 
primary hippocampal culture in response to PAR-2 activation (unpublished data 
by Dr. Sam Greenwood), it is reasonable to expect that gliotransmitters, 
including glutamate, could be released upon astrocytic PAR-2 activation. 
Therefore, the depression of synaptic transmission in the culture system could 
be as a result of other molecules. One potentially plausible candidate would be 
astrocytically released ATP. Recent studies demonstrated that ATP released 
from astrocytes induces synaptic depression in cultured hippocampal neurones 
via presynaptic purinergic receptors (Koizumi et al., 2003; Zhang et al., 2003). 
Thus, it would be interesting to employ purinergic antagonists to examine the 
consequence of the frequency of spontaneous APs and EPSPs in the culture 
system upon application of PAR-2-AP. 
 
Although all my results support the explanation that a reduction of 
glutamatergic synaptic transmission leads to the depression of the frequency of 
synaptcally driven APs, alternative mechanisms for the reduction of spontaneous 
AP firings upon PAR-2 activation may still exist in parallel because the proposed 
mechanism with reduced glutamatergic synaptic transmission may not be the 
sole contributing factor. One possibility is perhaps the direct modulation of ion 
channel conductances, most likely enhanced potassium conductances via 
activation of Ca2+-activated potassium channels, and perhaps decreased Ca2+ 
conductances.  It has been demonstrated that PAR-2 activation could modulate 
membrane channels (Kayssi et al., 2007). In order to test this hypothesis, one 
may have to first inspect the input resistance of the recorded neurone before 
and after the application of PAR-2-AP, SLIGRL.  
 
6.1.3 PAR-2-mediated long term depression 
In the acute slice preparation, I demonstrate for the first time that the 
application of PAR-2-AP induces a long lasting depression of glutamatergic 
synaptic transmission at the Schaffer collateral-to-CA1 synapse. This PAR-2- 
mediated depression of glutamatergic synaptic transmission seen in acute slices 
is consistent with my interpretation in chaper 3 that PAR-2 activation depresses 
glutamatergic synaptic transmission in the cultured hippocampal neurones as 
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demonstrated by the reduction of synaptically-driven APs upon PAR-2-AP 
application (see figure 3.6,17,18 and 19.). However, it is also noticed that the 
timecourse of PAR-2-induced synaptic depression is different under these two 
experimental conditions. In the cultured system, the PAR-2-mediated depression 
of synaptic transmission is rather transient as the frequency of synaptically-
driven APs return to control level after 5 minutes PAR-2-AP perfusion (see figure 
3.6), whereas, in acute slices, PAP-2-AP produced a relatively long term 
depression (up to 30mins) and this depression is not reversible upon washout 
PAR-2-AP. This timecourse difference may be explained by the fact that the 
cultured neurones have much less exposure time to PAR-2-AP (5mins) compared 
to neurones in slices (30mins). If this was the case, this might suggest that a 
short time exposure to PAR-2 activation leads to transient synaptic depression, 
whereas long term exposure gives rise to long lasting effect. However, this 
timecourse difference in two systems may also suggest there could be two 
independent mechanisms underlying short term modulation and long term 
modulation of basal synaptic transmission by PAR-2 activation, which would 
require perhaps differential signalling pathways and molecules. But nevertheless, 
a depression of glutamatergic synaptic transmission is observed in both culture 
and slice preparations. A recent publication demonstrated that certain serine 
proteinases are capable of inducing LTD at the Schafer collateral-to-CA1 synapse 
(MacGregor et al., 2007). Considering PAR-2 is very likely endogenously 
activated by proteinases, it is of interest to speculate that PAR-2 might be 
activated tonically by the endogenous ligand and that this enduring action might 
indeed be able to modulate basal excitatory synaptic transmission in vivo, which 
would provide a novel target for pharmacological and therapeutic intervention. 
In addition, it is also acknowledged that in this study, only the Shaffer 
collateral-to-CA1 synapse is investigated. However, whether this PAR-2-induced 
long lasting synaptic depression is universal to all excitatory synapses in the 
hippocampus is unkonwn. Furthermore, it would be also interesting to know 
whether PAR-2 activation modulate inhibitory synapses.  
It is noticed in the slice preparation that the PAR-2-mediated long lasting 
synaptic depression is irreversible. After ruling out that the irreversibility is due 
to the deterioration of slice quality in the process of these experiments (see 
figure 4.1, and figure 4.2), this feature may indicate that PAR-2-mediated LTD 
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could persist even without the ligand binding. In terms of mechanisms underlying 
this phenomenon, it might be plausible to firstly consider possible postsynaptic 
modifications associated with this form of LTD once established via PAR-2 
activation, because the magnitude of paired-pulse ratio alteration upon PAR-2-
AP application, though statistically significant, is relatively very modest (see 
figure 4.6). Thus, immediate speculations would include, for instance, a reduced 
number of functioning postsynaptic iontropic glutamate receptors. Because 
AMPA receptor internalisation has been widely proposed as the cellular response 
upon the expression of different forms of LTD (Malinow & Malenka, 2002; Kessels 
& Malinow, 2009), it may be of interest to compare the membrane expression 
level of AMPA receptors during normal synaptic transmission and the PAR-2-
mediated LTD. Another aspect consider would be a possible modulation of 
shapes and numbers of postsynaptic spines following PAR-2 activation because 
structural plasticity, which associates with different forms of synaptic plasticity 
including LTD, has been manifested by the dynamics of spines (Bourne & Harris, 
2008; De Roo et al., 2008; Bhatt et al., 2009; Yang & Zhou, 2009) and this has 
not yet been investigated in the PAR-2 knockout mouse.  
Finally, a question emerged from the PAR-2-mediated LTD is whether it is 
functionally physiological or pathophysiological. It has been recently 
demonstrated in our group that PAR-2 activation is neuroprotective in slice 
culture preparations (Greenwood & Bushell, 2010). My data in Chapter 4 may 
support this hypothesis from a synaptic aspect that a reduced excitatory synaptic 
transmission upon PAR-2 activation might be beneficial in nature for certain 
pathological conditions, for instance, in ischaemia and epilepsy. It has been 
widely documented that the penumbra surrounding stroke regions show aberrant 
plasticity (Calabresi et al., 2003; Di Filippo et al., 2008) and it is possible that 
this is accounted for by region experiencing PAR-2 activation as an upregulation 
of PAR-2 expression in neurones has been recorded in a mouse model of 
ischaemia (Jin et al., 2005). Furthermore, during these insults, the gross 
excitability in the neural network increases due to a pathologically increased 
glutamate level, and it has been confirmed excessive excitability is harmful to 
neurones and synapses (Arundine & Tymianski, 2004; Greenwood & Connolly, 
2007). Therefore, it seems logical that PAR-2 activation reduces global 
excitability by depressing excitatory synaptic transmission in the synapses as 
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well as network (see Chapter 5), which in turn protects the functionality of the 
synaptic signalling within the network. Furthermore, as PAR-2 might be 
activated endogenously, this mechanism could be utilised to provide tonic 
inhibiting force for the synapses against trauma-induced hyperexcitability insults. 
6.1.4 Glial involvement in the PAR-2-mediated modulation of 
neuronal signalling 
In my thesis, the involvement of glial function has been strongly indicated by 
experimental data from both primary culture and acute slice preparations. This 
consistency may suggest glial cells are indeed underlying the PAR-2-mediated 
modulation of neuroexcitability and synaptic transmission. In the culture 
experiments, my data strongly suggest that astrocytically released glutamate is 
causing membrane depolarisation and at least is contributing to the depression 
of spontaneous APs in neurones (see Chapter 3). In the acute slice experiments, 
normal glial function is at least partially contributing to the PAR-2-mediated LTD 
(see Chapter 4). However, it has to be acknowledged that this hypothesis suffers 
significantly due to the lack of direct evidence of astrocytically released 
gliotransmitters, most notably, glutamate. Without a direct measurement of 
glutamate, or perhaps other gliotransmitters, released from astrocytes, the 
basic conclusion that astrocytically released glutamate is contributing to the 
PAR-2-mediated modulation is only suggestive. Initial screen of astrocytic 
release of glutamate has been conducted in primary culture but the sensitivity of 
this assay was not optimal (unpublished observations, Dr. Sam Greenwood). 
However, several approaches are available to address this question, for instance 
the high-pressure liquid chromatography (HPLC) analysis, radioactive labelled 
glutamate assay, and perhaps ‘sniffer-patch’ technique (Allen, 1997). 
Nevertheless, several indirect but independent evidences from both culture and 
acute slice preparations (see figure 3.14, 3.15, 3.20, 4.13) point to a role of glial 
cells actively contributing to the PAR-2-mediated modulation.   
6.2 Significance of this study 
The importance of this investigation is outlined as following key points. 
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1. My thesis provides first evidence to address what is the physiological function 
of PAR-2 in the CNS at single neurone and synaptic levels, which is urgently 
needed as biochemical studies of PAR-2 in the CNS are already abundant. 
2. My thesis reveals a novel form of chemically-induced LTD which is NR2B 
subunit-containing NMDA receptor dependent. 
3. My thesis provides evidence for a potentially unique new form of synaptic 
modulation which might be endogenously activated upon enzymatic 
activation of PAR-2 to act as tonic suppressor for excitatory synaptic 
transmission.  
4. By studying the mechanisms underlying the modulatory role of PAR-2 in 
neuronal signalling, my thesis strongly suggests the functional importance of 
glial cells which provide key molecules to regulate neuronal excitability and 
synaptic transmission.   
 
6.3 Technical considerations 
From the aspect of methodology, the major disadvantage of this study is the 
concern over the selectivity of pharmacological manipulations. As discussed in 
the introduction, the selectivity of the PAR-2-AP, SLIGRL, when applied at a 
relatively high concentration at 100M, is the first consideration. Because at this 
concentration (100M), SLIGRL has been demonstrated to elicit the maximal 
responses in different cell types and tissue preparations (al-Ani et al., 1995; 
Saifeddine et al., 1996; Kawabata et al., 2004) as its EC50 is approximately 5M 
in rat aortic ring preparation and in rat gastric longitudinal muscle preparations 
respectively (al-Ani et al., 1995; Saifeddine et al., 1996). In order to minimise 
the potential ‘off-target’ effect at this high concentration, I carefully employed 
the ‘control peptide’, PAR-2-IP, LRGILS at same concentration of 100M, as 
vehicle control. Furthermore, I utilised PAR-2-AP from different sources to avoid 
potential ‘false positive’ responses due to purity or different solvents employed 
in the production process. Finally, in the slice preparation, I utilised a new PAR-
2-AP, 2f-LIGRL, whose potency relative to SLIGRL is approximately 10,20 and 100 
as determined by the Ca2+ singnalling assay in cell line, the vasorelaxation assay 
in rat superior mesenteric artery and the in vivo salivation assay in mice 
(Kawabata et al., 2004; Kawabata et al., 2005), to independently confirm the 
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observed phenomenon. However, it is acknowledged that all these 
considerations are in the aspect of pharmacological manipulation. In order to 
make firm conclusions, one might need to repeat the whole experiments 
employing the PAR-2 knockout mouse (Ferrell et al., 2003) (discussed further in 
6.4). 
Additional consideration is the employment of the glial cell metabolism inhibitor, 
FAc. Although it has been confirmed to selectively block the Krebs circle enzyme , 
aconitase (Fonnum et al., 1997), and it has been extensively used to depress 
glial functions in both culture and acute slice preparations in a variety of studies 
(Swanson & Graham, 1994; Zhang et al., 2003; Gordon et al., 2005; Shigetomi et 
al., 2008; Henneberger et al., 2010), the selectivity towards glial cells are still 
debated (unpublished communications during peer-review). In order to overcome 
this disadvantage, one may have to repeat culture experiments using a pure 
neuronal culture preparation (Bushell et al., 1999; Zhang et al., 2003). However, 
preliminary experiments suggest that this approach may be problematic as the 
procedure still results in a residual glial component in the culture. In the acute 
slice preparations, one may have to perform experiments using transgenic mouse 
whose glial cells are genetically silenced (Fiacco et al., 2007; Petravicz et al., 
2008; Agulhon et al., 2010). Alternatively, one might be able to locally inhibit 
astrocytes by loading Ca2+ chelator BAPTA into visually identified astrocytes 
(Shigetomi et al., 2008).  
6.4 Future studies 
The studies detailed in this thesis has opened the window for a full investigation 
of PARs involvement in modulating neuronal as well as synaptic properties with a 
detailed characterisation of underlying mechanisms. These pioneering 
experiments have laid the groundwork for future more detailed studies. Several 
further experiments needed urgently emerged from this thesis have been 
indicated in previous discussion. Here are a few unresolved questions may be 
worth further efforts: 
1. Is it possible to provide unequivocal evidence for the modulation of 
neurones/synaptic transmission by PAR-2 activation? Strategies to address 
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this would be the development of new more selective peptide and non-
peptide ligands. Especially, the development of potent PAR-2 antagonist is 
urgently required, which is currently lacking. Additionally, several 
experiments could be repeated in the PAR-2 knockout mouse preparations. 
These would require repeating whole cell recordings from hippocampal 
culture prepared from PAR-2 knockout mouse and its wildtype littermate. It 
is expected to observe similar membrane depolarisation/reduction of 
spontaneous APs in the cultured neurones upon SLIGRL application from the 
wildtype littermate but not from the PAR-2 knockout mouse. Subsequently, it 
would be a strong evidence to demonstrate that there is comparable LTD at 
the Schafer collateral-to-CA1 synapses upon SLIGRL application in the acute 
slices prepared from wildtype littermate but not from PAR-2 knockout mouse.  
2. Does PAR-2 receptor modulate all excitatory synapses in the hippocampus? Is 
there synapse-specific differences? Further field recording experiments will 
perhaps look at other major synapses such as mossy fibre-to-CA3 synapses 
and perforant path-to-granule cell synapses.  
 
3. Does PAR-2 activation modulate inhibitory synapses? Whole cell recording 
could be used to examine evoked pharmacologically isolated IPSCs at CA1 
pyramidal neuones to start with. 
 
4. In order to have single cell resolution of PAR-2-mediated modulation of 
neuronal intrinsic properties and synaptic transmission in situ, the following 
experiments would be interesting to consider: Whole-cell patch clamp 
recordings using intracellular solution supplemented with biocytin in acute 
slices prepared from PAR-2 knockout mouse and its littermate control to 
characterise: 
a. The cell type of recorded neurones following morphological 
reconstruction. 
b. Basic intrinsic properties of each neurone including current-voltage 
relationship, input resistance, maximal firing frequency, ‘Sag’, etc., 
before and following the application of PAR-2-AP. 
c. Evoked EPSCs upon long term application of PAR-2-AP to have better 
resolution of the PAR-2-mediated LTD with possible pre and post synaptic 
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manipulation to distinguish pre or post synaptic mechanism. 
 
In summary, it is clear that the current investigation has opened up a new area 
of research that PAR-2 has an overt action on central neurones and synapses. 
Clearly, this research has laid a strong foundation for a number of other 
important questions which will need to be resolved in the coming years if we are 
to understand fully the role and significance of PAR-2 actions in the physiology 
and diseases in the brain and indeed where there are potential therapeutic 
applications.
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